Background  ||| S:24 E:43 ||| NNP
Mammalian  ||| S:43 E:53 ||| NNP
protein  ||| S:53 E:61 ||| NN
phosphatase  ||| S:61 E:73 ||| VBD
5  ||| S:73 E:75 ||| CD
( ||| S:75 E:76 ||| -LRB-
PP5 ||| S:76 E:79 ||| NNP
)  ||| S:79 E:81 ||| -RRB-
and  ||| S:81 E:85 ||| CC
its  ||| S:85 E:89 ||| PRP$
homolog  ||| S:89 E:105 ||| FW
protein  ||| S:105 E:113 ||| FW
phosphatase  ||| S:113 E:125 ||| FW
T1  ||| S:125 E:128 ||| FW
( ||| S:128 E:129 ||| -LRB-
Ppt1p ||| S:129 E:134 ||| NNP
)  ||| S:134 E:136 ||| -RRB-
from  ||| S:136 E:141 ||| IN
the  ||| S:141 E:145 ||| DT
yeast  ||| S:145 E:160 ||| NN
Saccharomyces  ||| S:160 E:174 ||| NNP
cerevisiae  ||| S:174 E:185 ||| NNS
contain  ||| S:185 E:193 ||| VBP
a  ||| S:193 E:203 ||| DT
catalytic  ||| S:203 E:213 ||| JJ
domain  ||| S:213 E:220 ||| NN
structurally  ||| S:220 E:233 ||| RB
related  ||| S:233 E:241 ||| VBN
to  ||| S:241 E:244 ||| TO
the  ||| S:244 E:248 ||| DT
catalytic  ||| S:248 E:266 ||| JJ
subunits  ||| S:266 E:275 ||| NN
of  ||| S:275 E:278 ||| IN
PP1 ||| S:278 E:281 ||| NNP
,  ||| S:281 E:283 ||| ,
PP2A  ||| S:283 E:288 ||| NNP
and  ||| S:288 E:292 ||| CC
PP2B ||| S:292 E:296 ||| NNP
,  ||| S:296 E:298 ||| ,
and  ||| S:298 E:302 ||| CC
an  ||| S:302 E:305 ||| DT
N-terminal  ||| S:305 E:316 ||| JJ
domain  ||| S:316 E:331 ||| NN
consisting  ||| S:331 E:342 ||| VBG
of  ||| S:342 E:345 ||| IN
multiple  ||| S:345 E:354 ||| JJ
tetratricopeptide  ||| S:354 E:372 ||| JJ
repeats  ||| S:372 E:380 ||| NNS
( ||| S:380 E:381 ||| -LRB-
TPRs ||| S:381 E:385 ||| NNP
)  ||| S:385 E:387 ||| -RRB-
not  ||| S:387 E:399 ||| RB
found  ||| S:399 E:405 ||| VBN
in  ||| S:405 E:408 ||| IN
other  ||| S:408 E:414 ||| JJ
members  ||| S:414 E:422 ||| NNS
of  ||| S:422 E:425 ||| IN
this  ||| S:425 E:430 ||| DT
family  ||| S:430 E:437 ||| NN
of  ||| S:437 E:440 ||| IN
phosphatases  ||| S:440 E:453 ||| NNS
[  ||| S:453 E:455 ||| -LRB-
1  ||| S:455 E:457 ||| CD
2  ||| S:457 E:467 ||| CD
3  ||| S:467 E:469 ||| CD
]  ||| S:469 E:471 ||| -RRB-
.  ||| S:471 E:473 ||| .
Homologs  ||| S:473 E:482 ||| NNS
have  ||| S:482 E:487 ||| VBP
also  ||| S:487 E:492 ||| RB
been  ||| S:492 E:497 ||| VBN
identified  ||| S:497 E:508 ||| VBN
in  ||| S:508 E:520 ||| IN
Xenopus  ||| S:520 E:528 ||| NNP
laevis  ||| S:528 E:535 ||| NNS
[  ||| S:535 E:537 ||| -LRB-
4  ||| S:537 E:539 ||| LS
]  ||| S:539 E:541 ||| -RRB-
,  ||| S:541 E:552 ||| ,
Neurospora  ||| S:552 E:563 ||| NNP
crassa  ||| S:563 E:570 ||| NNS
[  ||| S:570 E:572 ||| -LRB-
5  ||| S:572 E:574 ||| LS
]  ||| S:574 E:576 ||| -RRB-
,  ||| S:576 E:587 ||| ,
Drosophila  ||| S:587 E:598 ||| NNP
melanogaster  ||| S:598 E:611 ||| NNS
[  ||| S:611 E:613 ||| -LRB-
6  ||| S:613 E:615 ||| CD
]  ||| S:615 E:617 ||| -RRB-
,  ||| S:617 E:628 ||| ,
Trypanosoma  ||| S:628 E:640 ||| NNP
brucei  ||| S:640 E:647 ||| NNS
[  ||| S:647 E:649 ||| -LRB-
7  ||| S:649 E:651 ||| CD
]  ||| S:651 E:653 ||| -RRB-
,  ||| S:653 E:664 ||| ,
Plasmodium  ||| S:664 E:675 ||| NNP
falciparum  ||| S:675 E:686 ||| NNS
[  ||| S:686 E:688 ||| -LRB-
8  ||| S:688 E:690 ||| CD
9  ||| S:690 E:692 ||| CD
]  ||| S:692 E:694 ||| -RRB-
,  ||| S:694 E:696 ||| ,
and  ||| S:696 E:708 ||| CC
cauliflower  ||| S:708 E:720 ||| NNS
[  ||| S:720 E:722 ||| -LRB-
10  ||| S:722 E:725 ||| CD
]  ||| S:725 E:727 ||| -RRB-
,  ||| S:727 E:729 ||| ,
and  ||| S:729 E:733 ||| CC
homologs  ||| S:733 E:742 ||| NN
for  ||| S:742 E:755 ||| IN
Caenorhabditis  ||| S:755 E:770 ||| NNP
elegans ||| S:770 E:777 ||| NN
,  ||| S:777 E:787 ||| ,
Schizosaccharomyces  ||| S:787 E:807 ||| NNP
pombe  ||| S:807 E:813 ||| NN
and  ||| S:813 E:826 ||| CC
Arabidopsis  ||| S:826 E:838 ||| NNP
thaliana  ||| S:838 E:847 ||| NNS
are  ||| S:847 E:851 ||| VBP
predicted  ||| S:851 E:869 ||| VBN
( ||| S:869 E:870 ||| -LRB-
accession  ||| S:870 E:880 ||| JJ
number  ||| S:880 E:887 ||| NN
CAB60937 ||| S:887 E:895 ||| NN
,  ||| S:895 E:897 ||| ,
CAA17690  ||| S:897 E:906 ||| NNP
and  ||| S:906 E:910 ||| CC
AAD21727 ||| S:910 E:918 ||| NNP
,  ||| S:918 E:928 ||| ,
respectively ||| S:928 E:940 ||| RB
) ||| S:940 E:941 ||| -RRB-
.  ||| S:941 E:951 ||| .
Protein  ||| S:951 E:959 ||| NN
phosphatase  ||| S:959 E:971 ||| VBD
5  ||| S:971 E:973 ||| CD
has  ||| S:973 E:977 ||| VBZ
been  ||| S:977 E:982 ||| VBN
implicated  ||| S:982 E:993 ||| VBN
in  ||| S:993 E:996 ||| IN
the  ||| S:996 E:1000 ||| DT
control  ||| S:1000 E:1016 ||| NN
of  ||| S:1016 E:1019 ||| IN
cell  ||| S:1019 E:1024 ||| NN
proliferation ||| S:1024 E:1037 ||| NN
,  ||| S:1037 E:1039 ||| ,
in  ||| S:1039 E:1042 ||| IN
hormonal  ||| S:1042 E:1051 ||| JJ
signal  ||| S:1051 E:1058 ||| NN
transduction ||| S:1058 E:1070 ||| NN
,  ||| S:1070 E:1072 ||| ,
and  ||| S:1072 E:1084 ||| CC
in  ||| S:1084 E:1087 ||| IN
hsp90  ||| S:1087 E:1093 ||| CD
chaperone  ||| S:1093 E:1103 ||| JJ
function  ||| S:1103 E:1112 ||| NN
[  ||| S:1112 E:1114 ||| -LRB-
3  ||| S:1114 E:1116 ||| CD
11  ||| S:1116 E:1119 ||| CD
12  ||| S:1119 E:1122 ||| CD
13  ||| S:1122 E:1125 ||| CD
14  ||| S:1125 E:1128 ||| CD
15  ||| S:1128 E:1131 ||| CD
16  ||| S:1131 E:1134 ||| CD
17  ||| S:1134 E:1137 ||| CD
]  ||| S:1137 E:1139 ||| -RRB-
.  ||| S:1139 E:1149 ||| .
However  ||| S:1149 E:1157 ||| RB
little  ||| S:1157 E:1164 ||| RB
is  ||| S:1164 E:1167 ||| VBZ
known  ||| S:1167 E:1173 ||| VBN
about  ||| S:1173 E:1179 ||| IN
the  ||| S:1179 E:1183 ||| DT
regulation  ||| S:1183 E:1194 ||| NN
of  ||| S:1194 E:1197 ||| IN
PP5  ||| S:1197 E:1201 ||| NNP
or  ||| S:1201 E:1204 ||| CC
its  ||| S:1204 E:1216 ||| PRP$
specific  ||| S:1216 E:1225 ||| JJ
role  ||| S:1225 E:1230 ||| NN
in  ||| S:1230 E:1233 ||| IN
these  ||| S:1233 E:1239 ||| DT
pathways ||| S:1239 E:1247 ||| NN
,  ||| S:1247 E:1249 ||| ,
and  ||| S:1249 E:1253 ||| CC
only  ||| S:1253 E:1258 ||| RB
one  ||| S:1258 E:1262 ||| CD
physiological  ||| S:1262 E:1284 ||| JJ
substrate  ||| S:1284 E:1294 ||| NN
for  ||| S:1294 E:1298 ||| IN
PP5  ||| S:1298 E:1302 ||| NNP
has  ||| S:1302 E:1306 ||| VBZ
been  ||| S:1306 E:1311 ||| VBN
identified  ||| S:1311 E:1322 ||| VBN
to  ||| S:1322 E:1325 ||| TO
date ||| S:1325 E:1329 ||| NN
,  ||| S:1329 E:1331 ||| ,
the  ||| S:1331 E:1343 ||| DT
apoptosis  ||| S:1343 E:1353 ||| FW
signaling  ||| S:1353 E:1363 ||| FW
kinase  ||| S:1363 E:1370 ||| FW
ASK  ||| S:1370 E:1374 ||| NNP
1  ||| S:1374 E:1376 ||| CD
[  ||| S:1376 E:1378 ||| -LRB-
13  ||| S:1378 E:1381 ||| CD
]  ||| S:1381 E:1383 ||| -RRB-
.  ||| S:1383 E:1385 ||| .
PP5  ||| S:1385 E:1389 ||| NNP
can  ||| S:1389 E:1393 ||| MD
be  ||| S:1393 E:1404 ||| VB
activated  ||| S:1404 E:1414 ||| VBN
by  ||| S:1414 E:1417 ||| IN
lipid  ||| S:1417 E:1432 ||| NN
in  ||| S:1432 E:1435 ||| IN
vitro  ||| S:1435 E:1441 ||| NN
,  ||| S:1441 E:1443 ||| ,
and  ||| S:1443 E:1447 ||| CC
removal  ||| S:1447 E:1455 ||| NN
of  ||| S:1455 E:1458 ||| IN
the  ||| S:1458 E:1462 ||| DT
TPR  ||| S:1462 E:1474 ||| NNP
domain  ||| S:1474 E:1481 ||| NN
or  ||| S:1481 E:1484 ||| CC
the  ||| S:1484 E:1488 ||| DT
C  ||| S:1488 E:1490 ||| NNP
terminus  ||| S:1490 E:1499 ||| NN
generates  ||| S:1499 E:1509 ||| VBZ
an  ||| S:1509 E:1512 ||| DT
active ||| S:1512 E:1518 ||| JJ
,  ||| S:1518 E:1520 ||| ,
lipid  ||| S:1520 E:1534 ||| JJ
insensitive  ||| S:1534 E:1546 ||| JJ
form  ||| S:1546 E:1551 ||| NN
of  ||| S:1551 E:1554 ||| IN
the  ||| S:1554 E:1558 ||| DT
enzyme  ||| S:1558 E:1565 ||| NN
[  ||| S:1565 E:1567 ||| -LRB-
18  ||| S:1567 E:1570 ||| CD
19  ||| S:1570 E:1573 ||| CD
20  ||| S:1573 E:1576 ||| CD
21  ||| S:1576 E:1579 ||| CD
]  ||| S:1579 E:1581 ||| -RRB-
.  ||| S:1581 E:1583 ||| .
PP5  ||| S:1583 E:1595 ||| NNP
phosphatase  ||| S:1595 E:1607 ||| JJ
activity  ||| S:1607 E:1616 ||| NN
is  ||| S:1616 E:1619 ||| VBZ
also  ||| S:1619 E:1624 ||| RB
altered  ||| S:1624 E:1632 ||| VBN
by  ||| S:1632 E:1635 ||| IN
hCRY2  ||| S:1635 E:1641 ||| NNP
and  ||| S:1641 E:1645 ||| CC
a  ||| S:1645 E:1655 ||| DT
fragment  ||| S:1655 E:1664 ||| NN
of  ||| S:1664 E:1667 ||| IN
hsp90  ||| S:1667 E:1682 ||| CD
in  ||| S:1682 E:1685 ||| IN
vitro  ||| S:1685 E:1691 ||| NNS
[  ||| S:1691 E:1693 ||| -LRB-
21  ||| S:1693 E:1696 ||| CD
22  ||| S:1696 E:1699 ||| CD
]  ||| S:1699 E:1701 ||| -RRB-
.  ||| S:1701 E:1703 ||| .
These  ||| S:1703 E:1709 ||| DT
findings  ||| S:1709 E:1726 ||| NNS
suggest  ||| S:1726 E:1734 ||| VBP
that  ||| S:1734 E:1739 ||| IN
PP5  ||| S:1739 E:1743 ||| NNP
may  ||| S:1743 E:1747 ||| MD
be  ||| S:1747 E:1750 ||| VB
autoinhibited  ||| S:1750 E:1764 ||| NNS
and  ||| S:1764 E:1768 ||| CC
that  ||| S:1768 E:1773 ||| IN
the  ||| S:1773 E:1777 ||| DT
binding  ||| S:1777 E:1793 ||| NN
of  ||| S:1793 E:1796 ||| IN
protein  ||| S:1796 E:1804 ||| NN
partners  ||| S:1804 E:1813 ||| NNS
or  ||| S:1813 E:1816 ||| CC
lipids  ||| S:1816 E:1823 ||| JJ
to  ||| S:1823 E:1826 ||| TO
the  ||| S:1826 E:1830 ||| DT
TPR  ||| S:1830 E:1834 ||| NNP
domain  ||| S:1834 E:1841 ||| NN
could  ||| S:1841 E:1855 ||| MD
potentially  ||| S:1855 E:1867 ||| RB
control  ||| S:1867 E:1875 ||| VB
PP5  ||| S:1875 E:1879 ||| CD
activity  ||| S:1879 E:1888 ||| NN
in  ||| S:1888 E:1891 ||| IN
cells ||| S:1891 E:1896 ||| NNS
,  ||| S:1896 E:1898 ||| ,
however  ||| S:1898 E:1906 ||| RB
no  ||| S:1906 E:1917 ||| DT
reports  ||| S:1917 E:1925 ||| NNS
have  ||| S:1925 E:1930 ||| VBP
yet  ||| S:1930 E:1934 ||| RB
documented  ||| S:1934 E:1945 ||| VBN
how  ||| S:1945 E:1949 ||| WRB
PP5  ||| S:1949 E:1953 ||| NNP
is  ||| S:1953 E:1956 ||| VBZ
regulated  ||| S:1956 E:1975 ||| VBN
in  ||| S:1975 E:1978 ||| IN
vivo  ||| S:1978 E:1983 ||| NN
.  ||| S:1983 E:1985 ||| .
The  ||| S:1985 E:1989 ||| DT
activity  ||| S:1989 E:1998 ||| NN
of  ||| S:1998 E:2001 ||| IN
PP5  ||| S:2001 E:2013 ||| CD
homologs  ||| S:2013 E:2022 ||| NN
from  ||| S:2022 E:2027 ||| IN
cauliflower ||| S:2027 E:2038 ||| NN
,  ||| S:2038 E:2049 ||| ,
T.  ||| S:2049 E:2052 ||| NNP
brucei  ||| S:2052 E:2059 ||| NN
and  ||| S:2059 E:2072 ||| CC
P.  ||| S:2072 E:2075 ||| NNP
falciparum  ||| S:2075 E:2086 ||| NN
is  ||| S:2086 E:2089 ||| VBZ
stimulated  ||| S:2089 E:2100 ||| VBN
by  ||| S:2100 E:2111 ||| IN
polyunsaturated  ||| S:2111 E:2127 ||| FW
fatty  ||| S:2127 E:2133 ||| FW
acids  ||| S:2133 E:2148 ||| FW
in  ||| S:2148 E:2151 ||| FW
vitro  ||| S:2151 E:2157 ||| FW
[  ||| S:2157 E:2159 ||| -LRB-
7  ||| S:2159 E:2161 ||| CD
8  ||| S:2161 E:2163 ||| CD
9  ||| S:2163 E:2165 ||| CD
10  ||| S:2165 E:2168 ||| CD
]  ||| S:2168 E:2170 ||| -RRB-
and  ||| S:2170 E:2174 ||| CC
removal  ||| S:2174 E:2182 ||| NN
of  ||| S:2182 E:2193 ||| IN
the  ||| S:2193 E:2197 ||| DT
TPR  ||| S:2197 E:2201 ||| NNP
domain  ||| S:2201 E:2208 ||| NN
from  ||| S:2208 E:2222 ||| IN
P.  ||| S:2222 E:2225 ||| NNP
falciparum  ||| S:2225 E:2236 ||| VBD
PP5  ||| S:2236 E:2240 ||| CD
increases  ||| S:2240 E:2250 ||| NNS
activity  ||| S:2250 E:2267 ||| NN
to  ||| S:2267 E:2270 ||| TO
the  ||| S:2270 E:2274 ||| DT
same  ||| S:2274 E:2279 ||| JJ
extent  ||| S:2279 E:2286 ||| NN
as  ||| S:2286 E:2289 ||| IN
lipid  ||| S:2289 E:2295 ||| JJ
treatment  ||| S:2295 E:2305 ||| NN
[  ||| S:2305 E:2307 ||| -LRB-
8  ||| S:2307 E:2309 ||| CD
9  ||| S:2309 E:2311 ||| CD
]  ||| S:2311 E:2313 ||| -RRB-
.  ||| S:2313 E:2315 ||| .
This  ||| S:2315 E:2328 ||| DT
suggests  ||| S:2328 E:2337 ||| VBZ
that  ||| S:2337 E:2342 ||| IN
the  ||| S:2342 E:2346 ||| DT
TPR  ||| S:2346 E:2350 ||| NNP
domain  ||| S:2350 E:2357 ||| NN
plays  ||| S:2357 E:2363 ||| VBZ
a  ||| S:2363 E:2365 ||| DT
similar  ||| S:2365 E:2373 ||| JJ
inhibitory  ||| S:2373 E:2392 ||| JJ
role  ||| S:2392 E:2397 ||| NN
for  ||| S:2397 E:2401 ||| IN
all  ||| S:2401 E:2405 ||| DT
PP5  ||| S:2405 E:2409 ||| JJ
homologs ||| S:2409 E:2417 ||| NN
.  ||| S:2417 E:2427 ||| .
Genetic  ||| S:2427 E:2435 ||| JJ
analyses  ||| S:2435 E:2444 ||| NNS
in  ||| S:2444 E:2456 ||| IN
S.  ||| S:2456 E:2459 ||| NNP
cerevisiae  ||| S:2459 E:2470 ||| NNS
have  ||| S:2470 E:2475 ||| VBP
yielded  ||| S:2475 E:2483 ||| VBN
few  ||| S:2483 E:2487 ||| JJ
clues  ||| S:2487 E:2501 ||| NNS
about  ||| S:2501 E:2507 ||| IN
the  ||| S:2507 E:2511 ||| DT
function  ||| S:2511 E:2520 ||| NN
of  ||| S:2520 E:2523 ||| IN
Ppt1p ||| S:2523 E:2528 ||| CD
.  ||| S:2528 E:2530 ||| .
Budding  ||| S:2530 E:2538 ||| VBG
yeast  ||| S:2538 E:2544 ||| NN
lacking  ||| S:2544 E:2561 ||| VBG
PPT1  ||| S:2561 E:2566 ||| RB
do  ||| S:2566 E:2569 ||| VBP
not  ||| S:2569 E:2573 ||| RB
exhibit  ||| S:2573 E:2581 ||| VB
obvious  ||| S:2581 E:2589 ||| JJ
growth  ||| S:2589 E:2604 ||| NN
defects  ||| S:2604 E:2612 ||| NNS
or  ||| S:2612 E:2615 ||| CC
detectable  ||| S:2615 E:2626 ||| JJ
phenotypes  ||| S:2626 E:2637 ||| NNS
[  ||| S:2637 E:2639 ||| -LRB-
2  ||| S:2639 E:2641 ||| LS
]  ||| S:2641 E:2643 ||| -RRB-
.  ||| S:2643 E:2645 ||| .
Disruption  ||| S:2645 E:2656 ||| NN
of  ||| S:2656 E:2668 ||| IN
PPT1  ||| S:2668 E:2673 ||| NNP
together  ||| S:2673 E:2682 ||| RB
with  ||| S:2682 E:2687 ||| IN
one  ||| S:2687 E:2691 ||| CD
of  ||| S:2691 E:2694 ||| IN
the  ||| S:2694 E:2698 ||| DT
other  ||| S:2698 E:2712 ||| JJ
known  ||| S:2712 E:2718 ||| JJ
phosphatases  ||| S:2718 E:2731 ||| NN
in  ||| S:2731 E:2734 ||| IN
budding  ||| S:2734 E:2742 ||| VBG
yeast  ||| S:2742 E:2748 ||| NN
also  ||| S:2748 E:2753 ||| RB
reveals  ||| S:2753 E:2761 ||| VBZ
no  ||| S:2761 E:2764 ||| DT
obvious  ||| S:2764 E:2780 ||| JJ
phenotype  ||| S:2780 E:2790 ||| NNS
[  ||| S:2790 E:2792 ||| -LRB-
23  ||| S:2792 E:2795 ||| CD
]  ||| S:2795 E:2797 ||| -RRB-
.  ||| S:2797 E:2799 ||| .
Thus ||| S:2799 E:2803 ||| RB
,  ||| S:2803 E:2805 ||| ,
if  ||| S:2805 E:2808 ||| IN
Ppt1p  ||| S:2808 E:2814 ||| NNP
has  ||| S:2814 E:2818 ||| VBZ
an  ||| S:2818 E:2821 ||| DT
essential  ||| S:2821 E:2831 ||| JJ
function  ||| S:2831 E:2848 ||| NN
in  ||| S:2848 E:2860 ||| IN
S.  ||| S:2860 E:2863 ||| NNP
cerevisiae  ||| S:2863 E:2874 ||| NN
,  ||| S:2874 E:2876 ||| ,
more  ||| S:2876 E:2881 ||| JJR
than  ||| S:2881 E:2886 ||| IN
one  ||| S:2886 E:2890 ||| CD
other  ||| S:2890 E:2904 ||| JJ
phosphatase  ||| S:2904 E:2916 ||| NN
can  ||| S:2916 E:2920 ||| MD
also  ||| S:2920 E:2925 ||| RB
carry  ||| S:2925 E:2931 ||| VB
out  ||| S:2931 E:2935 ||| RP
this  ||| S:2935 E:2940 ||| DT
role ||| S:2940 E:2944 ||| NN
.  ||| S:2944 E:2946 ||| .
In  ||| S:2946 E:2949 ||| IN
this  ||| S:2949 E:2954 ||| DT
report  ||| S:2954 E:2961 ||| NN
we  ||| S:2961 E:2972 ||| PRP
have  ||| S:2972 E:2977 ||| VBP
characterized  ||| S:2977 E:2991 ||| VBN
the  ||| S:2991 E:2995 ||| DT
activity  ||| S:2995 E:3004 ||| NN
of  ||| S:3004 E:3007 ||| IN
recombinant  ||| S:3007 E:3019 ||| JJ
Ppt1p ||| S:3019 E:3024 ||| NN
,  ||| S:3024 E:3034 ||| ,
analyzed  ||| S:3034 E:3043 ||| VBD
its  ||| S:3043 E:3047 ||| PRP$
expression  ||| S:3047 E:3058 ||| NN
at  ||| S:3058 E:3061 ||| IN
the  ||| S:3061 E:3065 ||| DT
level  ||| S:3065 E:3071 ||| NN
of  ||| S:3071 E:3074 ||| IN
protein  ||| S:3074 E:3082 ||| NN
and  ||| S:3082 E:3086 ||| CC
mRNA ||| S:3086 E:3090 ||| JJ
,  ||| S:3090 E:3100 ||| ,
and  ||| S:3100 E:3104 ||| CC
localized  ||| S:3104 E:3114 ||| JJ
Ppt1p  ||| S:3114 E:3120 ||| NN
in  ||| S:3120 E:3123 ||| IN
yeast ||| S:3123 E:3128 ||| NN
.  ||| S:3128 E:3130 ||| .
Ppt1p  ||| S:3130 E:3136 ||| NNP
can  ||| S:3136 E:3140 ||| MD
be  ||| S:3140 E:3143 ||| VB
activated  ||| S:3143 E:3153 ||| VBN
by  ||| S:3153 E:3164 ||| IN
lipid ||| S:3164 E:3169 ||| NN
,  ||| S:3169 E:3171 ||| ,
is  ||| S:3171 E:3174 ||| VBZ
most  ||| S:3174 E:3179 ||| RBS
highly  ||| S:3179 E:3186 ||| RB
expressed  ||| S:3186 E:3196 ||| VBN
in  ||| S:3196 E:3199 ||| IN
early  ||| S:3199 E:3205 ||| JJ
log  ||| S:3205 E:3209 ||| JJ
phase  ||| S:3209 E:3215 ||| NN
growth ||| S:3215 E:3221 ||| NN
,  ||| S:3221 E:3231 ||| ,
and  ||| S:3231 E:3235 ||| CC
is  ||| S:3235 E:3238 ||| VBZ
present  ||| S:3238 E:3246 ||| JJ
throughout  ||| S:3246 E:3257 ||| IN
the  ||| S:3257 E:3261 ||| DT
cell ||| S:3261 E:3265 ||| NN
.  ||| S:3265 E:3289 ||| .
Results  ||| S:3289 E:3316 ||| NNP
Comparison  ||| S:3316 E:3327 ||| NNP
of  ||| S:3327 E:3330 ||| IN
Ppt1p  ||| S:3330 E:3336 ||| NNP
and  ||| S:3336 E:3340 ||| CC
PP5  ||| S:3340 E:3344 ||| CD
activity  ||| S:3344 E:3353 ||| NN
and  ||| S:3353 E:3357 ||| CC
response  ||| S:3357 E:3376 ||| NN
to  ||| S:3376 E:3379 ||| TO
lipid  ||| S:3379 E:3385 ||| VB
treatment  ||| S:3385 E:3405 ||| NN
Recombinant  ||| S:3405 E:3417 ||| NNP
Ppt1p  ||| S:3417 E:3423 ||| NNP
expressed  ||| S:3423 E:3433 ||| VBD
as  ||| S:3433 E:3436 ||| IN
a  ||| S:3436 E:3438 ||| DT
GST-fusion  ||| S:3438 E:3449 ||| JJ
protein ||| S:3449 E:3456 ||| NN
,  ||| S:3456 E:3468 ||| ,
then  ||| S:3468 E:3473 ||| RB
affinity  ||| S:3473 E:3482 ||| JJ
purified  ||| S:3482 E:3491 ||| NN
and  ||| S:3491 E:3495 ||| CC
released  ||| S:3495 E:3504 ||| VBN
from  ||| S:3504 E:3509 ||| IN
GST  ||| S:3509 E:3513 ||| NNP
by  ||| S:3513 E:3516 ||| IN
thrombin  ||| S:3516 E:3535 ||| JJ
cleavage  ||| S:3535 E:3544 ||| NN
yielded  ||| S:3544 E:3552 ||| VBD
a  ||| S:3552 E:3554 ||| DT
single  ||| S:3554 E:3561 ||| JJ
band  ||| S:3561 E:3566 ||| NN
of  ||| S:3566 E:3569 ||| IN
the  ||| S:3569 E:3573 ||| DT
expected  ||| S:3573 E:3582 ||| JJ
molecular  ||| S:3582 E:3602 ||| JJ
weight ||| S:3602 E:3608 ||| NN
,  ||| S:3608 E:3610 ||| ,
58  ||| S:3610 E:3613 ||| CD
kDa  ||| S:3613 E:3617 ||| NNS
( ||| S:3617 E:3618 ||| -LRB-
Fig.  ||| S:3618 E:3623 ||| NNP
1A ||| S:3623 E:3625 ||| NNP
) ||| S:3625 E:3626 ||| -RRB-
.  ||| S:3626 E:3628 ||| .
When  ||| S:3628 E:3633 ||| WRB
assayed  ||| S:3633 E:3641 ||| NNS
side-by-side ||| S:3641 E:3653 ||| RB
,  ||| S:3653 E:3655 ||| ,
the  ||| S:3655 E:3669 ||| DT
basal  ||| S:3669 E:3675 ||| JJ
specific  ||| S:3675 E:3684 ||| JJ
activities  ||| S:3684 E:3695 ||| NNS
for  ||| S:3695 E:3699 ||| IN
recombinant  ||| S:3699 E:3711 ||| JJ
Ppt1p  ||| S:3711 E:3717 ||| NN
and  ||| S:3717 E:3721 ||| CC
PP5  ||| S:3721 E:3735 ||| NNP
were  ||| S:3735 E:3740 ||| VBD
similar  ||| S:3740 E:3748 ||| JJ
toward  ||| S:3748 E:3755 ||| IN
the  ||| S:3755 E:3759 ||| DT
artificial  ||| S:3759 E:3770 ||| JJ
substrates  ||| S:3770 E:3781 ||| JJ
32P-MBP  ||| S:3781 E:3789 ||| NN
and  ||| S:3789 E:3803 ||| CC
32P-casein ||| S:3803 E:3813 ||| NNP
,  ||| S:3813 E:3815 ||| ,
respectively  ||| S:3815 E:3828 ||| RB
( ||| S:3828 E:3829 ||| -LRB-
Fig.  ||| S:3829 E:3834 ||| NNP
1B ||| S:3834 E:3836 ||| NNP
) ||| S:3836 E:3837 ||| -RRB-
.  ||| S:3837 E:3839 ||| .
Like  ||| S:3839 E:3844 ||| IN
PP5 ||| S:3844 E:3847 ||| NNP
,  ||| S:3847 E:3849 ||| ,
the  ||| S:3849 E:3863 ||| DT
dephosphorylation  ||| S:3863 E:3881 ||| NN
of  ||| S:3881 E:3884 ||| IN
32P-MBP  ||| S:3884 E:3892 ||| CD
by  ||| S:3892 E:3895 ||| IN
Ppt1p  ||| S:3895 E:3901 ||| NNP
was  ||| S:3901 E:3905 ||| VBD
stimulated  ||| S:3905 E:3916 ||| VBN
by  ||| S:3916 E:3929 ||| IN
arachidonic  ||| S:3929 E:3941 ||| JJ
acid  ||| S:3941 E:3946 ||| NN
and  ||| S:3946 E:3950 ||| CC
other  ||| S:3950 E:3956 ||| JJ
unsaturated  ||| S:3956 E:3968 ||| JJ
fatty  ||| S:3968 E:3974 ||| JJ
acids ||| S:3974 E:3979 ||| NNS
,  ||| S:3979 E:3981 ||| ,
but  ||| S:3981 E:3995 ||| CC
lipids  ||| S:3995 E:4002 ||| JJ
lacking  ||| S:4002 E:4010 ||| NN
either  ||| S:4010 E:4017 ||| CC
a  ||| S:4017 E:4019 ||| DT
double  ||| S:4019 E:4026 ||| JJ
bond  ||| S:4026 E:4031 ||| NN
or  ||| S:4031 E:4034 ||| CC
a  ||| S:4034 E:4036 ||| DT
carboxylate  ||| S:4036 E:4058 ||| JJ
group  ||| S:4058 E:4064 ||| NN
were  ||| S:4064 E:4069 ||| VBD
not  ||| S:4069 E:4073 ||| RB
effective  ||| S:4073 E:4083 ||| JJ
( ||| S:4083 E:4084 ||| -LRB-
Table  ||| S:4084 E:4090 ||| NNP
1 ||| S:4090 E:4091 ||| CD
) ||| S:4091 E:4092 ||| -RRB-
.  ||| S:4092 E:4104 ||| .
In  ||| S:4104 E:4107 ||| IN
the  ||| S:4107 E:4111 ||| DT
case  ||| S:4111 E:4116 ||| NN
of  ||| S:4116 E:4119 ||| IN
pNPP  ||| S:4119 E:4124 ||| JJ
hydrolysis ||| S:4124 E:4134 ||| NN
,  ||| S:4134 E:4136 ||| ,
others  ||| S:4136 E:4143 ||| NNS
have  ||| S:4143 E:4148 ||| VBP
reported  ||| S:4148 E:4167 ||| VBN
both  ||| S:4167 E:4172 ||| DT
saturated  ||| S:4172 E:4182 ||| NN
and  ||| S:4182 E:4186 ||| CC
unsaturated  ||| S:4186 E:4198 ||| JJ
fatty  ||| S:4198 E:4204 ||| NNS
acyl  ||| S:4204 E:4209 ||| VBP
coenzyme  ||| S:4209 E:4218 ||| VBG
A  ||| S:4218 E:4230 ||| DT
esters  ||| S:4230 E:4237 ||| JJ
stimulate  ||| S:4237 E:4247 ||| NN
PP5  ||| S:4247 E:4251 ||| CD
activity ||| S:4251 E:4259 ||| NN
,  ||| S:4259 E:4261 ||| ,
with  ||| S:4261 E:4266 ||| IN
concentrations  ||| S:4266 E:4291 ||| NNS
required  ||| S:4291 E:4300 ||| VBN
for  ||| S:4300 E:4304 ||| IN
half-maximal  ||| S:4304 E:4317 ||| JJ
stimulation  ||| S:4317 E:4329 ||| NN
approximately  ||| S:4329 E:4353 ||| RB
10-fold  ||| S:4353 E:4361 ||| JJ
lower  ||| S:4361 E:4367 ||| JJR
than  ||| S:4367 E:4372 ||| IN
those  ||| S:4372 E:4378 ||| DT
of  ||| S:4378 E:4381 ||| IN
their  ||| S:4381 E:4387 ||| PRP$
corresponding  ||| S:4387 E:4401 ||| JJ
free  ||| S:4401 E:4416 ||| JJ
fatty  ||| S:4416 E:4422 ||| JJ
acids  ||| S:4422 E:4428 ||| NNS
[  ||| S:4428 E:4430 ||| -LRB-
21  ||| S:4430 E:4433 ||| CD
]  ||| S:4433 E:4435 ||| -RRB-
.  ||| S:4435 E:4437 ||| .
We  ||| S:4437 E:4440 ||| PRP
therefore  ||| S:4440 E:4450 ||| RB
tested  ||| S:4450 E:4457 ||| VBN
whether  ||| S:4457 E:4465 ||| IN
a  ||| S:4465 E:4477 ||| DT
saturated  ||| S:4477 E:4487 ||| JJ
fatty  ||| S:4487 E:4493 ||| NNS
acyl  ||| S:4493 E:4498 ||| VBP
coenzyme  ||| S:4498 E:4507 ||| VBG
A  ||| S:4507 E:4509 ||| DT
ester  ||| S:4509 E:4515 ||| NN
could  ||| S:4515 E:4521 ||| MD
also  ||| S:4521 E:4536 ||| RB
stimulate  ||| S:4536 E:4546 ||| VB
Ppt1p ||| S:4546 E:4551 ||| CD
.  ||| S:4551 E:4553 ||| .
Ppt1p  ||| S:4553 E:4559 ||| NNP
activity  ||| S:4559 E:4568 ||| NN
toward  ||| S:4568 E:4575 ||| IN
32P-MBP  ||| S:4575 E:4583 ||| NNP
was  ||| S:4583 E:4597 ||| VBD
stimulated  ||| S:4597 E:4608 ||| VBN
by  ||| S:4608 E:4611 ||| IN
arachidoyl  ||| S:4611 E:4622 ||| JJ
coenzyme  ||| S:4622 E:4631 ||| JJ
A  ||| S:4631 E:4633 ||| NN
in  ||| S:4633 E:4636 ||| IN
a  ||| S:4636 E:4638 ||| DT
concentration  ||| S:4638 E:4662 ||| NN
range  ||| S:4662 E:4668 ||| NN
similar  ||| S:4668 E:4676 ||| JJ
to  ||| S:4676 E:4679 ||| TO
that  ||| S:4679 E:4684 ||| WDT
observed  ||| S:4684 E:4693 ||| VBD
for  ||| S:4693 E:4697 ||| IN
AA ||| S:4697 E:4699 ||| NN
,  ||| S:4699 E:4701 ||| ,
with  ||| S:4701 E:4706 ||| IN
half-maximal  ||| S:4706 E:4729 ||| JJ
stimulation  ||| S:4729 E:4741 ||| NN
occurring  ||| S:4741 E:4751 ||| VBG
at  ||| S:4751 E:4754 ||| IN
approximately  ||| S:4754 E:4768 ||| RB
50  ||| S:4768 E:4771 ||| CD
μM  ||| S:4771 E:4774 ||| NN
for  ||| S:4774 E:4788 ||| IN
arachidoyl  ||| S:4788 E:4799 ||| JJ
coenzyme  ||| S:4799 E:4808 ||| JJ
A  ||| S:4808 E:4810 ||| NN
and  ||| S:4810 E:4814 ||| CC
75  ||| S:4814 E:4817 ||| CD
μM  ||| S:4817 E:4820 ||| NN
for  ||| S:4820 E:4824 ||| IN
AA ||| S:4824 E:4826 ||| NN
.  ||| S:4826 E:4828 ||| .
However ||| S:4828 E:4835 ||| RB
,  ||| S:4835 E:4837 ||| ,
in  ||| S:4837 E:4850 ||| IN
contrast  ||| S:4850 E:4859 ||| NN
to  ||| S:4859 E:4862 ||| TO
AA  ||| S:4862 E:4865 ||| NN
stimulation ||| S:4865 E:4876 ||| NN
,  ||| S:4876 E:4878 ||| ,
Ppt1p  ||| S:4878 E:4884 ||| CD
activity  ||| S:4884 E:4893 ||| NN
dropped  ||| S:4893 E:4901 ||| VBD
off  ||| S:4901 E:4915 ||| RP
sharply  ||| S:4915 E:4923 ||| RB
at  ||| S:4923 E:4926 ||| IN
80  ||| S:4926 E:4929 ||| CD
μM  ||| S:4929 E:4932 ||| JJ
arachidoyl  ||| S:4932 E:4943 ||| JJ
coenzyme  ||| S:4943 E:4952 ||| JJ
A  ||| S:4952 E:4954 ||| NN
and  ||| S:4954 E:4958 ||| CC
higher ||| S:4958 E:4964 ||| JJR
.  ||| S:4964 E:4976 ||| .
Similar  ||| S:4976 E:4984 ||| JJ
results  ||| S:4984 E:4992 ||| NNS
were  ||| S:4992 E:4997 ||| VBD
observed  ||| S:4997 E:5006 ||| VBN
for  ||| S:5006 E:5010 ||| IN
PP5  ||| S:5010 E:5014 ||| NNP
( ||| S:5014 E:5015 ||| -LRB-
data  ||| S:5015 E:5020 ||| NNS
not  ||| S:5020 E:5024 ||| RB
shown ||| S:5024 E:5029 ||| VBN
) ||| S:5029 E:5030 ||| -RRB-
.  ||| S:5030 E:5042 ||| .
This  ||| S:5042 E:5047 ||| DT
suggests  ||| S:5047 E:5056 ||| VBZ
that  ||| S:5056 E:5061 ||| DT
double  ||| S:5061 E:5068 ||| JJ
bonds  ||| S:5068 E:5074 ||| NNS
are  ||| S:5074 E:5078 ||| VBP
not  ||| S:5078 E:5082 ||| RB
required  ||| S:5082 E:5091 ||| VBN
to  ||| S:5091 E:5104 ||| TO
observe  ||| S:5104 E:5112 ||| VB
the  ||| S:5112 E:5116 ||| DT
effect  ||| S:5116 E:5123 ||| NN
of  ||| S:5123 E:5126 ||| IN
fatty  ||| S:5126 E:5132 ||| JJ
acyl  ||| S:5132 E:5137 ||| NNS
coenzyme  ||| S:5137 E:5146 ||| VBP
A  ||| S:5146 E:5148 ||| DT
esters ||| S:5148 E:5154 ||| NN
.  ||| S:5154 E:5166 ||| .
Unlike  ||| S:5166 E:5173 ||| IN
PP5 ||| S:5173 E:5176 ||| NNP
,  ||| S:5176 E:5178 ||| ,
the  ||| S:5178 E:5182 ||| DT
activity  ||| S:5182 E:5191 ||| NN
of  ||| S:5191 E:5194 ||| IN
Ppt1p  ||| S:5194 E:5200 ||| CD
toward  ||| S:5200 E:5207 ||| IN
32P-casein  ||| S:5207 E:5228 ||| NNP
was  ||| S:5228 E:5232 ||| VBD
not  ||| S:5232 E:5236 ||| RB
stimulated  ||| S:5236 E:5247 ||| VBN
by  ||| S:5247 E:5250 ||| IN
AA ||| S:5250 E:5252 ||| NN
,  ||| S:5252 E:5254 ||| ,
arachidoyl  ||| S:5254 E:5265 ||| FW
coenzyme  ||| S:5265 E:5274 ||| FW
A ||| S:5274 E:5275 ||| NNP
,  ||| S:5275 E:5277 ||| ,
or  ||| S:5277 E:5290 ||| CC
linoleoyl  ||| S:5290 E:5300 ||| JJ
coenzyme  ||| S:5300 E:5309 ||| JJ
A  ||| S:5309 E:5311 ||| NN
over  ||| S:5311 E:5316 ||| IN
a  ||| S:5316 E:5318 ||| DT
range  ||| S:5318 E:5324 ||| NN
in  ||| S:5324 E:5327 ||| IN
concentration  ||| S:5327 E:5341 ||| NN
from  ||| S:5341 E:5356 ||| IN
10-500  ||| S:5356 E:5363 ||| NNP
μM  ||| S:5363 E:5366 ||| NNP
( ||| S:5366 E:5367 ||| -LRB-
Fig.  ||| S:5367 E:5372 ||| CD
1Band  ||| S:5372 E:5378 ||| CD
data  ||| S:5378 E:5383 ||| NNS
not  ||| S:5383 E:5387 ||| RB
shown ||| S:5387 E:5392 ||| VBN
) ||| S:5392 E:5393 ||| -RRB-
.  ||| S:5393 E:5395 ||| .
Other  ||| S:5395 E:5401 ||| JJ
unsaturated  ||| S:5401 E:5423 ||| JJ
fatty  ||| S:5423 E:5429 ||| NNS
acids  ||| S:5429 E:5435 ||| VBP
also  ||| S:5435 E:5440 ||| RB
failed  ||| S:5440 E:5447 ||| VBN
to  ||| S:5447 E:5450 ||| TO
stimulate  ||| S:5450 E:5460 ||| VB
Ppt1p  ||| S:5460 E:5466 ||| CD
activity  ||| S:5466 E:5475 ||| NN
with  ||| S:5475 E:5490 ||| IN
this  ||| S:5490 E:5495 ||| DT
substrate  ||| S:5495 E:5505 ||| NN
( ||| S:5505 E:5506 ||| -LRB-
Table  ||| S:5506 E:5512 ||| NNP
1 ||| S:5512 E:5513 ||| CD
) ||| S:5513 E:5514 ||| -RRB-
.  ||| S:5514 E:5516 ||| .
These  ||| S:5516 E:5522 ||| DT
data  ||| S:5522 E:5527 ||| NNS
indicate  ||| S:5527 E:5536 ||| VBP
that  ||| S:5536 E:5541 ||| IN
Ppt1p  ||| S:5541 E:5557 ||| NNP
is  ||| S:5557 E:5560 ||| VBZ
stimulated  ||| S:5560 E:5571 ||| VBN
by  ||| S:5571 E:5574 ||| IN
polyunsaturated  ||| S:5574 E:5590 ||| JJ
fatty  ||| S:5590 E:5596 ||| JJ
acids ||| S:5596 E:5601 ||| NNS
,  ||| S:5601 E:5603 ||| ,
as  ||| S:5603 E:5606 ||| RB
well  ||| S:5606 E:5611 ||| RB
as  ||| S:5611 E:5624 ||| RB
by  ||| S:5624 E:5627 ||| IN
a  ||| S:5627 E:5629 ||| DT
saturated  ||| S:5629 E:5639 ||| JJ
fatty  ||| S:5639 E:5645 ||| NNS
acyl  ||| S:5645 E:5650 ||| VBP
coenzyme  ||| S:5650 E:5659 ||| VBG
A  ||| S:5659 E:5661 ||| DT
derivative ||| S:5661 E:5671 ||| JJ
,  ||| S:5671 E:5673 ||| ,
toward  ||| S:5673 E:5690 ||| IN
some  ||| S:5690 E:5695 ||| DT
but  ||| S:5695 E:5699 ||| CC
not  ||| S:5699 E:5703 ||| RB
all  ||| S:5703 E:5707 ||| DT
substrates  ||| S:5707 E:5718 ||| JJ
dephosphorylated  ||| S:5718 E:5735 ||| NN
by  ||| S:5735 E:5738 ||| IN
PP5 ||| S:5738 E:5741 ||| CD
.  ||| S:5741 E:5771 ||| .
Limited  ||| S:5771 E:5779 ||| JJ
proteolysis  ||| S:5779 E:5791 ||| NN
of  ||| S:5791 E:5794 ||| IN
Ppt1p  ||| S:5794 E:5810 ||| NNP
Removal  ||| S:5810 E:5818 ||| NNP
of  ||| S:5818 E:5821 ||| IN
the  ||| S:5821 E:5825 ||| DT
TPR  ||| S:5825 E:5829 ||| NNP
domain  ||| S:5829 E:5836 ||| NN
of  ||| S:5836 E:5839 ||| IN
PP5  ||| S:5839 E:5843 ||| CD
by  ||| S:5843 E:5846 ||| IN
limited  ||| S:5846 E:5864 ||| JJ
proteolysis  ||| S:5864 E:5876 ||| NN
increases  ||| S:5876 E:5886 ||| VBZ
enzyme  ||| S:5886 E:5893 ||| JJ
activity  ||| S:5893 E:5902 ||| NN
and  ||| S:5902 E:5906 ||| CC
the  ||| S:5906 E:5910 ||| DT
TPR  ||| S:5910 E:5914 ||| FW
domain  ||| S:5914 E:5931 ||| FW
binds  ||| S:5931 E:5937 ||| FW
lipid  ||| S:5937 E:5943 ||| FW
[  ||| S:5943 E:5945 ||| -LRB-
7  ||| S:5945 E:5947 ||| CD
8  ||| S:5947 E:5949 ||| CD
9  ||| S:5949 E:5951 ||| CD
19  ||| S:5951 E:5954 ||| CD
20  ||| S:5954 E:5957 ||| CD
]  ||| S:5957 E:5959 ||| -RRB-
.  ||| S:5959 E:5961 ||| .
Using  ||| S:5961 E:5967 ||| VBG
conditions  ||| S:5967 E:5978 ||| NNS
similar  ||| S:5978 E:5986 ||| JJ
to  ||| S:5986 E:5999 ||| TO
those  ||| S:5999 E:6005 ||| DT
employed  ||| S:6005 E:6014 ||| VBN
with  ||| S:6014 E:6019 ||| IN
PP5 ||| S:6019 E:6022 ||| NNP
,  ||| S:6022 E:6024 ||| ,
digestion  ||| S:6024 E:6034 ||| VBG
of  ||| S:6034 E:6037 ||| IN
Ppt1p  ||| S:6037 E:6043 ||| CD
with  ||| S:6043 E:6048 ||| IN
trypsin  ||| S:6048 E:6066 ||| NN
in  ||| S:6066 E:6069 ||| IN
the  ||| S:6069 E:6073 ||| DT
absence  ||| S:6073 E:6081 ||| NN
of  ||| S:6081 E:6084 ||| IN
lipid  ||| S:6084 E:6090 ||| NN
produced  ||| S:6090 E:6099 ||| VBD
a  ||| S:6099 E:6101 ||| DT
44  ||| S:6101 E:6104 ||| CD
kDa  ||| S:6104 E:6108 ||| JJ
catalytic  ||| S:6108 E:6128 ||| JJ
fragment  ||| S:6128 E:6137 ||| NN
that  ||| S:6137 E:6142 ||| WDT
was  ||| S:6142 E:6146 ||| VBD
stable  ||| S:6146 E:6153 ||| JJ
for  ||| S:6153 E:6157 ||| IN
at  ||| S:6157 E:6160 ||| IN
least  ||| S:6160 E:6166 ||| JJS
30  ||| S:6166 E:6169 ||| CD
min  ||| S:6169 E:6173 ||| NNS
and  ||| S:6173 E:6177 ||| CC
a  ||| S:6177 E:6179 ||| DT
20  ||| S:6179 E:6182 ||| CD
kDa  ||| S:6182 E:6196 ||| JJ
fragment  ||| S:6196 E:6205 ||| NN
that  ||| S:6205 E:6210 ||| WDT
was  ||| S:6210 E:6214 ||| VBD
degraded  ||| S:6214 E:6223 ||| VBN
within  ||| S:6223 E:6230 ||| IN
30  ||| S:6230 E:6233 ||| CD
min  ||| S:6233 E:6237 ||| NNS
( ||| S:6237 E:6238 ||| -LRB-
Fig.  ||| S:6238 E:6243 ||| NNP
2A ||| S:6243 E:6245 ||| NNP
) ||| S:6245 E:6246 ||| -RRB-
.  ||| S:6246 E:6258 ||| .
N-terminal  ||| S:6258 E:6269 ||| JJ
sequence  ||| S:6269 E:6278 ||| NN
analysis  ||| S:6278 E:6287 ||| NN
showed  ||| S:6287 E:6294 ||| VBD
that  ||| S:6294 E:6299 ||| IN
these  ||| S:6299 E:6305 ||| DT
fragments  ||| S:6305 E:6325 ||| NNS
are  ||| S:6325 E:6329 ||| VBP
derived  ||| S:6329 E:6337 ||| VBN
from  ||| S:6337 E:6342 ||| IN
the  ||| S:6342 E:6346 ||| DT
catalytic  ||| S:6346 E:6356 ||| JJ
and  ||| S:6356 E:6360 ||| CC
the  ||| S:6360 E:6364 ||| DT
TPR  ||| S:6364 E:6368 ||| NNP
domains ||| S:6368 E:6375 ||| NN
,  ||| S:6375 E:6387 ||| ,
respectively  ||| S:6387 E:6400 ||| RB
( ||| S:6400 E:6401 ||| -LRB-
Fig.  ||| S:6401 E:6406 ||| NNP
2A ||| S:6406 E:6408 ||| NNP
, ||| S:6408 E:6409 ||| ,
2B ||| S:6409 E:6411 ||| CD
) ||| S:6411 E:6412 ||| -RRB-
.  ||| S:6412 E:6414 ||| .
The  ||| S:6414 E:6418 ||| DT
crystal  ||| S:6418 E:6426 ||| NN
structure  ||| S:6426 E:6436 ||| NN
of  ||| S:6436 E:6439 ||| IN
the  ||| S:6439 E:6453 ||| DT
PP5  ||| S:6453 E:6457 ||| NNP
TPR  ||| S:6457 E:6461 ||| NNP
domain  ||| S:6461 E:6468 ||| NN
revealed  ||| S:6468 E:6477 ||| VBD
three  ||| S:6477 E:6483 ||| CD
TPRs  ||| S:6483 E:6488 ||| NNS
followed  ||| S:6488 E:6497 ||| VBN
by  ||| S:6497 E:6500 ||| IN
an  ||| S:6500 E:6513 ||| DT
extended  ||| S:6513 E:6522 ||| JJ
α  ||| S:6522 E:6524 ||| JJ
helix  ||| S:6524 E:6530 ||| NNS
[  ||| S:6530 E:6532 ||| -LRB-
24  ||| S:6532 E:6535 ||| CD
]  ||| S:6535 E:6537 ||| -RRB-
,  ||| S:6537 E:6539 ||| ,
however  ||| S:6539 E:6547 ||| RB
Ppt1p  ||| S:6547 E:6553 ||| RB
was  ||| S:6553 E:6557 ||| VBD
originally  ||| S:6557 E:6578 ||| RB
proposed  ||| S:6578 E:6587 ||| VBN
to  ||| S:6587 E:6590 ||| TO
contain  ||| S:6590 E:6598 ||| VB
one  ||| S:6598 E:6602 ||| CD
additional  ||| S:6602 E:6613 ||| JJ
TPR  ||| S:6613 E:6617 ||| NNP
[  ||| S:6617 E:6619 ||| -LRB-
2  ||| S:6619 E:6621 ||| LS
]  ||| S:6621 E:6623 ||| -RRB-
.  ||| S:6623 E:6625 ||| .
The  ||| S:6625 E:6639 ||| DT
pattern  ||| S:6639 E:6647 ||| NN
of  ||| S:6647 E:6650 ||| IN
proteolysis  ||| S:6650 E:6662 ||| NN
and  ||| S:6662 E:6666 ||| CC
sites  ||| S:6666 E:6672 ||| NNS
of  ||| S:6672 E:6675 ||| IN
cleavage  ||| S:6675 E:6684 ||| NN
for  ||| S:6684 E:6688 ||| IN
Ppt1p  ||| S:6688 E:6704 ||| NNP
are  ||| S:6704 E:6708 ||| VBP
very  ||| S:6708 E:6713 ||| RB
similar  ||| S:6713 E:6721 ||| JJ
to  ||| S:6721 E:6724 ||| TO
those  ||| S:6724 E:6730 ||| DT
seen  ||| S:6730 E:6735 ||| VBN
with  ||| S:6735 E:6740 ||| IN
PP5  ||| S:6740 E:6744 ||| CD
under  ||| S:6744 E:6750 ||| IN
these  ||| S:6750 E:6756 ||| DT
same  ||| S:6756 E:6771 ||| JJ
conditions  ||| S:6771 E:6782 ||| NNS
[  ||| S:6782 E:6784 ||| -LRB-
19  ||| S:6784 E:6787 ||| CD
]  ||| S:6787 E:6789 ||| -RRB-
.  ||| S:6789 E:6791 ||| .
This  ||| S:6791 E:6796 ||| DT
indicates  ||| S:6796 E:6806 ||| VBZ
that  ||| S:6806 E:6811 ||| IN
Ppt1p  ||| S:6811 E:6817 ||| NNP
also  ||| S:6817 E:6832 ||| RB
contains  ||| S:6832 E:6841 ||| VBZ
an  ||| S:6841 E:6844 ||| DT
accessible  ||| S:6844 E:6855 ||| JJ
region  ||| S:6855 E:6862 ||| NN
linking  ||| S:6862 E:6870 ||| VBG
the  ||| S:6870 E:6874 ||| DT
TPR  ||| S:6874 E:6878 ||| NNP
and  ||| S:6878 E:6892 ||| CC
catalytic  ||| S:6892 E:6902 ||| JJ
domains  ||| S:6902 E:6910 ||| NN
and  ||| S:6910 E:6914 ||| CC
is  ||| S:6914 E:6917 ||| VBZ
most  ||| S:6917 E:6922 ||| RBS
consistent  ||| S:6922 E:6933 ||| JJ
with  ||| S:6933 E:6938 ||| IN
the  ||| S:6938 E:6952 ||| DT
presence  ||| S:6952 E:6961 ||| NN
of  ||| S:6961 E:6964 ||| IN
three  ||| S:6964 E:6970 ||| CD
TPRs  ||| S:6970 E:6975 ||| NN
in  ||| S:6975 E:6978 ||| IN
Ppt1p ||| S:6978 E:6983 ||| CD
.  ||| S:6983 E:6985 ||| .
Limited  ||| S:6985 E:6993 ||| JJ
tryptic  ||| S:6993 E:7011 ||| JJ
proteolysis  ||| S:7011 E:7023 ||| NN
in  ||| S:7023 E:7026 ||| IN
the  ||| S:7026 E:7030 ||| DT
presence  ||| S:7030 E:7039 ||| NN
of  ||| S:7039 E:7042 ||| IN
250  ||| S:7042 E:7046 ||| CD
μM  ||| S:7046 E:7049 ||| JJ
AA  ||| S:7049 E:7052 ||| NN
generated  ||| S:7052 E:7062 ||| VBD
a  ||| S:7062 E:7074 ||| DT
distinct  ||| S:7074 E:7083 ||| JJ
pattern  ||| S:7083 E:7091 ||| NN
of  ||| S:7091 E:7094 ||| IN
fragmentation  ||| S:7094 E:7108 ||| NNS
( ||| S:7108 E:7109 ||| -LRB-
Fig.  ||| S:7109 E:7114 ||| NNP
2A ||| S:7114 E:7116 ||| NNP
) ||| S:7116 E:7117 ||| -RRB-
.  ||| S:7117 E:7119 ||| .
A  ||| S:7119 E:7121 ||| DT
20  ||| S:7121 E:7124 ||| CD
kDa  ||| S:7124 E:7138 ||| JJ
fragment  ||| S:7138 E:7147 ||| NN
was  ||| S:7147 E:7151 ||| VBD
observed  ||| S:7151 E:7160 ||| VBN
at  ||| S:7160 E:7163 ||| IN
early  ||| S:7163 E:7169 ||| JJ
times ||| S:7169 E:7174 ||| NNS
,  ||| S:7174 E:7176 ||| ,
but  ||| S:7176 E:7180 ||| CC
a  ||| S:7180 E:7182 ||| DT
series  ||| S:7182 E:7189 ||| NN
of  ||| S:7189 E:7202 ||| IN
four  ||| S:7202 E:7207 ||| CD
fragments  ||| S:7207 E:7217 ||| NNS
ranging  ||| S:7217 E:7225 ||| VBG
from  ||| S:7225 E:7230 ||| IN
14-16  ||| S:7230 E:7236 ||| NNP
kDa  ||| S:7236 E:7240 ||| NNP
appeared  ||| S:7240 E:7249 ||| VBD
between  ||| S:7249 E:7257 ||| IN
10  ||| S:7257 E:7270 ||| CD
and  ||| S:7270 E:7274 ||| CC
30  ||| S:7274 E:7277 ||| CD
min  ||| S:7277 E:7281 ||| NN
as  ||| S:7281 E:7284 ||| IN
the  ||| S:7284 E:7288 ||| DT
amount  ||| S:7288 E:7295 ||| NN
of  ||| S:7295 E:7298 ||| IN
the  ||| S:7298 E:7302 ||| DT
20  ||| S:7302 E:7305 ||| CD
kDa  ||| S:7305 E:7309 ||| JJ
fragment  ||| S:7309 E:7328 ||| NN
decreased ||| S:7328 E:7337 ||| VBD
.  ||| S:7337 E:7339 ||| .
These  ||| S:7339 E:7345 ||| DT
fragments ||| S:7345 E:7354 ||| NN
,  ||| S:7354 E:7356 ||| ,
which  ||| S:7356 E:7362 ||| WDT
are  ||| S:7362 E:7366 ||| VBP
derived  ||| S:7366 E:7374 ||| VBN
from  ||| S:7374 E:7379 ||| IN
the  ||| S:7379 E:7393 ||| DT
TPR  ||| S:7393 E:7397 ||| NNP
domain ||| S:7397 E:7403 ||| NN
,  ||| S:7403 E:7405 ||| ,
were  ||| S:7405 E:7410 ||| VBD
not  ||| S:7410 E:7414 ||| RB
observed  ||| S:7414 E:7423 ||| VBN
in  ||| S:7423 E:7426 ||| IN
the  ||| S:7426 E:7430 ||| DT
absence  ||| S:7430 E:7438 ||| NN
of  ||| S:7438 E:7441 ||| IN
AA ||| S:7441 E:7443 ||| NN
,  ||| S:7443 E:7455 ||| ,
suggesting  ||| S:7455 E:7466 ||| VBG
that  ||| S:7466 E:7471 ||| IN
lipid  ||| S:7471 E:7477 ||| JJ
binding  ||| S:7477 E:7485 ||| NNS
alters  ||| S:7485 E:7492 ||| VBP
the  ||| S:7492 E:7496 ||| DT
conformation  ||| S:7496 E:7509 ||| NN
of  ||| S:7509 E:7522 ||| IN
this  ||| S:7522 E:7527 ||| DT
domain  ||| S:7527 E:7534 ||| NN
and  ||| S:7534 E:7538 ||| CC
its  ||| S:7538 E:7542 ||| PRP$
susceptibility  ||| S:7542 E:7557 ||| NN
to  ||| S:7557 E:7560 ||| TO
proteolysis ||| S:7560 E:7571 ||| VB
.  ||| S:7571 E:7573 ||| .
A  ||| S:7573 E:7585 ||| DT
similar  ||| S:7585 E:7593 ||| JJ
change  ||| S:7593 E:7600 ||| NN
in  ||| S:7600 E:7603 ||| IN
susceptibility  ||| S:7603 E:7618 ||| VBG
to  ||| S:7618 E:7621 ||| TO
proteolysis  ||| S:7621 E:7633 ||| VB
upon  ||| S:7633 E:7648 ||| IN
lipid  ||| S:7648 E:7654 ||| JJ
binding  ||| S:7654 E:7662 ||| NN
was  ||| S:7662 E:7666 ||| VBD
observed  ||| S:7666 E:7675 ||| VBN
with  ||| S:7675 E:7680 ||| IN
PP5  ||| S:7680 E:7684 ||| NNP
[  ||| S:7684 E:7686 ||| -LRB-
19  ||| S:7686 E:7689 ||| CD
]  ||| S:7689 E:7691 ||| -RRB-
.  ||| S:7691 E:7693 ||| .
As  ||| S:7693 E:7696 ||| RB
with  ||| S:7696 E:7701 ||| IN
PP5 ||| S:7701 E:7704 ||| NNP
,  ||| S:7704 E:7716 ||| ,
only  ||| S:7716 E:7721 ||| RB
lipids  ||| S:7721 E:7728 ||| VBN
that  ||| S:7728 E:7733 ||| IN
stimulated  ||| S:7733 E:7744 ||| CD
32P-MBP  ||| S:7744 E:7752 ||| CD
dephosphorylation  ||| S:7752 E:7780 ||| NNS
slowed  ||| S:7780 E:7787 ||| VBD
degradation  ||| S:7787 E:7799 ||| VBN
of  ||| S:7799 E:7802 ||| IN
the  ||| S:7802 E:7806 ||| DT
20  ||| S:7806 E:7809 ||| CD
kDa  ||| S:7809 E:7813 ||| JJ
TPR  ||| S:7813 E:7817 ||| NNP
fragment  ||| S:7817 E:7826 ||| NN
( ||| S:7826 E:7827 ||| -LRB-
Table  ||| S:7827 E:7843 ||| NNP
1 ||| S:7843 E:7844 ||| CD
) ||| S:7844 E:7845 ||| -RRB-
.  ||| S:7845 E:7857 ||| .
Removal  ||| S:7857 E:7865 ||| NN
of  ||| S:7865 E:7868 ||| IN
the  ||| S:7868 E:7872 ||| DT
TPR  ||| S:7872 E:7876 ||| NNP
domain  ||| S:7876 E:7883 ||| NN
from  ||| S:7883 E:7888 ||| IN
Ppt1p  ||| S:7888 E:7894 ||| CD
by  ||| S:7894 E:7897 ||| IN
trypsin  ||| S:7897 E:7915 ||| JJ
treatment  ||| S:7915 E:7925 ||| NN
had  ||| S:7925 E:7929 ||| VBD
no  ||| S:7929 E:7932 ||| DT
effect  ||| S:7932 E:7939 ||| NN
on  ||| S:7939 E:7942 ||| IN
its  ||| S:7942 E:7946 ||| PRP$
activity  ||| S:7946 E:7955 ||| NN
toward  ||| S:7955 E:7972 ||| IN
32P-casein ||| S:7972 E:7982 ||| NNP
,  ||| S:7982 E:7984 ||| ,
but  ||| S:7984 E:7988 ||| CC
increased  ||| S:7988 E:7998 ||| JJ
activity  ||| S:7998 E:8007 ||| NN
toward  ||| S:8007 E:8014 ||| IN
32P-MBP  ||| S:8014 E:8032 ||| NNP
approximately  ||| S:8032 E:8046 ||| RB
two  ||| S:8046 E:8050 ||| CD
fold  ||| S:8050 E:8055 ||| NNS
( ||| S:8055 E:8056 ||| -LRB-
Fig.  ||| S:8056 E:8061 ||| NNP
2C ||| S:8061 E:8063 ||| NNP
) ||| S:8063 E:8064 ||| -RRB-
.  ||| S:8064 E:8066 ||| .
AA  ||| S:8066 E:8069 ||| NN
did  ||| S:8069 E:8073 ||| VBD
not  ||| S:8073 E:8077 ||| RB
stimulate  ||| S:8077 E:8097 ||| VB
32P-MBP  ||| S:8097 E:8105 ||| CD
dephosphorylation  ||| S:8105 E:8123 ||| NN
by  ||| S:8123 E:8126 ||| IN
Ppt1p  ||| S:8126 E:8132 ||| CD
after  ||| S:8132 E:8138 ||| IN
removal  ||| S:8138 E:8146 ||| NN
of  ||| S:8146 E:8149 ||| IN
the  ||| S:8149 E:8163 ||| DT
TPR  ||| S:8163 E:8167 ||| NNP
domain  ||| S:8167 E:8174 ||| NN
( ||| S:8174 E:8175 ||| -LRB-
data  ||| S:8175 E:8180 ||| NNS
not  ||| S:8180 E:8184 ||| RB
shown ||| S:8184 E:8189 ||| VBN
) ||| S:8189 E:8190 ||| -RRB-
.  ||| S:8190 E:8192 ||| .
Thus ||| S:8192 E:8196 ||| RB
,  ||| S:8196 E:8198 ||| ,
lipids  ||| S:8198 E:8205 ||| NN
that  ||| S:8205 E:8210 ||| WDT
activate  ||| S:8210 E:8229 ||| VBP
Ppt1p  ||| S:8229 E:8235 ||| RB
alter  ||| S:8235 E:8241 ||| VB
the  ||| S:8241 E:8245 ||| DT
sensitivity  ||| S:8245 E:8257 ||| NN
of  ||| S:8257 E:8260 ||| IN
the  ||| S:8260 E:8264 ||| DT
TPR  ||| S:8264 E:8268 ||| NNP
domain  ||| S:8268 E:8275 ||| NN
to  ||| S:8275 E:8288 ||| TO
proteolysis ||| S:8288 E:8299 ||| VB
,  ||| S:8299 E:8301 ||| ,
and  ||| S:8301 E:8305 ||| CC
removal  ||| S:8305 E:8313 ||| NN
of  ||| S:8313 E:8316 ||| IN
the  ||| S:8316 E:8320 ||| DT
TPR  ||| S:8320 E:8324 ||| NNP
domain  ||| S:8324 E:8331 ||| NN
causes  ||| S:8331 E:8338 ||| VBZ
a  ||| S:8338 E:8340 ||| DT
loss  ||| S:8340 E:8355 ||| NN
of  ||| S:8355 E:8358 ||| IN
the  ||| S:8358 E:8362 ||| DT
response  ||| S:8362 E:8371 ||| NN
of  ||| S:8371 E:8374 ||| IN
Ppt1p  ||| S:8374 E:8380 ||| CD
to  ||| S:8380 E:8383 ||| TO
lipid ||| S:8383 E:8388 ||| VB
.  ||| S:8388 E:8390 ||| .
However ||| S:8390 E:8397 ||| RB
,  ||| S:8397 E:8399 ||| ,
removal  ||| S:8399 E:8407 ||| NN
of  ||| S:8407 E:8420 ||| IN
the  ||| S:8420 E:8424 ||| DT
TPR  ||| S:8424 E:8428 ||| NNP
domain  ||| S:8428 E:8435 ||| NN
only  ||| S:8435 E:8440 ||| RB
modestly  ||| S:8440 E:8449 ||| RB
increases  ||| S:8449 E:8459 ||| VBZ
Ppt1p  ||| S:8459 E:8465 ||| CD
activity ||| S:8465 E:8473 ||| NN
,  ||| S:8473 E:8475 ||| ,
in  ||| S:8475 E:8488 ||| IN
contrast  ||| S:8488 E:8497 ||| NN
to  ||| S:8497 E:8500 ||| TO
the  ||| S:8500 E:8504 ||| DT
5-25  ||| S:8504 E:8509 ||| CD
fold  ||| S:8509 E:8514 ||| NNS
elevation  ||| S:8514 E:8524 ||| VBP
reported  ||| S:8524 E:8533 ||| VBN
after  ||| S:8533 E:8539 ||| IN
TPR  ||| S:8539 E:8553 ||| NNP
removal  ||| S:8553 E:8561 ||| NN
from  ||| S:8561 E:8566 ||| IN
PP5  ||| S:8566 E:8570 ||| NNP
[  ||| S:8570 E:8572 ||| -LRB-
19  ||| S:8572 E:8575 ||| CD
20  ||| S:8575 E:8578 ||| CD
]  ||| S:8578 E:8580 ||| -RRB-
.  ||| S:8580 E:8582 ||| .
Although  ||| S:8582 E:8591 ||| IN
we  ||| S:8591 E:8594 ||| PRP
cannot  ||| S:8594 E:8601 ||| RB
rule  ||| S:8601 E:8606 ||| VB
out  ||| S:8606 E:8620 ||| RP
the  ||| S:8620 E:8624 ||| DT
possibility  ||| S:8624 E:8636 ||| NN
that  ||| S:8636 E:8641 ||| IN
proteolyzed  ||| S:8641 E:8653 ||| JJ
Ppt1p  ||| S:8653 E:8659 ||| NN
is  ||| S:8659 E:8662 ||| VBZ
unresponsive  ||| S:8662 E:8675 ||| VBN
to  ||| S:8675 E:8688 ||| TO
lipid  ||| S:8688 E:8694 ||| VB
because  ||| S:8694 E:8702 ||| IN
it  ||| S:8702 E:8705 ||| PRP
is  ||| S:8705 E:8708 ||| VBZ
unstable ||| S:8708 E:8716 ||| JJ
,  ||| S:8716 E:8718 ||| ,
the  ||| S:8718 E:8722 ||| DT
observations  ||| S:8722 E:8735 ||| NNS
that  ||| S:8735 E:8740 ||| IN
the  ||| S:8740 E:8754 ||| DT
catalytic  ||| S:8754 E:8764 ||| JJ
fragment  ||| S:8764 E:8773 ||| NN
remains  ||| S:8773 E:8781 ||| VBZ
undegraded  ||| S:8781 E:8792 ||| VBN
and  ||| S:8792 E:8796 ||| CC
control  ||| S:8796 E:8814 ||| NN
activity  ||| S:8814 E:8823 ||| NN
is  ||| S:8823 E:8826 ||| VBZ
not  ||| S:8826 E:8830 ||| RB
decreased  ||| S:8830 E:8840 ||| VBN
argue  ||| S:8840 E:8846 ||| VBP
against  ||| S:8846 E:8854 ||| IN
this  ||| S:8854 E:8859 ||| DT
possibility ||| S:8859 E:8870 ||| NN
.  ||| S:8870 E:8882 ||| .
Alternatively ||| S:8882 E:8895 ||| RB
,  ||| S:8895 E:8897 ||| ,
an  ||| S:8897 E:8900 ||| DT
inhibitory  ||| S:8900 E:8911 ||| JJ
element  ||| S:8911 E:8919 ||| NN
in  ||| S:8919 E:8922 ||| IN
the  ||| S:8922 E:8926 ||| DT
linker  ||| S:8926 E:8933 ||| JJ
region  ||| S:8933 E:8950 ||| NN
may  ||| S:8950 E:8954 ||| MD
remain  ||| S:8954 E:8961 ||| VB
after  ||| S:8961 E:8967 ||| IN
TPR  ||| S:8967 E:8971 ||| NNP
domain  ||| S:8971 E:8978 ||| NN
removal ||| S:8978 E:8985 ||| NN
.  ||| S:8985 E:9015 ||| .
The  ||| S:9015 E:9019 ||| DT
effect  ||| S:9019 E:9026 ||| NN
of  ||| S:9026 E:9029 ||| IN
C-terminal  ||| S:9029 E:9040 ||| JJ
truncation  ||| S:9040 E:9051 ||| NN
on  ||| S:9051 E:9054 ||| IN
Ppt1p  ||| S:9054 E:9070 ||| CD
activity  ||| S:9070 E:9089 ||| NN
Removal  ||| S:9089 E:9097 ||| NNS
of  ||| S:9097 E:9100 ||| IN
10-13  ||| S:9100 E:9106 ||| CD
residues  ||| S:9106 E:9115 ||| NNS
from  ||| S:9115 E:9120 ||| IN
the  ||| S:9120 E:9124 ||| DT
C  ||| S:9124 E:9126 ||| NNP
terminus  ||| S:9126 E:9135 ||| NN
of  ||| S:9135 E:9138 ||| IN
PP5  ||| S:9138 E:9152 ||| CD
results  ||| S:9152 E:9160 ||| NNS
in  ||| S:9160 E:9163 ||| IN
a  ||| S:9163 E:9165 ||| DT
highly  ||| S:9165 E:9172 ||| RB
active  ||| S:9172 E:9179 ||| JJ
enzyme  ||| S:9179 E:9186 ||| NN
that  ||| S:9186 E:9191 ||| WDT
is  ||| S:9191 E:9194 ||| VBZ
only  ||| S:9194 E:9199 ||| RB
modestly  ||| S:9199 E:9218 ||| RB
stimulated  ||| S:9218 E:9229 ||| VBN
by  ||| S:9229 E:9232 ||| IN
lipid  ||| S:9232 E:9238 ||| NNS
[  ||| S:9238 E:9240 ||| -LRB-
19  ||| S:9240 E:9243 ||| CD
]  ||| S:9243 E:9245 ||| -RRB-
.  ||| S:9245 E:9247 ||| .
To  ||| S:9247 E:9250 ||| TO
examine  ||| S:9250 E:9258 ||| VB
the  ||| S:9258 E:9262 ||| DT
role  ||| S:9262 E:9267 ||| NN
of  ||| S:9267 E:9270 ||| IN
the  ||| S:9270 E:9274 ||| DT
C  ||| S:9274 E:9286 ||| NNP
terminus  ||| S:9286 E:9295 ||| NN
in  ||| S:9295 E:9298 ||| IN
controlling  ||| S:9298 E:9310 ||| VBG
Ppt1p  ||| S:9310 E:9316 ||| CD
phosphatase  ||| S:9316 E:9328 ||| JJ
activity ||| S:9328 E:9336 ||| NN
,  ||| S:9336 E:9338 ||| ,
a  ||| S:9338 E:9350 ||| DT
similar  ||| S:9350 E:9358 ||| JJ
truncation  ||| S:9358 E:9369 ||| JJ
mutant ||| S:9369 E:9375 ||| NN
,  ||| S:9375 E:9377 ||| ,
Ppt1p  ||| S:9377 E:9383 ||| NNP
( ||| S:9383 E:9384 ||| -LRB-
1-504 ||| S:9384 E:9389 ||| NNP
) ||| S:9389 E:9390 ||| -RRB-
,  ||| S:9390 E:9392 ||| ,
was  ||| S:9392 E:9396 ||| VBD
expressed  ||| S:9396 E:9416 ||| VBN
and  ||| S:9416 E:9420 ||| CC
characterized  ||| S:9420 E:9434 ||| NNS
( ||| S:9434 E:9435 ||| -LRB-
Fig.  ||| S:9435 E:9440 ||| CD
1Aand  ||| S:9440 E:9446 ||| CD
3 ||| S:9446 E:9447 ||| CD
) ||| S:9447 E:9448 ||| -RRB-
.  ||| S:9448 E:9450 ||| .
Compared  ||| S:9450 E:9459 ||| VBN
to  ||| S:9459 E:9462 ||| TO
full-length  ||| S:9462 E:9484 ||| JJ
enzyme  ||| S:9484 E:9491 ||| JJ
Ppt1p  ||| S:9491 E:9497 ||| NNP
( ||| S:9497 E:9498 ||| -LRB-
1-504 ||| S:9498 E:9503 ||| NNP
)  ||| S:9503 E:9505 ||| -RRB-
exhibited  ||| S:9505 E:9515 ||| VBZ
a  ||| S:9515 E:9517 ||| DT
two-fold  ||| S:9517 E:9526 ||| JJ
increase  ||| S:9526 E:9535 ||| NN
in  ||| S:9535 E:9548 ||| IN
control  ||| S:9548 E:9556 ||| NN
specific  ||| S:9556 E:9565 ||| JJ
activity  ||| S:9565 E:9574 ||| NN
with  ||| S:9574 E:9579 ||| IN
both  ||| S:9579 E:9584 ||| DT
32P-casein  ||| S:9584 E:9595 ||| NNP
and  ||| S:9595 E:9609 ||| CC
32P-MBP ||| S:9609 E:9616 ||| NNP
.  ||| S:9616 E:9618 ||| .
Lipid  ||| S:9618 E:9624 ||| NNP
did  ||| S:9624 E:9628 ||| VBD
not  ||| S:9628 E:9632 ||| RB
stimulate  ||| S:9632 E:9642 ||| VB
Ppt1p  ||| S:9642 E:9648 ||| NNP
( ||| S:9648 E:9649 ||| -LRB-
1-504 ||| S:9649 E:9654 ||| NNP
)  ||| S:9654 E:9656 ||| -RRB-
toward  ||| S:9656 E:9673 ||| IN
32P-casein ||| S:9673 E:9683 ||| NNP
,  ||| S:9683 E:9685 ||| ,
but  ||| S:9685 E:9689 ||| CC
still  ||| S:9689 E:9695 ||| RB
increased  ||| S:9695 E:9705 ||| VBN
activity  ||| S:9705 E:9714 ||| NN
with  ||| S:9714 E:9719 ||| IN
32P-MBP  ||| S:9719 E:9737 ||| CD
12-fold ||| S:9737 E:9744 ||| CD
.  ||| S:9744 E:9746 ||| .
In  ||| S:9746 E:9749 ||| IN
contrast ||| S:9749 E:9757 ||| NN
,  ||| S:9757 E:9759 ||| ,
C-terminal  ||| S:9759 E:9770 ||| JJ
truncation  ||| S:9770 E:9781 ||| NN
of  ||| S:9781 E:9784 ||| IN
PP5  ||| S:9784 E:9798 ||| NNP
activates  ||| S:9798 E:9808 ||| VBD
the  ||| S:9808 E:9812 ||| DT
enzyme  ||| S:9812 E:9819 ||| NN
as  ||| S:9819 E:9822 ||| IN
extensively  ||| S:9822 E:9834 ||| NN
as  ||| S:9834 E:9837 ||| IN
lipid  ||| S:9837 E:9843 ||| JJ
treatment ||| S:9843 E:9852 ||| NN
,  ||| S:9852 E:9864 ||| ,
and  ||| S:9864 E:9868 ||| CC
little  ||| S:9868 E:9875 ||| JJ
further  ||| S:9875 E:9883 ||| JJ
activation  ||| S:9883 E:9894 ||| NN
is  ||| S:9894 E:9897 ||| VBZ
seen  ||| S:9897 E:9902 ||| VBN
with  ||| S:9902 E:9907 ||| IN
lipid  ||| S:9907 E:9913 ||| NNS
[  ||| S:9913 E:9915 ||| -LRB-
19  ||| S:9915 E:9918 ||| CD
]  ||| S:9918 E:9920 ||| -RRB-
.  ||| S:9920 E:9932 ||| .
In  ||| S:9932 E:9935 ||| IN
the  ||| S:9935 E:9939 ||| DT
case  ||| S:9939 E:9944 ||| NN
of  ||| S:9944 E:9947 ||| IN
PP5 ||| S:9947 E:9950 ||| NNP
,  ||| S:9950 E:9952 ||| ,
subtilisin  ||| S:9952 E:9963 ||| NNS
digestion  ||| S:9963 E:9973 ||| VBP
removed  ||| S:9973 E:9981 ||| VBN
both  ||| S:9981 E:9986 ||| PDT
the  ||| S:9986 E:10000 ||| DT
TPR  ||| S:10000 E:10004 ||| NNP
domain  ||| S:10004 E:10011 ||| NN
and  ||| S:10011 E:10015 ||| CC
the  ||| S:10015 E:10019 ||| DT
C  ||| S:10019 E:10021 ||| NNP
terminus  ||| S:10021 E:10030 ||| NNS
[  ||| S:10030 E:10032 ||| -LRB-
19  ||| S:10032 E:10035 ||| CD
]  ||| S:10035 E:10037 ||| -RRB-
.  ||| S:10037 E:10039 ||| .
The  ||| S:10039 E:10043 ||| DT
observation  ||| S:10043 E:10065 ||| NN
that  ||| S:10065 E:10070 ||| IN
C-terminal  ||| S:10070 E:10081 ||| JJ
truncation  ||| S:10081 E:10092 ||| NN
increased  ||| S:10092 E:10102 ||| VBD
Ppt1p  ||| S:10102 E:10108 ||| CD
activity  ||| S:10108 E:10127 ||| NN
toward  ||| S:10127 E:10134 ||| IN
both  ||| S:10134 E:10139 ||| DT
32P-casein  ||| S:10139 E:10150 ||| NNP
and  ||| S:10150 E:10154 ||| CC
32P-MBP ||| S:10154 E:10161 ||| NNP
,  ||| S:10161 E:10163 ||| ,
but  ||| S:10163 E:10167 ||| CC
subtilisin  ||| S:10167 E:10188 ||| JJ
digestion  ||| S:10188 E:10198 ||| NN
increased  ||| S:10198 E:10208 ||| VBD
activity  ||| S:10208 E:10217 ||| NN
only  ||| S:10217 E:10222 ||| RB
toward  ||| S:10222 E:10229 ||| IN
32P-MBP  ||| S:10229 E:10237 ||| NNP
( ||| S:10237 E:10238 ||| -LRB-
see  ||| S:10238 E:10252 ||| VB
Fig.  ||| S:10252 E:10257 ||| CD
2C ||| S:10257 E:10259 ||| CD
)  ||| S:10259 E:10261 ||| -RRB-
suggests  ||| S:10261 E:10270 ||| VBZ
that  ||| S:10270 E:10275 ||| IN
the  ||| S:10275 E:10279 ||| DT
C  ||| S:10279 E:10281 ||| NNP
terminus  ||| S:10281 E:10290 ||| NN
of  ||| S:10290 E:10293 ||| IN
Ppt1p  ||| S:10293 E:10299 ||| NNP
remained  ||| S:10299 E:10318 ||| VBD
intact  ||| S:10318 E:10325 ||| JJ
during  ||| S:10325 E:10332 ||| IN
subtilisin  ||| S:10332 E:10343 ||| JJ
digestion ||| S:10343 E:10352 ||| NN
.  ||| S:10352 E:10354 ||| .
However ||| S:10354 E:10361 ||| RB
,  ||| S:10361 E:10363 ||| ,
mass  ||| S:10363 E:10378 ||| JJ
analysis  ||| S:10378 E:10387 ||| NN
of  ||| S:10387 E:10390 ||| IN
the  ||| S:10390 E:10394 ||| DT
subtilisin-derived  ||| S:10394 E:10413 ||| JJ
catalytic  ||| S:10413 E:10423 ||| JJ
fragment  ||| S:10423 E:10442 ||| NN
would  ||| S:10442 E:10448 ||| MD
be  ||| S:10448 E:10451 ||| VB
required  ||| S:10451 E:10460 ||| VBN
to  ||| S:10460 E:10463 ||| TO
confirm  ||| S:10463 E:10471 ||| VB
this ||| S:10471 E:10475 ||| DT
.  ||| S:10475 E:10505 ||| .
Expression  ||| S:10505 E:10516 ||| NN
and  ||| S:10516 E:10520 ||| CC
localization  ||| S:10520 E:10533 ||| NN
of  ||| S:10533 E:10536 ||| IN
HA-Ppt1p  ||| S:10536 E:10545 ||| CD
in  ||| S:10545 E:10548 ||| IN
yeast  ||| S:10548 E:10564 ||| NN
cells  ||| S:10564 E:10580 ||| NNS
To  ||| S:10580 E:10583 ||| TO
examine  ||| S:10583 E:10591 ||| VB
when  ||| S:10591 E:10596 ||| WRB
Ppt1p  ||| S:10596 E:10602 ||| NNP
is  ||| S:10602 E:10605 ||| VBZ
expressed  ||| S:10605 E:10615 ||| VBN
and  ||| S:10615 E:10619 ||| CC
where  ||| S:10619 E:10625 ||| WRB
it  ||| S:10625 E:10628 ||| PRP
is  ||| S:10628 E:10641 ||| VBZ
localized ||| S:10641 E:10650 ||| VBN
,  ||| S:10650 E:10652 ||| ,
a  ||| S:10652 E:10654 ||| DT
yeast  ||| S:10654 E:10660 ||| NN
strain  ||| S:10660 E:10667 ||| NN
( ||| S:10667 E:10668 ||| -LRB-
WHT4-1 ||| S:10668 E:10674 ||| NNP
)  ||| S:10674 E:10676 ||| -RRB-
was  ||| S:10676 E:10680 ||| VBD
generated  ||| S:10680 E:10690 ||| VBN
in  ||| S:10690 E:10693 ||| IN
which  ||| S:10693 E:10709 ||| WDT
the  ||| S:10709 E:10724 ||| DT
PPT1  ||| S:10724 E:10729 ||| JJ
gene  ||| S:10729 E:10734 ||| NN
was  ||| S:10734 E:10738 ||| VBD
replaced  ||| S:10738 E:10747 ||| VBN
with  ||| S:10747 E:10752 ||| IN
cDNA  ||| S:10752 E:10767 ||| FW
encoding  ||| S:10767 E:10776 ||| FW
hemagglutinin-tagged  ||| S:10776 E:10797 ||| FW
Ppt1p  ||| S:10797 E:10803 ||| FW
( ||| S:10803 E:10804 ||| -LRB-
HA-Ppt1p ||| S:10804 E:10812 ||| NNP
) ||| S:10812 E:10813 ||| -RRB-
.  ||| S:10813 E:10825 ||| .
Immunoblotting  ||| S:10825 E:10840 ||| NNP
showed  ||| S:10840 E:10847 ||| VBD
that  ||| S:10847 E:10852 ||| IN
HA-Ppt1p  ||| S:10852 E:10861 ||| CD
levels  ||| S:10861 E:10868 ||| NNS
were  ||| S:10868 E:10873 ||| VBD
highest  ||| S:10873 E:10891 ||| JJS
in  ||| S:10891 E:10894 ||| IN
early  ||| S:10894 E:10900 ||| JJ
log  ||| S:10900 E:10904 ||| JJ
phase ||| S:10904 E:10909 ||| NN
,  ||| S:10909 E:10911 ||| ,
and  ||| S:10911 E:10915 ||| CC
then  ||| S:10915 E:10920 ||| RB
decreased  ||| S:10920 E:10930 ||| VBD
dramatically  ||| S:10930 E:10953 ||| RB
during  ||| S:10953 E:10960 ||| IN
the  ||| S:10960 E:10964 ||| DT
stationary  ||| S:10964 E:10975 ||| JJ
phase  ||| S:10975 E:10981 ||| NN
( ||| S:10981 E:10982 ||| -LRB-
Fig.  ||| S:10982 E:10987 ||| NNP
4A ||| S:10987 E:10989 ||| NNP
, ||| S:10989 E:10990 ||| ,
4B ||| S:10990 E:10992 ||| CD
) ||| S:10992 E:10993 ||| -RRB-
.  ||| S:10993 E:10995 ||| .
Northern  ||| S:10995 E:11014 ||| JJ
analysis  ||| S:11014 E:11023 ||| NN
showed  ||| S:11023 E:11030 ||| VBD
that  ||| S:11030 E:11035 ||| IN
the  ||| S:11035 E:11050 ||| DT
PPT1  ||| S:11050 E:11055 ||| JJ
mRNA  ||| S:11055 E:11060 ||| JJ
levels  ||| S:11060 E:11067 ||| NNS
also  ||| S:11067 E:11072 ||| RB
increased  ||| S:11072 E:11082 ||| VBN
in  ||| S:11082 E:11095 ||| IN
early  ||| S:11095 E:11101 ||| JJ
log  ||| S:11101 E:11105 ||| JJ
phase  ||| S:11105 E:11111 ||| NN
and  ||| S:11111 E:11115 ||| CC
decreased  ||| S:11115 E:11125 ||| VBD
as  ||| S:11125 E:11128 ||| IN
the  ||| S:11128 E:11132 ||| DT
cell  ||| S:11132 E:11137 ||| NN
division  ||| S:11137 E:11156 ||| NN
decreased  ||| S:11156 E:11166 ||| VBD
upon  ||| S:11166 E:11171 ||| IN
entering  ||| S:11171 E:11180 ||| VBG
the  ||| S:11180 E:11184 ||| DT
stationary  ||| S:11184 E:11195 ||| JJ
phase  ||| S:11195 E:11201 ||| NN
( ||| S:11201 E:11202 ||| -LRB-
Fig.  ||| S:11202 E:11207 ||| NNP
4C ||| S:11207 E:11209 ||| NNP
) ||| S:11209 E:11210 ||| -RRB-
,  ||| S:11210 E:11222 ||| ,
correlating  ||| S:11222 E:11234 ||| VBG
with  ||| S:11234 E:11239 ||| IN
protein  ||| S:11239 E:11247 ||| NN
expression ||| S:11247 E:11257 ||| NN
.  ||| S:11257 E:11259 ||| .
The  ||| S:11259 E:11263 ||| DT
pattern  ||| S:11263 E:11271 ||| NN
of  ||| S:11271 E:11285 ||| IN
PPT1  ||| S:11285 E:11290 ||| CD
gene  ||| S:11290 E:11295 ||| NN
expression  ||| S:11295 E:11306 ||| NN
was  ||| S:11306 E:11310 ||| VBD
identical  ||| S:11310 E:11330 ||| JJ
in  ||| S:11330 E:11333 ||| IN
wild-type  ||| S:11333 E:11343 ||| JJ
cells  ||| S:11343 E:11349 ||| NNS
and  ||| S:11349 E:11353 ||| CC
cells  ||| S:11353 E:11359 ||| NNS
expressing  ||| S:11359 E:11370 ||| VBG
HA-Ppt1p ||| S:11370 E:11378 ||| NNP
,  ||| S:11378 E:11390 ||| ,
indicating  ||| S:11390 E:11401 ||| VBG
that  ||| S:11401 E:11406 ||| IN
the  ||| S:11406 E:11410 ||| DT
epitope  ||| S:11410 E:11418 ||| JJ
tag  ||| S:11418 E:11422 ||| NN
did  ||| S:11422 E:11426 ||| VBD
not  ||| S:11426 E:11430 ||| RB
alter  ||| S:11430 E:11446 ||| VB
transcription  ||| S:11446 E:11460 ||| NNS
or  ||| S:11460 E:11463 ||| CC
message  ||| S:11463 E:11471 ||| NN
stability  ||| S:11471 E:11481 ||| NN
( ||| S:11481 E:11482 ||| -LRB-
data  ||| S:11482 E:11487 ||| NNS
not  ||| S:11487 E:11491 ||| RB
shown ||| S:11491 E:11496 ||| VBN
) ||| S:11496 E:11497 ||| -RRB-
.  ||| S:11497 E:11509 ||| .
Cells  ||| S:11509 E:11515 ||| NNS
in  ||| S:11515 E:11518 ||| IN
early  ||| S:11518 E:11524 ||| JJ
log  ||| S:11524 E:11528 ||| JJ
phase  ||| S:11528 E:11534 ||| NN
growth  ||| S:11534 E:11541 ||| NN
when  ||| S:11541 E:11557 ||| WRB
PPT1  ||| S:11557 E:11562 ||| JJ
gene  ||| S:11562 E:11567 ||| NN
expression  ||| S:11567 E:11578 ||| NN
was  ||| S:11578 E:11582 ||| VBD
maximal  ||| S:11582 E:11600 ||| RB
were  ||| S:11600 E:11605 ||| VBD
used  ||| S:11605 E:11610 ||| VBN
to  ||| S:11610 E:11613 ||| TO
localize  ||| S:11613 E:11622 ||| CD
HA-Ppt1p ||| S:11622 E:11630 ||| CD
.  ||| S:11630 E:11632 ||| .
Indirect  ||| S:11632 E:11651 ||| JJ
immunofluorescence  ||| S:11651 E:11670 ||| NN
was  ||| S:11670 E:11674 ||| VBD
required  ||| S:11674 E:11683 ||| VBN
to  ||| S:11683 E:11686 ||| TO
detect  ||| S:11686 E:11693 ||| VB
HA-Ppt1p ||| S:11693 E:11701 ||| CD
.  ||| S:11701 E:11713 ||| .
Fluorescence  ||| S:11713 E:11726 ||| NNP
microscopy  ||| S:11726 E:11737 ||| VBD
indicated  ||| S:11737 E:11747 ||| VBN
that  ||| S:11747 E:11752 ||| IN
HA-Ppt1p  ||| S:11752 E:11761 ||| NNP
was  ||| S:11761 E:11775 ||| VBD
present  ||| S:11775 E:11783 ||| JJ
throughout  ||| S:11783 E:11794 ||| IN
the  ||| S:11794 E:11798 ||| DT
cell ||| S:11798 E:11802 ||| NN
,  ||| S:11802 E:11804 ||| ,
including  ||| S:11804 E:11814 ||| VBG
the  ||| S:11814 E:11818 ||| DT
nucleus  ||| S:11818 E:11826 ||| NN
( ||| S:11826 E:11827 ||| -LRB-
Fig.  ||| S:11827 E:11842 ||| NNP
5A ||| S:11842 E:11844 ||| NNP
) ||| S:11844 E:11845 ||| -RRB-
.  ||| S:11845 E:11847 ||| .
Localization  ||| S:11847 E:11860 ||| NNP
and  ||| S:11860 E:11864 ||| CC
staining  ||| S:11864 E:11873 ||| JJ
intensity  ||| S:11873 E:11883 ||| NN
did  ||| S:11883 E:11887 ||| VBD
not  ||| S:11887 E:11891 ||| RB
appear  ||| S:11891 E:11908 ||| VB
to  ||| S:11908 E:11911 ||| TO
change  ||| S:11911 E:11918 ||| VB
as  ||| S:11918 E:11921 ||| IN
a  ||| S:11921 E:11923 ||| DT
function  ||| S:11923 E:11932 ||| NN
of  ||| S:11932 E:11935 ||| IN
bud  ||| S:11935 E:11939 ||| JJ
size  ||| S:11939 E:11944 ||| NN
or  ||| S:11944 E:11947 ||| CC
morphology ||| S:11947 E:11957 ||| NN
,  ||| S:11957 E:11969 ||| ,
suggesting  ||| S:11969 E:11980 ||| VBG
that  ||| S:11980 E:11985 ||| IN
Ppt1p  ||| S:11985 E:11991 ||| CD
expression  ||| S:11991 E:12002 ||| NN
and  ||| S:12002 E:12006 ||| CC
localization  ||| S:12006 E:12019 ||| NN
is  ||| S:12019 E:12022 ||| VBZ
not  ||| S:12022 E:12036 ||| RB
cell  ||| S:12036 E:12041 ||| JJ
cycle  ||| S:12041 E:12047 ||| NN
dependent ||| S:12047 E:12056 ||| NN
.  ||| S:12056 E:12068 ||| .
To  ||| S:12068 E:12071 ||| TO
confirm  ||| S:12071 E:12079 ||| VB
that  ||| S:12079 E:12084 ||| IN
the  ||| S:12084 E:12088 ||| DT
indirect  ||| S:12088 E:12097 ||| JJ
immunofluorescence  ||| S:12097 E:12126 ||| JJ
procedure  ||| S:12126 E:12136 ||| NN
did  ||| S:12136 E:12140 ||| VBD
not  ||| S:12140 E:12144 ||| RB
generate  ||| S:12144 E:12153 ||| VB
artifacts ||| S:12153 E:12162 ||| NNS
,  ||| S:12162 E:12164 ||| ,
the  ||| S:12164 E:12168 ||| DT
localization  ||| S:12168 E:12181 ||| NN
of  ||| S:12181 E:12194 ||| IN
the  ||| S:12194 E:12198 ||| DT
spindle  ||| S:12198 E:12206 ||| JJ
pole  ||| S:12206 E:12211 ||| JJ
body  ||| S:12211 E:12216 ||| NN
protein  ||| S:12216 E:12224 ||| NN
Spc42p  ||| S:12224 E:12231 ||| NN
was  ||| S:12231 E:12235 ||| VBD
also  ||| S:12235 E:12240 ||| RB
examined  ||| S:12240 E:12249 ||| VBN
by  ||| S:12249 E:12262 ||| IN
this  ||| S:12262 E:12267 ||| DT
method ||| S:12267 E:12273 ||| NN
.  ||| S:12273 E:12275 ||| .
A  ||| S:12275 E:12277 ||| DT
yeast  ||| S:12277 E:12283 ||| NN
centromeric  ||| S:12283 E:12295 ||| NNS
plasmid  ||| S:12295 E:12303 ||| VBP
encoding  ||| S:12303 E:12312 ||| VBG
the  ||| S:12312 E:12326 ||| DT
fusion  ||| S:12326 E:12333 ||| NN
protein  ||| S:12333 E:12341 ||| NN
Spc42p-EGFP  ||| S:12341 E:12353 ||| NN
was  ||| S:12353 E:12357 ||| VBD
transformed  ||| S:12357 E:12369 ||| VBN
into  ||| S:12369 E:12374 ||| IN
W303  ||| S:12374 E:12389 ||| CD
cells ||| S:12389 E:12394 ||| NNS
.  ||| S:12394 E:12396 ||| .
Direct  ||| S:12396 E:12403 ||| JJ
fluorescence  ||| S:12403 E:12416 ||| NN
from  ||| S:12416 E:12421 ||| IN
EGFP  ||| S:12421 E:12426 ||| NNP
and  ||| S:12426 E:12430 ||| CC
indirect  ||| S:12430 E:12449 ||| JJ
immunofluorescence  ||| S:12449 E:12468 ||| NNS
using  ||| S:12468 E:12474 ||| VBG
the  ||| S:12474 E:12478 ||| DT
amplification  ||| S:12478 E:12492 ||| JJ
protocol  ||| S:12492 E:12501 ||| NN
with  ||| S:12501 E:12516 ||| IN
anti-EGFP  ||| S:12516 E:12526 ||| JJ
antibody  ||| S:12526 E:12535 ||| NN
were  ||| S:12535 E:12540 ||| VBD
compared ||| S:12540 E:12548 ||| VBN
.  ||| S:12548 E:12550 ||| .
Both  ||| S:12550 E:12555 ||| DT
signals  ||| S:12555 E:12563 ||| NNS
revealed  ||| S:12563 E:12582 ||| VBD
specific  ||| S:12582 E:12591 ||| JJ
localization  ||| S:12591 E:12604 ||| NN
of  ||| S:12604 E:12607 ||| IN
Spc42p-EGFP  ||| S:12607 E:12619 ||| CD
to  ||| S:12619 E:12622 ||| TO
the  ||| S:12622 E:12626 ||| DT
spindle  ||| S:12626 E:12634 ||| JJ
pole  ||| S:12634 E:12649 ||| JJ
body  ||| S:12649 E:12654 ||| NN
( ||| S:12654 E:12655 ||| -LRB-
Fig.  ||| S:12655 E:12660 ||| NNP
5B ||| S:12660 E:12662 ||| NNP
) ||| S:12662 E:12663 ||| -RRB-
.  ||| S:12663 E:12675 ||| .
When  ||| S:12675 E:12680 ||| WRB
HA-Ppt1p  ||| S:12680 E:12689 ||| NNP
or  ||| S:12689 E:12692 ||| CC
EGFP-Ppt1p  ||| S:12692 E:12703 ||| NNP
was  ||| S:12703 E:12707 ||| VBD
overexpressed  ||| S:12707 E:12721 ||| VBN
from  ||| S:12721 E:12726 ||| IN
the  ||| S:12726 E:12751 ||| DT
GAL1  ||| S:12751 E:12756 ||| JJ
promoter  ||| S:12756 E:12765 ||| NN
in  ||| S:12765 E:12768 ||| IN
a  ||| S:12768 E:12770 ||| DT
centromeric  ||| S:12770 E:12782 ||| NN
or  ||| S:12782 E:12795 ||| CC
episomal  ||| S:12795 E:12804 ||| JJ
plasmid ||| S:12804 E:12811 ||| NN
,  ||| S:12811 E:12813 ||| ,
respectively ||| S:12813 E:12825 ||| RB
,  ||| S:12825 E:12827 ||| ,
indirect  ||| S:12827 E:12846 ||| JJ
immunofluorescence  ||| S:12846 E:12865 ||| NN
of  ||| S:12865 E:12868 ||| IN
HA-Ppt1p  ||| S:12868 E:12877 ||| NNP
or  ||| S:12877 E:12880 ||| CC
direct  ||| S:12880 E:12887 ||| JJ
fluorescence  ||| S:12887 E:12910 ||| NN
from  ||| S:12910 E:12915 ||| IN
EGFP-Ppt1p  ||| S:12915 E:12926 ||| NNP
showed  ||| S:12926 E:12933 ||| VBD
that  ||| S:12933 E:12938 ||| IN
both  ||| S:12938 E:12943 ||| DT
proteins  ||| S:12943 E:12952 ||| NNS
were  ||| S:12952 E:12957 ||| VBD
also  ||| S:12957 E:12972 ||| RB
localized  ||| S:12972 E:12982 ||| VBN
throughout  ||| S:12982 E:12993 ||| IN
the  ||| S:12993 E:12997 ||| DT
cell ||| S:12997 E:13001 ||| NN
.  ||| S:13001 E:13034 ||| .
Discussion  ||| S:13034 E:13053 ||| NNP
PP5  ||| S:13053 E:13057 ||| NNP
and  ||| S:13057 E:13061 ||| CC
its  ||| S:13061 E:13065 ||| PRP$
homologs  ||| S:13065 E:13074 ||| NN
in  ||| S:13074 E:13077 ||| IN
other  ||| S:13077 E:13083 ||| JJ
species  ||| S:13083 E:13091 ||| NNS
represent  ||| S:13091 E:13101 ||| VBP
a  ||| S:13101 E:13111 ||| DT
subfamily  ||| S:13111 E:13121 ||| NN
of  ||| S:13121 E:13124 ||| IN
PPP  ||| S:13124 E:13128 ||| NNP
enzymes  ||| S:13128 E:13136 ||| VBD
distinguished  ||| S:13136 E:13150 ||| VBN
by  ||| S:13150 E:13153 ||| IN
the  ||| S:13153 E:13157 ||| DT
presence  ||| S:13157 E:13166 ||| NN
of  ||| S:13166 E:13177 ||| IN
an  ||| S:13177 E:13180 ||| DT
N-terminal  ||| S:13180 E:13191 ||| JJ
domain  ||| S:13191 E:13198 ||| NN
containing  ||| S:13198 E:13209 ||| VBG
multiple  ||| S:13209 E:13218 ||| JJ
TPR  ||| S:13218 E:13222 ||| NN
repeats ||| S:13222 E:13229 ||| NNS
.  ||| S:13229 E:13231 ||| .
Ppt1p  ||| S:13231 E:13245 ||| NNP
from  ||| S:13245 E:13250 ||| IN
the  ||| S:13250 E:13254 ||| DT
yeast  ||| S:13254 E:13269 ||| NN
Saccharomyces  ||| S:13269 E:13283 ||| NNP
cerevisiae  ||| S:13283 E:13294 ||| NN
was  ||| S:13294 E:13298 ||| VBD
the  ||| S:13298 E:13310 ||| DT
first  ||| S:13310 E:13316 ||| JJ
homolog  ||| S:13316 E:13324 ||| NN
of  ||| S:13324 E:13327 ||| IN
mammalian  ||| S:13327 E:13337 ||| CD
PP5  ||| S:13337 E:13341 ||| CD
to  ||| S:13341 E:13344 ||| TO
be  ||| S:13344 E:13347 ||| VB
described ||| S:13347 E:13356 ||| VBN
.  ||| S:13356 E:13358 ||| .
Thus  ||| S:13358 E:13363 ||| RB
far ||| S:13363 E:13366 ||| RB
,  ||| S:13366 E:13376 ||| ,
genetic  ||| S:13376 E:13384 ||| JJ
approaches  ||| S:13384 E:13395 ||| NNS
have  ||| S:13395 E:13400 ||| VBP
not  ||| S:13400 E:13404 ||| RB
revealed  ||| S:13404 E:13413 ||| JJ
functions  ||| S:13413 E:13423 ||| NNS
for  ||| S:13423 E:13427 ||| IN
budding  ||| S:13427 E:13443 ||| VBG
yeast  ||| S:13443 E:13449 ||| NN
Ppt1p ||| S:13449 E:13454 ||| NN
.  ||| S:13454 E:13456 ||| .
In  ||| S:13456 E:13459 ||| IN
this  ||| S:13459 E:13464 ||| DT
report ||| S:13464 E:13470 ||| NN
,  ||| S:13470 E:13472 ||| ,
we  ||| S:13472 E:13475 ||| PRP
have  ||| S:13475 E:13480 ||| VBP
characterized  ||| S:13480 E:13494 ||| VBN
Ppt1p  ||| S:13494 E:13508 ||| CD
activity  ||| S:13508 E:13526 ||| NN
in  ||| S:13526 E:13529 ||| IN
vitro  ||| S:13529 E:13535 ||| NN
and  ||| S:13535 E:13539 ||| CC
examined  ||| S:13539 E:13548 ||| VBD
its  ||| S:13548 E:13560 ||| PRP$
expression ||| S:13560 E:13570 ||| NN
.  ||| S:13570 E:13580 ||| .
In  ||| S:13580 E:13583 ||| IN
the  ||| S:13583 E:13587 ||| DT
case  ||| S:13587 E:13592 ||| NN
of  ||| S:13592 E:13595 ||| IN
mammalian  ||| S:13595 E:13605 ||| CD
PP5 ||| S:13605 E:13608 ||| CD
,  ||| S:13608 E:13610 ||| ,
results  ||| S:13610 E:13618 ||| NNS
from  ||| S:13618 E:13623 ||| IN
lipid  ||| S:13623 E:13637 ||| JJ
stimulation  ||| S:13637 E:13649 ||| NN
and  ||| S:13649 E:13653 ||| CC
binding ||| S:13653 E:13660 ||| JJ
,  ||| S:13660 E:13662 ||| ,
limited  ||| S:13662 E:13670 ||| JJ
proteolysis  ||| S:13670 E:13682 ||| NN
and  ||| S:13682 E:13686 ||| CC
truncation  ||| S:13686 E:13705 ||| JJ
studies  ||| S:13705 E:13713 ||| NNS
taken  ||| S:13713 E:13719 ||| VBN
together  ||| S:13719 E:13728 ||| RB
suggest  ||| S:13728 E:13736 ||| VB
the  ||| S:13736 E:13740 ||| DT
TPR  ||| S:13740 E:13744 ||| NNP
domain  ||| S:13744 E:13751 ||| NN
and  ||| S:13751 E:13755 ||| CC
the  ||| S:13755 E:13759 ||| DT
C  ||| S:13759 E:13769 ||| $
terminus  ||| S:13769 E:13778 ||| CD
inhibit  ||| S:13778 E:13786 ||| CD
PP5  ||| S:13786 E:13790 ||| CD
activity  ||| S:13790 E:13799 ||| NN
in  ||| S:13799 E:13802 ||| IN
a  ||| S:13802 E:13804 ||| DT
coordinated  ||| S:13804 E:13816 ||| JJ
manner  ||| S:13816 E:13823 ||| NN
and  ||| S:13823 E:13835 ||| CC
that  ||| S:13835 E:13840 ||| DT
lipid  ||| S:13840 E:13846 ||| JJ
binding  ||| S:13846 E:13854 ||| NN
to  ||| S:13854 E:13857 ||| TO
the  ||| S:13857 E:13861 ||| DT
TPR  ||| S:13861 E:13865 ||| NNP
domain  ||| S:13865 E:13872 ||| NN
activates  ||| S:13872 E:13882 ||| VBD
the  ||| S:13882 E:13886 ||| DT
enzyme  ||| S:13886 E:13902 ||| NN
in  ||| S:13902 E:13905 ||| IN
vitro  ||| S:13905 E:13911 ||| NNS
[  ||| S:13911 E:13913 ||| -LRB-
18  ||| S:13913 E:13916 ||| CD
19  ||| S:13916 E:13919 ||| CD
20  ||| S:13919 E:13922 ||| CD
]  ||| S:13922 E:13924 ||| -RRB-
.  ||| S:13924 E:13926 ||| .
In  ||| S:13926 E:13929 ||| IN
the  ||| S:13929 E:13941 ||| DT
present  ||| S:13941 E:13949 ||| JJ
study  ||| S:13949 E:13955 ||| NN
we  ||| S:13955 E:13958 ||| PRP
used  ||| S:13958 E:13963 ||| VBD
assay  ||| S:13963 E:13969 ||| JJ
conditions  ||| S:13969 E:13980 ||| NNS
for  ||| S:13980 E:13984 ||| IN
Ppt1p  ||| S:13984 E:13990 ||| CD
identical  ||| S:13990 E:14008 ||| JJ
to  ||| S:14008 E:14011 ||| TO
those  ||| S:14011 E:14017 ||| DT
in  ||| S:14017 E:14020 ||| IN
which  ||| S:14020 E:14026 ||| WDT
PP5  ||| S:14026 E:14030 ||| NNP
was  ||| S:14030 E:14034 ||| VBD
shown  ||| S:14034 E:14040 ||| VBN
to  ||| S:14040 E:14043 ||| TO
be  ||| S:14043 E:14046 ||| VB
activated  ||| S:14046 E:14056 ||| VBN
by  ||| S:14056 E:14059 ||| IN
removal  ||| S:14059 E:14075 ||| NN
of  ||| S:14075 E:14078 ||| IN
the  ||| S:14078 E:14082 ||| DT
TPR  ||| S:14082 E:14086 ||| NNP
or  ||| S:14086 E:14089 ||| CC
C-terminal  ||| S:14089 E:14100 ||| JJ
regions  ||| S:14100 E:14108 ||| NNS
[  ||| S:14108 E:14110 ||| -LRB-
19  ||| S:14110 E:14113 ||| CD
]  ||| S:14113 E:14115 ||| -RRB-
.  ||| S:14115 E:14117 ||| .
Under  ||| S:14117 E:14123 ||| IN
these  ||| S:14123 E:14137 ||| DT
conditions  ||| S:14137 E:14148 ||| NNS
Ppt1p  ||| S:14148 E:14154 ||| RB
is  ||| S:14154 E:14157 ||| VBZ
also  ||| S:14157 E:14162 ||| RB
stimulated  ||| S:14162 E:14173 ||| VBN
by  ||| S:14173 E:14176 ||| IN
lipids  ||| S:14176 E:14183 ||| NN
toward  ||| S:14183 E:14198 ||| IN
32P-MBP ||| S:14198 E:14205 ||| NNP
,  ||| S:14205 E:14207 ||| ,
and  ||| S:14207 E:14211 ||| CC
activating  ||| S:14211 E:14222 ||| FW
lipids  ||| S:14222 E:14229 ||| FW
slow  ||| S:14229 E:14234 ||| FW
TPR  ||| S:14234 E:14238 ||| FW
domain  ||| S:14238 E:14245 ||| FW
proteolysis ||| S:14245 E:14256 ||| FW
.  ||| S:14256 E:14266 ||| .
These  ||| S:14266 E:14272 ||| DT
results  ||| S:14272 E:14280 ||| NNS
indicate  ||| S:14280 E:14289 ||| VBP
that  ||| S:14289 E:14294 ||| IN
Ppt1p  ||| S:14294 E:14300 ||| NNP
has  ||| S:14300 E:14304 ||| VBZ
a  ||| S:14304 E:14306 ||| DT
similar  ||| S:14306 E:14314 ||| JJ
domain  ||| S:14314 E:14329 ||| NN
structure  ||| S:14329 E:14339 ||| NN
to  ||| S:14339 E:14342 ||| TO
PP5  ||| S:14342 E:14346 ||| CD
and  ||| S:14346 E:14350 ||| CC
is  ||| S:14350 E:14353 ||| VBZ
activated  ||| S:14353 E:14363 ||| VBN
in  ||| S:14363 E:14366 ||| IN
a  ||| S:14366 E:14368 ||| DT
similar  ||| S:14368 E:14376 ||| JJ
manner  ||| S:14376 E:14383 ||| NN
by  ||| S:14383 E:14394 ||| IN
lipid  ||| S:14394 E:14400 ||| JJ
binding  ||| S:14400 E:14408 ||| NN
to  ||| S:14408 E:14411 ||| TO
the  ||| S:14411 E:14415 ||| DT
TPR  ||| S:14415 E:14419 ||| NNP
domain ||| S:14419 E:14425 ||| NN
.  ||| S:14425 E:14427 ||| .
Removal  ||| S:14427 E:14435 ||| NN
of  ||| S:14435 E:14438 ||| IN
the  ||| S:14438 E:14442 ||| DT
TPR  ||| S:14442 E:14446 ||| NNP
domain  ||| S:14446 E:14461 ||| NN
prevents  ||| S:14461 E:14470 ||| VBZ
stimulation  ||| S:14470 E:14482 ||| VBN
by  ||| S:14482 E:14485 ||| IN
lipid ||| S:14485 E:14490 ||| NN
,  ||| S:14490 E:14492 ||| ,
but  ||| S:14492 E:14496 ||| CC
only  ||| S:14496 E:14501 ||| RB
modestly  ||| S:14501 E:14510 ||| RB
increases  ||| S:14510 E:14528 ||| VBZ
Ppt1p  ||| S:14528 E:14534 ||| CD
activity ||| S:14534 E:14542 ||| NN
.  ||| S:14542 E:14544 ||| .
Carboxyl-terminal  ||| S:14544 E:14562 ||| JJ
truncation  ||| S:14562 E:14573 ||| NNS
modestly  ||| S:14573 E:14590 ||| RB
increases  ||| S:14590 E:14600 ||| VBZ
Ppt1p  ||| S:14600 E:14606 ||| CD
activity  ||| S:14606 E:14615 ||| NN
toward  ||| S:14615 E:14622 ||| IN
both  ||| S:14622 E:14627 ||| DT
32P-MBP  ||| S:14627 E:14635 ||| NNP
and  ||| S:14635 E:14647 ||| CC
32P-casein ||| S:14647 E:14657 ||| NNP
,  ||| S:14657 E:14659 ||| ,
and  ||| S:14659 E:14663 ||| CC
does  ||| S:14663 E:14668 ||| VBZ
not  ||| S:14668 E:14672 ||| RB
prevent  ||| S:14672 E:14680 ||| VB
further  ||| S:14680 E:14688 ||| RBR
lipid  ||| S:14688 E:14694 ||| JJ
stimulation  ||| S:14694 E:14714 ||| NN
of  ||| S:14714 E:14717 ||| IN
32P-MBP  ||| S:14717 E:14725 ||| CD
dephosphorylation ||| S:14725 E:14742 ||| NNS
.  ||| S:14742 E:14744 ||| .
These  ||| S:14744 E:14750 ||| DT
results  ||| S:14750 E:14758 ||| NNS
distinguish  ||| S:14758 E:14778 ||| VBD
Ppt1p  ||| S:14778 E:14784 ||| CD
from  ||| S:14784 E:14789 ||| IN
mammalian  ||| S:14789 E:14799 ||| JJ
PP5  ||| S:14799 E:14803 ||| NN
and  ||| S:14803 E:14807 ||| CC
suggest  ||| S:14807 E:14815 ||| VBP
that  ||| S:14815 E:14820 ||| IN
the  ||| S:14820 E:14824 ||| DT
C  ||| S:14824 E:14826 ||| NNP
terminus  ||| S:14826 E:14835 ||| NN
is  ||| S:14835 E:14846 ||| VBZ
less  ||| S:14846 E:14851 ||| RBR
important  ||| S:14851 E:14861 ||| JJ
in  ||| S:14861 E:14864 ||| IN
controlling  ||| S:14864 E:14876 ||| VBG
Ppt1p  ||| S:14876 E:14882 ||| CD
activity ||| S:14882 E:14890 ||| NN
.  ||| S:14890 E:14892 ||| .
Although  ||| S:14892 E:14901 ||| IN
more  ||| S:14901 E:14914 ||| JJR
work  ||| S:14914 E:14919 ||| NN
will  ||| S:14919 E:14924 ||| MD
be  ||| S:14924 E:14927 ||| VB
required  ||| S:14927 E:14936 ||| VBN
to  ||| S:14936 E:14939 ||| TO
determine  ||| S:14939 E:14949 ||| VB
its  ||| S:14949 E:14953 ||| PRP$
role  ||| S:14953 E:14958 ||| NN
in  ||| S:14958 E:14961 ||| IN
lipid  ||| S:14961 E:14975 ||| JJ
stimulation ||| S:14975 E:14986 ||| NN
,  ||| S:14986 E:14988 ||| ,
removal  ||| S:14988 E:14996 ||| NN
of  ||| S:14996 E:14999 ||| IN
the  ||| S:14999 E:15003 ||| DT
TPR  ||| S:15003 E:15007 ||| NNP
domain  ||| S:15007 E:15014 ||| NN
had  ||| S:15014 E:15018 ||| VBD
only  ||| S:15018 E:15023 ||| RB
a  ||| S:15023 E:15025 ||| DT
small  ||| S:15025 E:15039 ||| JJ
effect  ||| S:15039 E:15046 ||| NN
on  ||| S:15046 E:15049 ||| IN
Ppt1p  ||| S:15049 E:15055 ||| CD
activation ||| S:15055 E:15065 ||| NNS
.  ||| S:15065 E:15067 ||| .
Ppt1p  ||| S:15067 E:15073 ||| NNP
contains  ||| S:15073 E:15082 ||| VBZ
two  ||| S:15082 E:15086 ||| CD
short  ||| S:15086 E:15100 ||| JJ
stretches  ||| S:15100 E:15110 ||| NNS
of  ||| S:15110 E:15113 ||| IN
amino  ||| S:15113 E:15119 ||| JJ
acids ||| S:15119 E:15124 ||| NNS
,  ||| S:15124 E:15126 ||| ,
a  ||| S:15126 E:15128 ||| DT
15-residue  ||| S:15128 E:15139 ||| JJ
sequence  ||| S:15139 E:15148 ||| NN
between  ||| S:15148 E:15156 ||| IN
the  ||| S:15156 E:15168 ||| DT
linker  ||| S:15168 E:15175 ||| JJ
helix  ||| S:15175 E:15181 ||| NN
and  ||| S:15181 E:15185 ||| CC
the  ||| S:15185 E:15189 ||| DT
catalytic  ||| S:15189 E:15199 ||| JJ
domain  ||| S:15199 E:15206 ||| NN
( ||| S:15206 E:15207 ||| -LRB-
residues  ||| S:15207 E:15216 ||| FW
174-188 ||| S:15216 E:15223 ||| FW
) ||| S:15223 E:15224 ||| -RRB-
,  ||| S:15224 E:15234 ||| ,
and  ||| S:15234 E:15238 ||| CC
a  ||| S:15238 E:15240 ||| DT
ten-residue  ||| S:15240 E:15252 ||| JJ
sequence  ||| S:15252 E:15261 ||| NN
just  ||| S:15261 E:15266 ||| RB
preceding  ||| S:15266 E:15276 ||| VBG
the  ||| S:15276 E:15280 ||| DT
extreme  ||| S:15280 E:15288 ||| JJ
C  ||| S:15288 E:15298 ||| NNP
terminus  ||| S:15298 E:15307 ||| NNS
( ||| S:15307 E:15308 ||| -LRB-
residues  ||| S:15308 E:15317 ||| FW
474-484 ||| S:15317 E:15324 ||| FW
) ||| S:15324 E:15325 ||| -RRB-
,  ||| S:15325 E:15327 ||| ,
that  ||| S:15327 E:15332 ||| WDT
are  ||| S:15332 E:15336 ||| VBP
not  ||| S:15336 E:15340 ||| RB
found  ||| S:15340 E:15346 ||| VBN
in  ||| S:15346 E:15349 ||| IN
other  ||| S:15349 E:15363 ||| JJ
PP5  ||| S:15363 E:15367 ||| CD
homologs  ||| S:15367 E:15376 ||| NNS
reported  ||| S:15376 E:15385 ||| VBD
thus  ||| S:15385 E:15390 ||| RB
far  ||| S:15390 E:15394 ||| RB
(  ||| S:15394 E:15396 ||| -LRB-
[  ||| S:15396 E:15398 ||| CD
1  ||| S:15398 E:15400 ||| CD
2  ||| S:15400 E:15402 ||| CD
3  ||| S:15402 E:15404 ||| CD
4  ||| S:15404 E:15406 ||| CD
5  ||| S:15406 E:15408 ||| CD
6  ||| S:15408 E:15410 ||| CD
7  ||| S:15410 E:15412 ||| CD
8  ||| S:15412 E:15414 ||| CD
9  ||| S:15414 E:15416 ||| CD
10  ||| S:15416 E:15419 ||| CD
]  ||| S:15419 E:15421 ||| -RRB-
,  ||| S:15421 E:15431 ||| ,
and  ||| S:15431 E:15435 ||| CC
accession  ||| S:15435 E:15445 ||| JJ
numbers  ||| S:15445 E:15453 ||| NNS
CAB60937 ||| S:15453 E:15461 ||| RB
,  ||| S:15461 E:15463 ||| ,
CAA17690  ||| S:15463 E:15472 ||| NNP
and  ||| S:15472 E:15476 ||| CC
AAD21727 ||| S:15476 E:15484 ||| CD
) ||| S:15484 E:15485 ||| -RRB-
.  ||| S:15485 E:15487 ||| .
The  ||| S:15487 E:15499 ||| DT
presence  ||| S:15499 E:15508 ||| NN
of  ||| S:15508 E:15511 ||| IN
these  ||| S:15511 E:15517 ||| DT
additional  ||| S:15517 E:15528 ||| JJ
sequences  ||| S:15528 E:15538 ||| NN
in  ||| S:15538 E:15541 ||| IN
Ppt1p  ||| S:15541 E:15547 ||| NNP
may  ||| S:15547 E:15559 ||| MD
underlie  ||| S:15559 E:15568 ||| VB
the  ||| S:15568 E:15572 ||| DT
differences  ||| S:15572 E:15584 ||| NNS
in  ||| S:15584 E:15587 ||| IN
the  ||| S:15587 E:15591 ||| DT
responses  ||| S:15591 E:15601 ||| NNS
of  ||| S:15601 E:15604 ||| IN
Ppt1p  ||| S:15604 E:15610 ||| NNP
and  ||| S:15610 E:15614 ||| CC
PP5  ||| S:15614 E:15626 ||| CD
to  ||| S:15626 E:15629 ||| TO
N  ||| S:15629 E:15631 ||| NNP
or  ||| S:15631 E:15634 ||| CC
C-terminal  ||| S:15634 E:15645 ||| JJ
truncation ||| S:15645 E:15655 ||| NN
.  ||| S:15655 E:15657 ||| .
Additional  ||| S:15657 E:15668 ||| JJ
studies  ||| S:15668 E:15676 ||| NNS
will  ||| S:15676 E:15681 ||| MD
be  ||| S:15681 E:15692 ||| VB
required  ||| S:15692 E:15701 ||| VBN
to  ||| S:15701 E:15704 ||| TO
determine  ||| S:15704 E:15714 ||| VB
if  ||| S:15714 E:15717 ||| IN
our  ||| S:15717 E:15721 ||| PRP$
observations  ||| S:15721 E:15734 ||| NNS
reflect  ||| S:15734 E:15750 ||| VBP
structural  ||| S:15750 E:15761 ||| JJ
and  ||| S:15761 E:15765 ||| CC
regulatory  ||| S:15765 E:15776 ||| JJ
properties  ||| S:15776 E:15787 ||| NNS
unique  ||| S:15787 E:15794 ||| JJ
to  ||| S:15794 E:15797 ||| TO
Ppt1p ||| S:15797 E:15802 ||| CD
.  ||| S:15802 E:15812 ||| .
Ppt1p  ||| S:15812 E:15818 ||| NNP
and  ||| S:15818 E:15822 ||| CC
PP5  ||| S:15822 E:15826 ||| CD
exhibit  ||| S:15826 E:15834 ||| NN
similar  ||| S:15834 E:15842 ||| JJ
specific  ||| S:15842 E:15851 ||| JJ
activities  ||| S:15851 E:15862 ||| NNS
toward  ||| S:15862 E:15877 ||| IN
32P-casein  ||| S:15877 E:15888 ||| CD
in  ||| S:15888 E:15891 ||| IN
the  ||| S:15891 E:15895 ||| DT
absence  ||| S:15895 E:15903 ||| NN
of  ||| S:15903 E:15906 ||| IN
lipid ||| S:15906 E:15911 ||| NN
.  ||| S:15911 E:15913 ||| .
However  ||| S:15913 E:15921 ||| RB
Ppt1p  ||| S:15921 E:15927 ||| CD
activity  ||| S:15927 E:15944 ||| NN
toward  ||| S:15944 E:15951 ||| IN
this  ||| S:15951 E:15956 ||| DT
substrate  ||| S:15956 E:15966 ||| NN
was  ||| S:15966 E:15970 ||| VBD
not  ||| S:15970 E:15974 ||| RB
stimulated  ||| S:15974 E:15985 ||| VBN
by  ||| S:15985 E:15988 ||| IN
lipids ||| S:15988 E:15994 ||| NN
.  ||| S:15994 E:15996 ||| .
These  ||| S:15996 E:16010 ||| DT
results  ||| S:16010 E:16018 ||| NNS
highlight  ||| S:16018 E:16028 ||| VB
the  ||| S:16028 E:16032 ||| DT
fact  ||| S:16032 E:16037 ||| NN
that  ||| S:16037 E:16042 ||| IN
PPP  ||| S:16042 E:16046 ||| NNP
enzymes  ||| S:16046 E:16054 ||| VBD
often  ||| S:16054 E:16060 ||| RB
exhibit  ||| S:16060 E:16076 ||| VB
substrate  ||| S:16076 E:16086 ||| JJ
specific  ||| S:16086 E:16095 ||| JJ
effects  ||| S:16095 E:16112 ||| NNS
in  ||| S:16112 E:16115 ||| IN
vitro  ||| S:16115 E:16121 ||| NN
and  ||| S:16121 E:16125 ||| CC
that  ||| S:16125 E:16130 ||| IN
the  ||| S:16130 E:16134 ||| DT
use  ||| S:16134 E:16138 ||| NN
of  ||| S:16138 E:16141 ||| IN
a  ||| S:16141 E:16143 ||| DT
single  ||| S:16143 E:16158 ||| JJ
substrate  ||| S:16158 E:16168 ||| NN
to  ||| S:16168 E:16171 ||| TO
study  ||| S:16171 E:16177 ||| VB
this  ||| S:16177 E:16182 ||| DT
family  ||| S:16182 E:16189 ||| NN
of  ||| S:16189 E:16192 ||| IN
enzymes  ||| S:16192 E:16200 ||| NNS
can  ||| S:16200 E:16204 ||| MD
be  ||| S:16204 E:16215 ||| VB
misleading ||| S:16215 E:16225 ||| JJ
.  ||| S:16225 E:16227 ||| .
Like  ||| S:16227 E:16232 ||| IN
PP5 ||| S:16232 E:16235 ||| NNP
,  ||| S:16235 E:16237 ||| ,
the  ||| S:16237 E:16241 ||| DT
control  ||| S:16241 E:16249 ||| NN
activity  ||| S:16249 E:16258 ||| NN
of  ||| S:16258 E:16261 ||| IN
Ppt1p  ||| S:16261 E:16267 ||| NNP
is  ||| S:16267 E:16270 ||| VBZ
low  ||| S:16270 E:16282 ||| JJ
toward  ||| S:16282 E:16289 ||| IN
the  ||| S:16289 E:16293 ||| DT
commonly  ||| S:16293 E:16302 ||| RB
used  ||| S:16302 E:16307 ||| VBN
artificial  ||| S:16307 E:16318 ||| JJ
substrates  ||| S:16318 E:16329 ||| JJ
such  ||| S:16329 E:16334 ||| JJ
as  ||| S:16334 E:16345 ||| IN
32P-casein  ||| S:16345 E:16356 ||| NNP
and  ||| S:16356 E:16360 ||| CC
32P-MBP  ||| S:16360 E:16368 ||| RB
compared  ||| S:16368 E:16377 ||| VBN
to  ||| S:16377 E:16380 ||| TO
other  ||| S:16380 E:16386 ||| JJ
PPP  ||| S:16386 E:16390 ||| NN
enzymes  ||| S:16390 E:16398 ||| NNS
[  ||| S:16398 E:16400 ||| -LRB-
18  ||| S:16400 E:16403 ||| CD
]  ||| S:16403 E:16413 ||| -RRB-
.  ||| S:16413 E:16415 ||| .
Thus ||| S:16415 E:16419 ||| RB
,  ||| S:16419 E:16421 ||| ,
it  ||| S:16421 E:16424 ||| PRP
is  ||| S:16424 E:16427 ||| VBZ
not  ||| S:16427 E:16431 ||| RB
clear  ||| S:16431 E:16437 ||| JJ
whether  ||| S:16437 E:16445 ||| IN
the  ||| S:16445 E:16449 ||| DT
selective  ||| S:16449 E:16459 ||| JJ
lipid  ||| S:16459 E:16473 ||| JJ
stimulation  ||| S:16473 E:16485 ||| NN
of  ||| S:16485 E:16488 ||| IN
Ppt1p  ||| S:16488 E:16494 ||| CD
toward  ||| S:16494 E:16501 ||| IN
32P-MBP  ||| S:16501 E:16509 ||| NNP
reflects  ||| S:16509 E:16518 ||| VBZ
a  ||| S:16518 E:16528 ||| DT
substrate-directed  ||| S:16528 E:16547 ||| JJ
effect ||| S:16547 E:16553 ||| NN
,  ||| S:16553 E:16555 ||| ,
or  ||| S:16555 E:16558 ||| CC
whether  ||| S:16558 E:16566 ||| IN
32P-casein  ||| S:16566 E:16577 ||| NNP
is  ||| S:16577 E:16580 ||| VBZ
simply  ||| S:16580 E:16595 ||| RB
a  ||| S:16595 E:16597 ||| DT
poor  ||| S:16597 E:16602 ||| JJ
substrate  ||| S:16602 E:16612 ||| NN
for  ||| S:16612 E:16616 ||| IN
Ppt1p ||| S:16616 E:16621 ||| CD
.  ||| S:16621 E:16623 ||| .
Egloff  ||| S:16623 E:16630 ||| NNP
and  ||| S:16630 E:16634 ||| CC
colleagues  ||| S:16634 E:16653 ||| NNS
identified  ||| S:16653 E:16664 ||| VBD
seven  ||| S:16664 E:16670 ||| CD
acidic  ||| S:16670 E:16677 ||| JJ
surface  ||| S:16677 E:16685 ||| NN
residues  ||| S:16685 E:16694 ||| NNS
on  ||| S:16694 E:16697 ||| IN
the  ||| S:16697 E:16701 ||| DT
catalytic  ||| S:16701 E:16719 ||| JJ
face  ||| S:16719 E:16724 ||| NN
of  ||| S:16724 E:16727 ||| IN
PP1c  ||| S:16727 E:16732 ||| CD
γ  ||| S:16732 E:16734 ||| NNS
that  ||| S:16734 E:16739 ||| WDT
are  ||| S:16739 E:16743 ||| VBP
replaced  ||| S:16743 E:16752 ||| VBN
by  ||| S:16752 E:16755 ||| IN
neutral  ||| S:16755 E:16763 ||| JJ
or  ||| S:16763 E:16766 ||| CC
basic  ||| S:16766 E:16780 ||| JJ
residues  ||| S:16780 E:16789 ||| NNS
in  ||| S:16789 E:16792 ||| IN
PP2A  ||| S:16792 E:16797 ||| NNP
[  ||| S:16797 E:16799 ||| -LRB-
25  ||| S:16799 E:16802 ||| CD
]  ||| S:16802 E:16804 ||| -RRB-
.  ||| S:16804 E:16806 ||| .
They  ||| S:16806 E:16811 ||| PRP
suggest  ||| S:16811 E:16819 ||| VBP
the  ||| S:16819 E:16823 ||| DT
presence  ||| S:16823 E:16832 ||| NN
of  ||| S:16832 E:16843 ||| IN
these  ||| S:16843 E:16849 ||| DT
acidic  ||| S:16849 E:16856 ||| JJ
residues  ||| S:16856 E:16865 ||| NNS
in  ||| S:16865 E:16868 ||| IN
PP1c  ||| S:16868 E:16873 ||| CD
γ  ||| S:16873 E:16875 ||| NNS
may  ||| S:16875 E:16879 ||| MD
explain  ||| S:16879 E:16887 ||| VB
why  ||| S:16887 E:16891 ||| WRB
casein  ||| S:16891 E:16898 ||| NN
is  ||| S:16898 E:16901 ||| VBZ
a  ||| S:16901 E:16911 ||| DT
good  ||| S:16911 E:16916 ||| JJ
substrate  ||| S:16916 E:16926 ||| NN
for  ||| S:16926 E:16930 ||| IN
PP2A ||| S:16930 E:16934 ||| NNP
,  ||| S:16934 E:16936 ||| ,
but  ||| S:16936 E:16940 ||| CC
not  ||| S:16940 E:16944 ||| RB
for  ||| S:16944 E:16948 ||| IN
PP1 ||| S:16948 E:16951 ||| CD
.  ||| S:16951 E:16953 ||| .
Based  ||| S:16953 E:16959 ||| VBN
on  ||| S:16959 E:16962 ||| IN
a  ||| S:16962 E:16972 ||| DT
sequence  ||| S:16972 E:16981 ||| JJ
alignment  ||| S:16981 E:16991 ||| NN
with  ||| S:16991 E:16996 ||| IN
PP1c  ||| S:16996 E:17001 ||| CD
γ ||| S:17001 E:17002 ||| NN
,  ||| S:17002 E:17004 ||| ,
these  ||| S:17004 E:17010 ||| DT
seven  ||| S:17010 E:17016 ||| CD
acidic  ||| S:17016 E:17023 ||| CD
residues  ||| S:17023 E:17040 ||| NNS
are  ||| S:17040 E:17044 ||| VBP
not  ||| S:17044 E:17048 ||| RB
conserved  ||| S:17048 E:17058 ||| VBN
in  ||| S:17058 E:17061 ||| IN
Ppt1p ||| S:17061 E:17066 ||| CD
.  ||| S:17066 E:17068 ||| .
Using  ||| S:17068 E:17074 ||| VBG
the  ||| S:17074 E:17078 ||| DT
program  ||| S:17078 E:17086 ||| NN
Modeller  ||| S:17086 E:17095 ||| NNP
[  ||| S:17095 E:17097 ||| -LRB-
26  ||| S:17097 E:17108 ||| CD
]  ||| S:17108 E:17110 ||| -RRB-
,  ||| S:17110 E:17112 ||| ,
a  ||| S:17112 E:17114 ||| DT
homology  ||| S:17114 E:17123 ||| JJ
model  ||| S:17123 E:17129 ||| NN
of  ||| S:17129 E:17132 ||| IN
the  ||| S:17132 E:17136 ||| DT
catalytic  ||| S:17136 E:17146 ||| JJ
domain  ||| S:17146 E:17153 ||| NN
of  ||| S:17153 E:17156 ||| IN
Ppt1p  ||| S:17156 E:17162 ||| NNP
was  ||| S:17162 E:17174 ||| VBD
built  ||| S:17174 E:17180 ||| VBN
based  ||| S:17180 E:17186 ||| VBN
on  ||| S:17186 E:17189 ||| IN
three  ||| S:17189 E:17195 ||| CD
PP1  ||| S:17195 E:17199 ||| CD
structures  ||| S:17199 E:17210 ||| NNS
-  ||| S:17210 E:17212 ||| :
PDB  ||| S:17212 E:17224 ||| NNP
http://www.pdb.org  ||| S:17224 E:17243 ||| NNP
[  ||| S:17243 E:17245 ||| -LRB-
27  ||| S:17245 E:17248 ||| CD
]  ||| S:17248 E:17250 ||| -RRB-
codes  ||| S:17250 E:17256 ||| FW
1FJM  ||| S:17256 E:17261 ||| FW
[  ||| S:17261 E:17263 ||| -LRB-
28  ||| S:17263 E:17266 ||| CD
]  ||| S:17266 E:17268 ||| -RRB-
,  ||| S:17268 E:17270 ||| ,
1IT6  ||| S:17270 E:17275 ||| NNP
[  ||| S:17275 E:17277 ||| -LRB-
29  ||| S:17277 E:17280 ||| CD
]  ||| S:17280 E:17290 ||| -RRB-
and  ||| S:17290 E:17294 ||| CC
1JK7  ||| S:17294 E:17299 ||| NNP
[  ||| S:17299 E:17301 ||| -LRB-
30  ||| S:17301 E:17304 ||| CD
]  ||| S:17304 E:17306 ||| -RRB-
.  ||| S:17306 E:17308 ||| .
This  ||| S:17308 E:17313 ||| DT
model  ||| S:17313 E:17319 ||| NN
shows  ||| S:17319 E:17325 ||| NNS
that  ||| S:17325 E:17330 ||| IN
the  ||| S:17330 E:17334 ||| DT
catalytic  ||| S:17334 E:17344 ||| JJ
face  ||| S:17344 E:17357 ||| NN
of  ||| S:17357 E:17360 ||| IN
Ppt1p  ||| S:17360 E:17366 ||| NNP
is  ||| S:17366 E:17369 ||| VBZ
generally  ||| S:17369 E:17379 ||| RB
less  ||| S:17379 E:17384 ||| JJR
acidic  ||| S:17384 E:17391 ||| NN
than  ||| S:17391 E:17396 ||| IN
that  ||| S:17396 E:17401 ||| DT
of  ||| S:17401 E:17404 ||| IN
PP1c  ||| S:17404 E:17409 ||| CD
γ  ||| S:17409 E:17411 ||| NNS
and  ||| S:17411 E:17423 ||| CC
does  ||| S:17423 E:17428 ||| VBZ
not  ||| S:17428 E:17432 ||| RB
indicate  ||| S:17432 E:17441 ||| VB
the  ||| S:17441 E:17445 ||| DT
presence  ||| S:17445 E:17454 ||| NN
of  ||| S:17454 E:17457 ||| IN
other  ||| S:17457 E:17463 ||| JJ
acidic  ||| S:17463 E:17470 ||| JJ
residues  ||| S:17470 E:17487 ||| NNS
that  ||| S:17487 E:17492 ||| WDT
could  ||| S:17492 E:17498 ||| MD
act  ||| S:17498 E:17502 ||| VB
in  ||| S:17502 E:17505 ||| IN
the  ||| S:17505 E:17509 ||| DT
same  ||| S:17509 E:17514 ||| JJ
fashion  ||| S:17514 E:17522 ||| NN
as  ||| S:17522 E:17525 ||| IN
those  ||| S:17525 E:17531 ||| DT
on  ||| S:17531 E:17534 ||| IN
PP1c  ||| S:17534 E:17539 ||| CD
γ ||| S:17539 E:17540 ||| NNS
.  ||| S:17540 E:17542 ||| .
Thus  ||| S:17542 E:17555 ||| RB
the  ||| S:17555 E:17559 ||| DT
reason  ||| S:17559 E:17566 ||| NN
for  ||| S:17566 E:17570 ||| IN
low  ||| S:17570 E:17574 ||| JJ
Ppt1p  ||| S:17574 E:17580 ||| CD
activity  ||| S:17580 E:17589 ||| NN
toward  ||| S:17589 E:17596 ||| IN
this  ||| S:17596 E:17601 ||| DT
acidic  ||| S:17601 E:17616 ||| JJ
substrate  ||| S:17616 E:17626 ||| NN
may  ||| S:17626 E:17630 ||| MD
be  ||| S:17630 E:17633 ||| VB
more  ||| S:17633 E:17638 ||| RBR
complex  ||| S:17638 E:17646 ||| JJ
than  ||| S:17646 E:17651 ||| IN
can  ||| S:17651 E:17655 ||| MD
be  ||| S:17655 E:17658 ||| VB
explained  ||| S:17658 E:17668 ||| VBN
by  ||| S:17668 E:17679 ||| IN
electrostatic  ||| S:17679 E:17693 ||| JJ
repulsion ||| S:17693 E:17702 ||| NN
.  ||| S:17702 E:17712 ||| .
Others  ||| S:17712 E:17719 ||| NNS
have  ||| S:17719 E:17724 ||| VBP
proposed  ||| S:17724 E:17733 ||| VBN
that  ||| S:17733 E:17738 ||| IN
fatty  ||| S:17738 E:17744 ||| JJ
acyl  ||| S:17744 E:17749 ||| NNS
coenzyme  ||| S:17749 E:17758 ||| VBP
A  ||| S:17758 E:17760 ||| DT
esters  ||| S:17760 E:17775 ||| NNS
are  ||| S:17775 E:17779 ||| VBP
potential  ||| S:17779 E:17789 ||| JJ
physiologic  ||| S:17789 E:17801 ||| JJ
regulators  ||| S:17801 E:17812 ||| NNS
of  ||| S:17812 E:17815 ||| IN
PP5 ||| S:17815 E:17818 ||| NNP
,  ||| S:17818 E:17820 ||| ,
since  ||| S:17820 E:17826 ||| IN
these  ||| S:17826 E:17840 ||| DT
compounds  ||| S:17840 E:17850 ||| JJ
stimulate  ||| S:17850 E:17860 ||| JJ
pNPP  ||| S:17860 E:17865 ||| JJ
hydrolysis  ||| S:17865 E:17876 ||| NN
by  ||| S:17876 E:17879 ||| IN
PP5  ||| S:17879 E:17892 ||| CD
in  ||| S:17892 E:17895 ||| IN
vitro  ||| S:17895 E:17901 ||| NN
at  ||| S:17901 E:17904 ||| IN
physiologically  ||| S:17904 E:17920 ||| JJ
relevant  ||| S:17920 E:17937 ||| JJ
concentrations  ||| S:17937 E:17952 ||| NNS
and  ||| S:17952 E:17956 ||| CC
are  ||| S:17956 E:17960 ||| VBP
approximately  ||| S:17960 E:17974 ||| RB
10-fold  ||| S:17974 E:17982 ||| JJ
more  ||| S:17982 E:17987 ||| RBR
potent  ||| S:17987 E:18002 ||| JJ
than  ||| S:18002 E:18007 ||| IN
their  ||| S:18007 E:18013 ||| PRP$
free  ||| S:18013 E:18018 ||| JJ
fatty  ||| S:18018 E:18024 ||| JJ
acid  ||| S:18024 E:18029 ||| NN
counterparts  ||| S:18029 E:18042 ||| NNS
[  ||| S:18042 E:18044 ||| -LRB-
21  ||| S:18044 E:18047 ||| CD
]  ||| S:18047 E:18049 ||| -RRB-
.  ||| S:18049 E:18051 ||| .
Although  ||| S:18051 E:18068 ||| IN
we  ||| S:18068 E:18071 ||| PRP
confirmed  ||| S:18071 E:18081 ||| VBD
this  ||| S:18081 E:18086 ||| DT
observation  ||| S:18086 E:18098 ||| NN
using  ||| S:18098 E:18104 ||| VBG
PP5  ||| S:18104 E:18108 ||| NNP
and  ||| S:18108 E:18112 ||| CC
pNPP  ||| S:18112 E:18117 ||| NNP
( ||| S:18117 E:18118 ||| -LRB-
data  ||| S:18118 E:18123 ||| NNS
not  ||| S:18123 E:18135 ||| RB
shown ||| S:18135 E:18140 ||| VBN
) ||| S:18140 E:18141 ||| -RRB-
,  ||| S:18141 E:18143 ||| ,
in  ||| S:18143 E:18146 ||| IN
our  ||| S:18146 E:18150 ||| PRP$
hands  ||| S:18150 E:18156 ||| NNS
similar  ||| S:18156 E:18164 ||| JJ
levels  ||| S:18164 E:18171 ||| NNS
of  ||| S:18171 E:18174 ||| IN
AA  ||| S:18174 E:18177 ||| NN
and  ||| S:18177 E:18181 ||| CC
arachidoyl  ||| S:18181 E:18200 ||| JJ
coenzyme  ||| S:18200 E:18209 ||| JJ
A  ||| S:18209 E:18211 ||| NN
were  ||| S:18211 E:18216 ||| VBD
required  ||| S:18216 E:18225 ||| VBN
for  ||| S:18225 E:18229 ||| IN
half-maximal  ||| S:18229 E:18242 ||| JJ
stimulation  ||| S:18242 E:18254 ||| NN
of  ||| S:18254 E:18265 ||| IN
32P-MBP  ||| S:18265 E:18273 ||| CD
dephosphorylation  ||| S:18273 E:18291 ||| NN
in  ||| S:18291 E:18294 ||| IN
the  ||| S:18294 E:18298 ||| DT
case  ||| S:18298 E:18303 ||| NN
of  ||| S:18303 E:18306 ||| IN
both  ||| S:18306 E:18311 ||| DT
Ppt1p  ||| S:18311 E:18317 ||| NNP
and  ||| S:18317 E:18329 ||| CC
PP5 ||| S:18329 E:18332 ||| NNP
.  ||| S:18332 E:18334 ||| .
Although  ||| S:18334 E:18343 ||| IN
more  ||| S:18343 E:18348 ||| JJR
work  ||| S:18348 E:18353 ||| NN
is  ||| S:18353 E:18356 ||| VBZ
required  ||| S:18356 E:18365 ||| VBN
to  ||| S:18365 E:18368 ||| TO
examine  ||| S:18368 E:18376 ||| VB
this  ||| S:18376 E:18381 ||| DT
issue  ||| S:18381 E:18395 ||| NN
thoroughly ||| S:18395 E:18405 ||| RB
,  ||| S:18405 E:18407 ||| ,
our  ||| S:18407 E:18411 ||| PRP$
results  ||| S:18411 E:18419 ||| NNS
suggest  ||| S:18419 E:18427 ||| VBP
that  ||| S:18427 E:18432 ||| IN
the  ||| S:18432 E:18436 ||| DT
large  ||| S:18436 E:18442 ||| JJ
differences  ||| S:18442 E:18462 ||| NNS
in  ||| S:18462 E:18465 ||| IN
potency  ||| S:18465 E:18473 ||| NN
between  ||| S:18473 E:18481 ||| IN
free  ||| S:18481 E:18486 ||| JJ
fatty  ||| S:18486 E:18492 ||| JJ
acids  ||| S:18492 E:18498 ||| NNS
and  ||| S:18498 E:18502 ||| CC
fatty  ||| S:18502 E:18508 ||| JJ
acyl  ||| S:18508 E:18513 ||| NNS
coenzyme  ||| S:18513 E:18530 ||| VBP
A  ||| S:18530 E:18532 ||| DT
esters  ||| S:18532 E:18539 ||| NN
seen  ||| S:18539 E:18544 ||| VBN
using  ||| S:18544 E:18550 ||| VBG
pNPP  ||| S:18550 E:18555 ||| NN
may  ||| S:18555 E:18559 ||| MD
not  ||| S:18559 E:18563 ||| RB
extend  ||| S:18563 E:18570 ||| VB
to  ||| S:18570 E:18573 ||| TO
all  ||| S:18573 E:18577 ||| DT
protein  ||| S:18577 E:18593 ||| NN
substrates ||| S:18593 E:18603 ||| NN
.  ||| S:18603 E:18605 ||| .
In  ||| S:18605 E:18608 ||| IN
addition ||| S:18608 E:18616 ||| NN
,  ||| S:18616 E:18618 ||| ,
it  ||| S:18618 E:18621 ||| PRP
will  ||| S:18621 E:18626 ||| MD
be  ||| S:18626 E:18629 ||| VB
important  ||| S:18629 E:18639 ||| JJ
to  ||| S:18639 E:18642 ||| TO
determine  ||| S:18642 E:18660 ||| VB
if  ||| S:18660 E:18663 ||| IN
lipids  ||| S:18663 E:18670 ||| NN
in  ||| S:18670 E:18673 ||| IN
any  ||| S:18673 E:18677 ||| DT
form  ||| S:18677 E:18682 ||| NN
play  ||| S:18682 E:18687 ||| VB
a  ||| S:18687 E:18689 ||| DT
role  ||| S:18689 E:18694 ||| NN
in  ||| S:18694 E:18697 ||| IN
the  ||| S:18697 E:18701 ||| DT
regulation  ||| S:18701 E:18712 ||| NN
of  ||| S:18712 E:18715 ||| IN
PP5  ||| S:18715 E:18727 ||| NNP
or  ||| S:18727 E:18730 ||| CC
Ppt1p  ||| S:18730 E:18745 ||| CD
in  ||| S:18745 E:18748 ||| IN
vivo  ||| S:18748 E:18753 ||| NN
.  ||| S:18753 E:18763 ||| .
Ppt1p  ||| S:18763 E:18769 ||| NNP
was  ||| S:18769 E:18773 ||| VBD
present  ||| S:18773 E:18781 ||| JJ
in  ||| S:18781 E:18784 ||| IN
both  ||| S:18784 E:18789 ||| PDT
the  ||| S:18789 E:18793 ||| DT
nucleus  ||| S:18793 E:18801 ||| NN
and  ||| S:18801 E:18805 ||| CC
cytoplasm  ||| S:18805 E:18815 ||| NN
of  ||| S:18815 E:18827 ||| IN
S.  ||| S:18827 E:18830 ||| NNP
cerevisiae  ||| S:18830 E:18841 ||| NN
.  ||| S:18841 E:18843 ||| .
No  ||| S:18843 E:18846 ||| DT
difference  ||| S:18846 E:18857 ||| NN
in  ||| S:18857 E:18868 ||| IN
compartmentalization  ||| S:18868 E:18889 ||| NN
or  ||| S:18889 E:18892 ||| CC
staining  ||| S:18892 E:18901 ||| JJ
intensity  ||| S:18901 E:18911 ||| NN
in  ||| S:18911 E:18914 ||| IN
cells  ||| S:18914 E:18920 ||| NNS
was  ||| S:18920 E:18932 ||| VBD
observed  ||| S:18932 E:18941 ||| VBN
as  ||| S:18941 E:18944 ||| IN
a  ||| S:18944 E:18946 ||| DT
function  ||| S:18946 E:18955 ||| NN
of  ||| S:18955 E:18958 ||| IN
cell  ||| S:18958 E:18963 ||| NN
or  ||| S:18963 E:18966 ||| CC
bud  ||| S:18966 E:18970 ||| JJ
size ||| S:18970 E:18974 ||| NN
.  ||| S:18974 E:18976 ||| .
This  ||| S:18976 E:18981 ||| DT
suggests  ||| S:18981 E:18998 ||| VBZ
that  ||| S:18998 E:19003 ||| IN
the  ||| S:19003 E:19007 ||| DT
level  ||| S:19007 E:19013 ||| NN
or  ||| S:19013 E:19016 ||| CC
localization  ||| S:19016 E:19029 ||| NN
of  ||| S:19029 E:19032 ||| IN
Ppt1p  ||| S:19032 E:19038 ||| NNP
is  ||| S:19038 E:19041 ||| VBZ
not  ||| S:19041 E:19045 ||| RB
controlled  ||| S:19045 E:19064 ||| VBN
as  ||| S:19064 E:19067 ||| IN
a  ||| S:19067 E:19069 ||| DT
function  ||| S:19069 E:19078 ||| NN
of  ||| S:19078 E:19081 ||| IN
cell  ||| S:19081 E:19086 ||| NN
cycle  ||| S:19086 E:19092 ||| NN
progression ||| S:19092 E:19103 ||| NN
.  ||| S:19103 E:19105 ||| .
Both  ||| S:19105 E:19110 ||| DT
nuclear  ||| S:19110 E:19118 ||| JJ
and  ||| S:19118 E:19130 ||| CC
cytoplasmic  ||| S:19130 E:19142 ||| JJ
localization  ||| S:19142 E:19155 ||| NNS
have  ||| S:19155 E:19160 ||| VBP
been  ||| S:19160 E:19165 ||| VBN
reported  ||| S:19165 E:19174 ||| VBN
for  ||| S:19174 E:19178 ||| IN
other  ||| S:19178 E:19184 ||| JJ
PP5  ||| S:19184 E:19196 ||| CD
homologs ||| S:19196 E:19204 ||| NNS
.  ||| S:19204 E:19206 ||| .
In  ||| S:19206 E:19209 ||| IN
some  ||| S:19209 E:19214 ||| DT
cases ||| S:19214 E:19219 ||| NNS
,  ||| S:19219 E:19221 ||| ,
including  ||| S:19221 E:19240 ||| VBG
P.  ||| S:19240 E:19243 ||| NNP
falciparum  ||| S:19243 E:19254 ||| NN
and  ||| S:19254 E:19258 ||| CC
HeLa  ||| S:19258 E:19263 ||| JJ
cells ||| S:19263 E:19268 ||| NNS
,  ||| S:19268 E:19270 ||| ,
nuclear  ||| S:19270 E:19286 ||| JJ
staining  ||| S:19286 E:19295 ||| NN
appeared  ||| S:19295 E:19304 ||| VBD
more  ||| S:19304 E:19309 ||| RBR
intense  ||| S:19309 E:19317 ||| JJ
than  ||| S:19317 E:19322 ||| IN
cytoplasmic  ||| S:19322 E:19334 ||| JJ
staining  ||| S:19334 E:19343 ||| NNS
[  ||| S:19343 E:19353 ||| -LRB-
2  ||| S:19353 E:19355 ||| CD
9  ||| S:19355 E:19357 ||| CD
]  ||| S:19357 E:19359 ||| -RRB-
.  ||| S:19359 E:19361 ||| .
Based  ||| S:19361 E:19367 ||| VBN
on  ||| S:19367 E:19370 ||| IN
studies  ||| S:19370 E:19378 ||| NNS
with  ||| S:19378 E:19383 ||| IN
heterologously  ||| S:19383 E:19398 ||| NN
expressed  ||| S:19398 E:19416 ||| VBD
human  ||| S:19416 E:19422 ||| JJ
PP5-GFP  ||| S:19422 E:19430 ||| CD
fusion  ||| S:19430 E:19437 ||| NN
proteins ||| S:19437 E:19445 ||| NNS
,  ||| S:19445 E:19447 ||| ,
it  ||| S:19447 E:19450 ||| PRP
has  ||| S:19450 E:19454 ||| VBZ
been  ||| S:19454 E:19459 ||| VBN
proposed  ||| S:19459 E:19468 ||| VBN
that  ||| S:19468 E:19481 ||| IN
nuclear  ||| S:19481 E:19489 ||| JJ
localization  ||| S:19489 E:19502 ||| NN
requires  ||| S:19502 E:19511 ||| VBZ
a  ||| S:19511 E:19513 ||| DT
stretch  ||| S:19513 E:19521 ||| NN
of  ||| S:19521 E:19524 ||| IN
sequence  ||| S:19524 E:19533 ||| NN
in  ||| S:19533 E:19536 ||| IN
the  ||| S:19536 E:19548 ||| DT
C  ||| S:19548 E:19550 ||| NNP
terminus  ||| S:19550 E:19559 ||| NNS
[  ||| S:19559 E:19561 ||| -LRB-
31  ||| S:19561 E:19564 ||| CD
]  ||| S:19564 E:19566 ||| -RRB-
.  ||| S:19566 E:19568 ||| .
However ||| S:19568 E:19575 ||| RB
,  ||| S:19575 E:19577 ||| ,
other  ||| S:19577 E:19583 ||| JJ
sequences  ||| S:19583 E:19593 ||| NN
or  ||| S:19593 E:19596 ||| CC
signals  ||| S:19596 E:19604 ||| NNS
are  ||| S:19604 E:19616 ||| VBP
also  ||| S:19616 E:19621 ||| RB
likely  ||| S:19621 E:19628 ||| JJ
to  ||| S:19628 E:19631 ||| TO
contribute  ||| S:19631 E:19642 ||| VB
to  ||| S:19642 E:19645 ||| TO
nuclear  ||| S:19645 E:19653 ||| JJ
localization  ||| S:19653 E:19666 ||| NN
of  ||| S:19666 E:19669 ||| IN
PP5  ||| S:19669 E:19681 ||| NNP
and  ||| S:19681 E:19685 ||| CC
its  ||| S:19685 E:19689 ||| PRP$
homologs ||| S:19689 E:19697 ||| NN
,  ||| S:19697 E:19699 ||| ,
since  ||| S:19699 E:19705 ||| IN
rat  ||| S:19705 E:19709 ||| NN
and  ||| S:19709 E:19713 ||| CC
mouse  ||| S:19713 E:19719 ||| CD
PP5 ||| S:19719 E:19722 ||| CD
,  ||| S:19722 E:19724 ||| ,
which  ||| S:19724 E:19730 ||| WDT
are  ||| S:19730 E:19742 ||| VBP
identical  ||| S:19742 E:19752 ||| JJ
to  ||| S:19752 E:19755 ||| TO
human  ||| S:19755 E:19761 ||| JJ
PP5  ||| S:19761 E:19765 ||| NN
in  ||| S:19765 E:19768 ||| IN
this  ||| S:19768 E:19773 ||| DT
region  ||| S:19773 E:19780 ||| NN
do  ||| S:19780 E:19783 ||| VBP
not  ||| S:19783 E:19787 ||| RB
appear  ||| S:19787 E:19794 ||| VB
to  ||| S:19794 E:19797 ||| TO
be  ||| S:19797 E:19808 ||| VB
nuclear  ||| S:19808 E:19816 ||| JJ
in  ||| S:19816 E:19819 ||| IN
all  ||| S:19819 E:19823 ||| DT
cell  ||| S:19823 E:19828 ||| NN
types  ||| S:19828 E:19834 ||| NNS
[  ||| S:19834 E:19836 ||| -LRB-
32  ||| S:19836 E:19839 ||| CD
33  ||| S:19839 E:19842 ||| CD
]  ||| S:19842 E:19844 ||| -RRB-
.  ||| S:19844 E:19846 ||| .
In  ||| S:19846 E:19849 ||| IN
addition  ||| S:19849 E:19867 ||| NN
P.  ||| S:19867 E:19870 ||| NNP
falciparum  ||| S:19870 E:19881 ||| FW
PP5  ||| S:19881 E:19885 ||| FW
is  ||| S:19885 E:19888 ||| VBZ
primarily  ||| S:19888 E:19906 ||| RB
nuclear  ||| S:19906 E:19914 ||| JJ
[  ||| S:19914 E:19916 ||| -LRB-
9  ||| S:19916 E:19918 ||| CD
]  ||| S:19918 E:19920 ||| -RRB-
,  ||| S:19920 E:19922 ||| ,
although  ||| S:19922 E:19931 ||| IN
it  ||| S:19931 E:19934 ||| PRP
is  ||| S:19934 E:19937 ||| VBZ
not  ||| S:19937 E:19941 ||| RB
well  ||| S:19941 E:19946 ||| RB
conserved  ||| S:19946 E:19956 ||| VBN
in  ||| S:19956 E:19959 ||| IN
the  ||| S:19959 E:19971 ||| DT
relevant  ||| S:19971 E:19980 ||| JJ
C-terminal  ||| S:19980 E:19991 ||| JJ
region  ||| S:19991 E:19998 ||| NN
but  ||| S:19998 E:20002 ||| CC
contains  ||| S:20002 E:20011 ||| VBZ
a  ||| S:20011 E:20013 ||| DT
potential  ||| S:20013 E:20031 ||| JJ
bipartite  ||| S:20031 E:20041 ||| JJ
nuclear  ||| S:20041 E:20049 ||| JJ
localization  ||| S:20049 E:20062 ||| NNS
signal  ||| S:20062 E:20069 ||| VBP
not  ||| S:20069 E:20073 ||| RB
found  ||| S:20073 E:20079 ||| VBN
in  ||| S:20079 E:20082 ||| IN
other  ||| S:20082 E:20096 ||| JJ
PP5  ||| S:20096 E:20100 ||| CD
sequences  ||| S:20100 E:20110 ||| NNS
reported  ||| S:20110 E:20119 ||| VBD
thus  ||| S:20119 E:20124 ||| RB
far ||| S:20124 E:20127 ||| RB
.  ||| S:20127 E:20129 ||| .
The  ||| S:20129 E:20133 ||| DT
functional  ||| S:20133 E:20152 ||| JJ
significance  ||| S:20152 E:20165 ||| NN
of  ||| S:20165 E:20168 ||| IN
differential  ||| S:20168 E:20181 ||| JJ
localization  ||| S:20181 E:20194 ||| NN
is  ||| S:20194 E:20197 ||| VBZ
not  ||| S:20197 E:20201 ||| RB
known  ||| S:20201 E:20207 ||| VBN
at  ||| S:20207 E:20218 ||| IN
this  ||| S:20218 E:20223 ||| DT
time ||| S:20223 E:20227 ||| NN
.  ||| S:20227 E:20237 ||| .
Ppt1p  ||| S:20237 E:20243 ||| NNP
levels  ||| S:20243 E:20250 ||| NNS
are  ||| S:20250 E:20254 ||| VBP
highest  ||| S:20254 E:20262 ||| JJS
during  ||| S:20262 E:20269 ||| IN
periods  ||| S:20269 E:20277 ||| NNS
of  ||| S:20277 E:20280 ||| IN
rapid  ||| S:20280 E:20286 ||| JJ
growth  ||| S:20286 E:20301 ||| NN
and  ||| S:20301 E:20305 ||| CC
drop  ||| S:20305 E:20310 ||| VB
off  ||| S:20310 E:20314 ||| RP
when  ||| S:20314 E:20319 ||| WRB
growth  ||| S:20319 E:20326 ||| NN
slows  ||| S:20326 E:20332 ||| VBZ
( ||| S:20332 E:20333 ||| -LRB-
Fig.  ||| S:20333 E:20338 ||| NNP
4B ||| S:20338 E:20340 ||| NNP
) ||| S:20340 E:20341 ||| -RRB-
,  ||| S:20341 E:20343 ||| ,
raising  ||| S:20343 E:20351 ||| VBG
the  ||| S:20351 E:20363 ||| DT
possibility  ||| S:20363 E:20375 ||| NN
that  ||| S:20375 E:20380 ||| IN
this  ||| S:20380 E:20385 ||| DT
enzyme  ||| S:20385 E:20392 ||| NN
may  ||| S:20392 E:20396 ||| MD
have  ||| S:20396 E:20401 ||| VB
a  ||| S:20401 E:20403 ||| DT
role  ||| S:20403 E:20408 ||| NN
in  ||| S:20408 E:20411 ||| IN
controlling  ||| S:20411 E:20431 ||| VBG
cell  ||| S:20431 E:20436 ||| NN
growth  ||| S:20436 E:20443 ||| NN
[  ||| S:20443 E:20445 ||| -LRB-
34  ||| S:20445 E:20448 ||| CD
]  ||| S:20448 E:20450 ||| -RRB-
and  ||| S:20450 E:20454 ||| CC
its  ||| S:20454 E:20458 ||| PRP$
expression  ||| S:20458 E:20469 ||| NN
may  ||| S:20469 E:20473 ||| MD
be  ||| S:20473 E:20476 ||| VB
regulated  ||| S:20476 E:20486 ||| VBN
by  ||| S:20486 E:20489 ||| IN
a  ||| S:20489 E:20499 ||| DT
metabolic  ||| S:20499 E:20509 ||| NN
or  ||| S:20509 E:20512 ||| CC
nutritional  ||| S:20512 E:20524 ||| JJ
signal  ||| S:20524 E:20531 ||| NN
[  ||| S:20531 E:20533 ||| -LRB-
35  ||| S:20533 E:20536 ||| CD
]  ||| S:20536 E:20538 ||| -RRB-
.  ||| S:20538 E:20540 ||| .
The  ||| S:20540 E:20544 ||| DT
observation  ||| S:20544 E:20564 ||| NN
that  ||| S:20564 E:20569 ||| IN
Ppt1p  ||| S:20569 E:20575 ||| CD
levels  ||| S:20575 E:20582 ||| NNS
rose  ||| S:20582 E:20587 ||| VBD
and  ||| S:20587 E:20591 ||| CC
fell  ||| S:20591 E:20596 ||| VBD
in  ||| S:20596 E:20599 ||| IN
parallel  ||| S:20599 E:20608 ||| NN
with  ||| S:20608 E:20613 ||| IN
mRNA  ||| S:20613 E:20626 ||| JJ
levels  ||| S:20626 E:20633 ||| NNS
suggests  ||| S:20633 E:20642 ||| VBZ
that  ||| S:20642 E:20647 ||| IN
Ppt1p  ||| S:20647 E:20653 ||| CD
expression  ||| S:20653 E:20664 ||| NN
is  ||| S:20664 E:20667 ||| VBZ
primarily  ||| S:20667 E:20685 ||| RB
controlled  ||| S:20685 E:20696 ||| VBN
at  ||| S:20696 E:20699 ||| IN
the  ||| S:20699 E:20703 ||| DT
level  ||| S:20703 E:20709 ||| NN
of  ||| S:20709 E:20712 ||| IN
gene  ||| S:20712 E:20717 ||| NN
transcription ||| S:20717 E:20730 ||| NN
.  ||| S:20730 E:20732 ||| .
Studies  ||| S:20732 E:20740 ||| NNS
of  ||| S:20740 E:20751 ||| IN
PP5  ||| S:20751 E:20755 ||| NNP
and  ||| S:20755 E:20759 ||| CC
its  ||| S:20759 E:20763 ||| PRP$
homologs  ||| S:20763 E:20772 ||| NN
in  ||| S:20772 E:20775 ||| IN
cultured  ||| S:20775 E:20784 ||| JJ
cells  ||| S:20784 E:20790 ||| NNS
and  ||| S:20790 E:20794 ||| CC
various  ||| S:20794 E:20810 ||| JJ
organisms  ||| S:20810 E:20820 ||| NNS
also  ||| S:20820 E:20825 ||| RB
suggest  ||| S:20825 E:20833 ||| VBP
it  ||| S:20833 E:20836 ||| PRP
may  ||| S:20836 E:20840 ||| MD
play  ||| S:20840 E:20845 ||| VB
a  ||| S:20845 E:20847 ||| DT
role  ||| S:20847 E:20852 ||| NN
in  ||| S:20852 E:20855 ||| IN
development  ||| S:20855 E:20867 ||| NN
[  ||| S:20867 E:20877 ||| -LRB-
5  ||| S:20877 E:20879 ||| CD
6  ||| S:20879 E:20881 ||| CD
]  ||| S:20881 E:20883 ||| -RRB-
or  ||| S:20883 E:20886 ||| CC
during  ||| S:20886 E:20893 ||| IN
rapid  ||| S:20893 E:20899 ||| JJ
cell  ||| S:20899 E:20904 ||| NN
growth  ||| S:20904 E:20911 ||| NN
[  ||| S:20911 E:20913 ||| -LRB-
2  ||| S:20913 E:20915 ||| CD
7  ||| S:20915 E:20917 ||| CD
]  ||| S:20917 E:20919 ||| -RRB-
.  ||| S:20919 E:20943 ||| .
Conclusions  ||| S:20943 E:20963 ||| NNP
Ppt1p  ||| S:20963 E:20969 ||| NNP
shares  ||| S:20969 E:20976 ||| NNS
several  ||| S:20976 E:20984 ||| JJ
biochemical  ||| S:20984 E:20996 ||| JJ
properties  ||| S:20996 E:21007 ||| NNS
with  ||| S:21007 E:21012 ||| IN
PP5  ||| S:21012 E:21016 ||| NNP
and  ||| S:21016 E:21028 ||| CC
other  ||| S:21028 E:21034 ||| JJ
homologs ||| S:21034 E:21042 ||| NN
,  ||| S:21042 E:21044 ||| ,
including  ||| S:21044 E:21054 ||| VBG
a  ||| S:21054 E:21056 ||| DT
similar  ||| S:21056 E:21064 ||| JJ
domain  ||| S:21064 E:21071 ||| NN
structure  ||| S:21071 E:21081 ||| NN
and  ||| S:21081 E:21093 ||| CC
stimulation  ||| S:21093 E:21105 ||| NN
by  ||| S:21105 E:21108 ||| IN
lipid  ||| S:21108 E:21123 ||| NN
in  ||| S:21123 E:21126 ||| IN
vitro  ||| S:21126 E:21132 ||| NN
.  ||| S:21132 E:21134 ||| .
Unlike  ||| S:21134 E:21141 ||| IN
PP5 ||| S:21141 E:21144 ||| NNP
,  ||| S:21144 E:21146 ||| ,
Ppt1p  ||| S:21146 E:21152 ||| NNP
is  ||| S:21152 E:21155 ||| VBZ
not  ||| S:21155 E:21167 ||| RB
fully  ||| S:21167 E:21173 ||| RB
activated  ||| S:21173 E:21183 ||| VBN
by  ||| S:21183 E:21186 ||| IN
removal  ||| S:21186 E:21194 ||| NN
of  ||| S:21194 E:21197 ||| IN
the  ||| S:21197 E:21201 ||| DT
TPR  ||| S:21201 E:21205 ||| NNP
domain  ||| S:21205 E:21212 ||| NN
or  ||| S:21212 E:21215 ||| CC
by  ||| S:21215 E:21218 ||| IN
removal  ||| S:21218 E:21234 ||| NN
of  ||| S:21234 E:21237 ||| IN
9  ||| S:21237 E:21239 ||| CD
C-terminal  ||| S:21239 E:21250 ||| JJ
residues ||| S:21250 E:21258 ||| NNS
,  ||| S:21258 E:21260 ||| ,
suggesting  ||| S:21260 E:21271 ||| VBG
that  ||| S:21271 E:21276 ||| IN
these  ||| S:21276 E:21282 ||| DT
regions  ||| S:21282 E:21290 ||| NNS
may  ||| S:21290 E:21302 ||| MD
not  ||| S:21302 E:21306 ||| RB
play  ||| S:21306 E:21311 ||| VB
an  ||| S:21311 E:21314 ||| DT
autoinhibitory  ||| S:21314 E:21329 ||| JJ
role  ||| S:21329 E:21334 ||| NN
in  ||| S:21334 E:21337 ||| IN
Ppt1p ||| S:21337 E:21342 ||| CD
.  ||| S:21342 E:21344 ||| .
Ppt1p  ||| S:21344 E:21350 ||| NNP
is  ||| S:21350 E:21361 ||| VBZ
expressed  ||| S:21361 E:21371 ||| VBN
in  ||| S:21371 E:21374 ||| IN
early  ||| S:21374 E:21380 ||| JJ
log  ||| S:21380 E:21384 ||| JJ
phase  ||| S:21384 E:21390 ||| NN
growth  ||| S:21390 E:21397 ||| NN
and  ||| S:21397 E:21401 ||| CC
decreases  ||| S:21401 E:21419 ||| VBZ
dramatically  ||| S:21419 E:21432 ||| RB
as  ||| S:21432 E:21435 ||| IN
cells  ||| S:21435 E:21441 ||| NNS
approach  ||| S:21441 E:21450 ||| VBP
the  ||| S:21450 E:21454 ||| DT
stationary  ||| S:21454 E:21465 ||| JJ
phase ||| S:21465 E:21470 ||| NN
,  ||| S:21470 E:21480 ||| ,
suggesting  ||| S:21480 E:21491 ||| VBG
that  ||| S:21491 E:21496 ||| IN
Ppt1p  ||| S:21496 E:21502 ||| NNP
could  ||| S:21502 E:21508 ||| MD
play  ||| S:21508 E:21513 ||| VB
a  ||| S:21513 E:21515 ||| DT
role  ||| S:21515 E:21520 ||| NN
in  ||| S:21520 E:21523 ||| IN
cell  ||| S:21523 E:21528 ||| NN
growth  ||| S:21528 E:21535 ||| NN
or  ||| S:21535 E:21546 ||| CC
may  ||| S:21546 E:21550 ||| MD
be  ||| S:21550 E:21553 ||| VB
controlled  ||| S:21553 E:21564 ||| VBN
by  ||| S:21564 E:21567 ||| IN
metabolic  ||| S:21567 E:21577 ||| NN
or  ||| S:21577 E:21580 ||| CC
nutritional  ||| S:21580 E:21592 ||| JJ
signals ||| S:21592 E:21599 ||| NNS
.  ||| S:21599 E:21601 ||| .
Like  ||| S:21601 E:21614 ||| IN
PP5 ||| S:21614 E:21617 ||| NNP
,  ||| S:21617 E:21619 ||| ,
the  ||| S:21619 E:21623 ||| DT
observation  ||| S:21623 E:21635 ||| NN
that  ||| S:21635 E:21640 ||| IN
Ppt1p  ||| S:21640 E:21646 ||| NNP
is  ||| S:21646 E:21649 ||| VBZ
localized  ||| S:21649 E:21659 ||| VBN
in  ||| S:21659 E:21662 ||| IN
both  ||| S:21662 E:21667 ||| PDT
the  ||| S:21667 E:21679 ||| DT
nucleus  ||| S:21679 E:21687 ||| NN
and  ||| S:21687 E:21691 ||| CC
cytoplasm  ||| S:21691 E:21701 ||| NN
implies  ||| S:21701 E:21709 ||| VBZ
that  ||| S:21709 E:21714 ||| IN
it  ||| S:21714 E:21717 ||| PRP
may  ||| S:21717 E:21721 ||| MD
function  ||| S:21721 E:21730 ||| VB
in  ||| S:21730 E:21741 ||| IN
several  ||| S:21741 E:21749 ||| JJ
subcellular  ||| S:21749 E:21761 ||| JJ
compartments ||| S:21761 E:21773 ||| NN
.  ||| S:21773 E:21783 ||| .
Although  ||| S:21783 E:21792 ||| IN
our  ||| S:21792 E:21796 ||| PRP$
findings  ||| S:21796 E:21805 ||| NNS
suggest  ||| S:21805 E:21813 ||| VBP
some  ||| S:21813 E:21818 ||| DT
differences  ||| S:21818 E:21830 ||| NNS
may  ||| S:21830 E:21834 ||| MD
exist  ||| S:21834 E:21848 ||| VB
in  ||| S:21848 E:21851 ||| IN
regulatory  ||| S:21851 E:21862 ||| JJ
properties  ||| S:21862 E:21873 ||| NNS
of  ||| S:21873 E:21876 ||| IN
Ppt1p  ||| S:21876 E:21882 ||| NNP
and  ||| S:21882 E:21886 ||| CC
PP5 ||| S:21886 E:21889 ||| NNP
,  ||| S:21889 E:21891 ||| ,
many  ||| S:21891 E:21896 ||| JJ
biochemical  ||| S:21896 E:21916 ||| NN
and  ||| S:21916 E:21920 ||| CC
cellular  ||| S:21920 E:21929 ||| JJ
properties  ||| S:21929 E:21940 ||| NNS
are  ||| S:21940 E:21944 ||| VBP
shared ||| S:21944 E:21950 ||| VBN
.  ||| S:21950 E:21952 ||| .
In  ||| S:21952 E:21955 ||| IN
addition  ||| S:21955 E:21964 ||| NN
a  ||| S:21964 E:21966 ||| DT
recent  ||| S:21966 E:21981 ||| JJ
report  ||| S:21981 E:21988 ||| NN
has  ||| S:21988 E:21992 ||| VBZ
shown  ||| S:21992 E:21998 ||| VBN
that  ||| S:21998 E:22003 ||| IN
Ppt1p  ||| S:22003 E:22009 ||| NNP
is  ||| S:22009 E:22012 ||| VBZ
co-purified  ||| S:22012 E:22024 ||| JJ
with  ||| S:22024 E:22029 ||| IN
Hsp82p  ||| S:22029 E:22036 ||| NNP
and  ||| S:22036 E:22048 ||| CC
Hsc82p ||| S:22048 E:22054 ||| NNP
,  ||| S:22054 E:22056 ||| ,
the  ||| S:22056 E:22069 ||| DT
S.  ||| S:22069 E:22072 ||| NNP
cerevisiae  ||| S:22072 E:22083 ||| VBD
homologs  ||| S:22083 E:22092 ||| VBN
of  ||| S:22092 E:22095 ||| IN
hsp90  ||| S:22095 E:22101 ||| NNP
[  ||| S:22101 E:22103 ||| -LRB-
36  ||| S:22103 E:22114 ||| CD
]  ||| S:22114 E:22116 ||| -RRB-
,  ||| S:22116 E:22118 ||| ,
indicating  ||| S:22118 E:22129 ||| VBG
that  ||| S:22129 E:22134 ||| IN
Ppt1p  ||| S:22134 E:22140 ||| NNP
and  ||| S:22140 E:22144 ||| CC
PP5  ||| S:22144 E:22148 ||| NNP
have  ||| S:22148 E:22153 ||| VBP
at  ||| S:22153 E:22156 ||| IN
least  ||| S:22156 E:22162 ||| JJS
one  ||| S:22162 E:22166 ||| CD
common  ||| S:22166 E:22181 ||| JJ
protein  ||| S:22181 E:22189 ||| NN
partner  ||| S:22189 E:22197 ||| NN
and  ||| S:22197 E:22201 ||| CC
suggesting  ||| S:22201 E:22212 ||| VBG
that ||| S:22212 E:22216 ||| IN
,  ||| S:22216 E:22218 ||| ,
like  ||| S:22218 E:22223 ||| IN
PP5 ||| S:22223 E:22226 ||| NNP
,  ||| S:22226 E:22228 ||| ,
Ppt1p  ||| S:22228 E:22242 ||| CD
functions  ||| S:22242 E:22252 ||| NNS
in  ||| S:22252 E:22255 ||| IN
chaperone  ||| S:22255 E:22265 ||| JJ
complexes ||| S:22265 E:22274 ||| NNS
.  ||| S:22274 E:22276 ||| .
Thus ||| S:22276 E:22280 ||| RB
,  ||| S:22280 E:22291 ||| ,
S.  ||| S:22291 E:22294 ||| NNP
cerevisiae  ||| S:22294 E:22305 ||| FW
Ppt1p  ||| S:22305 E:22311 ||| FW
is  ||| S:22311 E:22314 ||| VBZ
likely  ||| S:22314 E:22321 ||| JJ
to  ||| S:22321 E:22324 ||| TO
be  ||| S:22324 E:22327 ||| VB
a  ||| S:22327 E:22337 ||| DT
valuable  ||| S:22337 E:22346 ||| JJ
model  ||| S:22346 E:22352 ||| NN
for  ||| S:22352 E:22356 ||| IN
probing  ||| S:22356 E:22364 ||| VBG
the  ||| S:22364 E:22368 ||| DT
cellular  ||| S:22368 E:22377 ||| JJ
role  ||| S:22377 E:22382 ||| NN
of  ||| S:22382 E:22385 ||| IN
PP5 ||| S:22385 E:22388 ||| CD
.  ||| S:22388 E:22412 ||| .
Methods  ||| S:22412 E:22439 ||| NNP
Materials  ||| S:22439 E:22459 ||| NNPS
Restriction  ||| S:22459 E:22471 ||| NNP
enzymes  ||| S:22471 E:22479 ||| NN
and  ||| S:22479 E:22483 ||| CC
DNA  ||| S:22483 E:22487 ||| NNP
modifying  ||| S:22487 E:22497 ||| NN
enzymes  ||| S:22497 E:22505 ||| NNS
were  ||| S:22505 E:22520 ||| VBD
purchased  ||| S:22520 E:22530 ||| VBN
from  ||| S:22530 E:22535 ||| IN
New  ||| S:22535 E:22539 ||| NNP
England  ||| S:22539 E:22547 ||| NNP
Biolabs ||| S:22547 E:22554 ||| NNP
,  ||| S:22554 E:22556 ||| ,
Promega  ||| S:22556 E:22564 ||| NNP
or  ||| S:22564 E:22567 ||| CC
Gibco  ||| S:22567 E:22573 ||| NNP
BRL ||| S:22573 E:22576 ||| NNP
.  ||| S:22576 E:22588 ||| .
Reagents  ||| S:22588 E:22597 ||| NNP
for  ||| S:22597 E:22601 ||| IN
bacterial  ||| S:22601 E:22611 ||| JJ
and  ||| S:22611 E:22615 ||| CC
yeast  ||| S:22615 E:22621 ||| NN
culture  ||| S:22621 E:22629 ||| NN
were  ||| S:22629 E:22634 ||| VBD
purchased  ||| S:22634 E:22654 ||| VBN
from  ||| S:22654 E:22659 ||| IN
Difco ||| S:22659 E:22664 ||| NNP
.  ||| S:22664 E:22666 ||| .
All  ||| S:22666 E:22670 ||| DT
other  ||| S:22670 E:22676 ||| JJ
materials  ||| S:22676 E:22686 ||| NNS
were  ||| S:22686 E:22691 ||| VBD
from  ||| S:22691 E:22696 ||| IN
Sigma  ||| S:22696 E:22702 ||| NNP
unless  ||| S:22702 E:22719 ||| IN
otherwise  ||| S:22719 E:22729 ||| RB
noted ||| S:22729 E:22734 ||| VBD
.  ||| S:22734 E:22736 ||| .
The  ||| S:22736 E:22740 ||| DT
yeast  ||| S:22740 E:22746 ||| NN
centromeric  ||| S:22746 E:22758 ||| NNS
plasmid  ||| S:22758 E:22766 ||| VBP
encoding  ||| S:22766 E:22785 ||| VBG
the  ||| S:22785 E:22789 ||| DT
Spc42p-EGFP  ||| S:22789 E:22801 ||| JJ
fusion  ||| S:22801 E:22808 ||| NN
protein  ||| S:22808 E:22816 ||| NN
was  ||| S:22816 E:22820 ||| VBD
a  ||| S:22820 E:22822 ||| DT
kind  ||| S:22822 E:22827 ||| NN
gift  ||| S:22827 E:22832 ||| NN
from  ||| S:22832 E:22847 ||| IN
Younghoon  ||| S:22847 E:22857 ||| NNP
Oh  ||| S:22857 E:22860 ||| NNP
and  ||| S:22860 E:22864 ||| CC
Dr.  ||| S:22864 E:22868 ||| NNP
Harry  ||| S:22868 E:22874 ||| NNP
Charbonneau  ||| S:22874 E:22886 ||| NNP
( ||| S:22886 E:22887 ||| -LRB-
Department  ||| S:22887 E:22898 ||| NNP
of  ||| S:22898 E:22911 ||| IN
Biochemistry ||| S:22911 E:22923 ||| NNP
,  ||| S:22923 E:22925 ||| ,
Purdue  ||| S:22925 E:22932 ||| NNP
University ||| S:22932 E:22942 ||| NNP
) ||| S:22942 E:22943 ||| -RRB-
.  ||| S:22943 E:22973 ||| .
Cloning  ||| S:22973 E:22981 ||| NNP
and  ||| S:22981 E:22985 ||| CC
expression  ||| S:22985 E:22996 ||| NN
of  ||| S:22996 E:22999 ||| IN
recombinant  ||| S:22999 E:23011 ||| JJ
Ppt1p ||| S:23011 E:23016 ||| NN
,  ||| S:23016 E:23018 ||| ,
Ppt1p  ||| S:23018 E:23034 ||| NNP
( ||| S:23034 E:23035 ||| -LRB-
1-504 ||| S:23035 E:23040 ||| NNP
) ||| S:23040 E:23041 ||| -RRB-
,  ||| S:23041 E:23043 ||| ,
and  ||| S:23043 E:23047 ||| CC
PP5  ||| S:23047 E:23051 ||| CD
in  ||| S:23051 E:23054 ||| IN
E.  ||| S:23054 E:23057 ||| NNP
coli  ||| S:23057 E:23072 ||| VBD
PP5  ||| S:23072 E:23076 ||| NNP
was  ||| S:23076 E:23080 ||| VBD
expressed  ||| S:23080 E:23090 ||| VBN
and  ||| S:23090 E:23094 ||| CC
purified  ||| S:23094 E:23103 ||| VBP
as  ||| S:23103 E:23106 ||| RB
described  ||| S:23106 E:23116 ||| VBN
previously  ||| S:23116 E:23137 ||| RB
[  ||| S:23137 E:23139 ||| -LRB-
18  ||| S:23139 E:23142 ||| CD
]  ||| S:23142 E:23144 ||| -RRB-
.  ||| S:23144 E:23146 ||| .
To  ||| S:23146 E:23149 ||| TO
generate  ||| S:23149 E:23158 ||| VB
the  ||| S:23158 E:23162 ||| DT
expression  ||| S:23162 E:23173 ||| NN
plasmid  ||| S:23173 E:23181 ||| VBD
pET-GST-PPT1 ||| S:23181 E:23193 ||| CD
,  ||| S:23193 E:23216 ||| ,
Saccharomyces  ||| S:23216 E:23230 ||| FW
cerevisiae  ||| S:23230 E:23241 ||| FW
genomic  ||| S:23241 E:23259 ||| FW
DNA  ||| S:23259 E:23263 ||| NNP
was  ||| S:23263 E:23267 ||| VBD
used  ||| S:23267 E:23272 ||| VBN
as  ||| S:23272 E:23275 ||| IN
template  ||| S:23275 E:23284 ||| NN
in  ||| S:23284 E:23287 ||| IN
a  ||| S:23287 E:23289 ||| DT
polymerase  ||| S:23289 E:23300 ||| JJ
chain  ||| S:23300 E:23306 ||| NN
reaction  ||| S:23306 E:23325 ||| NN
( ||| S:23325 E:23326 ||| -LRB-
PCR ||| S:23326 E:23329 ||| NNP
)  ||| S:23329 E:23331 ||| -RRB-
with  ||| S:23331 E:23347 ||| IN
PPT1  ||| S:23347 E:23352 ||| CD
-specific  ||| S:23352 E:23362 ||| JJ
oligonucleotide  ||| S:23362 E:23388 ||| JJ
primers ||| S:23388 E:23395 ||| NN
,  ||| S:23395 E:23397 ||| ,
( ||| S:23397 E:23398 ||| -LRB-
5 ||| S:23398 E:23399 ||| CD
'  ||| S:23399 E:23401 ||| POS
primer ||| S:23401 E:23407 ||| NN
,  ||| S:23407 E:23409 ||| ,
5 ||| S:23409 E:23410 ||| CD
' ||| S:23410 E:23411 ||| POS
-ATGtcaacacccacagcagcagat ||| S:23411 E:23436 ||| JJ
;  ||| S:23436 E:23438 ||| :
3 ||| S:23438 E:23439 ||| CD
'  ||| S:23439 E:23451 ||| POS
primer ||| S:23451 E:23457 ||| NN
,  ||| S:23457 E:23459 ||| ,
5 ||| S:23459 E:23460 ||| CD
' ||| S:23460 E:23461 ||| POS
-CTAtaaaccaaaaccaccattagaa ||| S:23461 E:23487 ||| JJ
)  ||| S:23487 E:23489 ||| -RRB-
that  ||| S:23489 E:23494 ||| WDT
contained  ||| S:23494 E:23514 ||| VBD
initiation  ||| S:23514 E:23525 ||| JJ
and  ||| S:23525 E:23529 ||| CC
stop  ||| S:23529 E:23534 ||| VB
codons ||| S:23534 E:23540 ||| NNS
,  ||| S:23540 E:23542 ||| ,
respectively ||| S:23542 E:23554 ||| RB
.  ||| S:23554 E:23556 ||| .
A  ||| S:23556 E:23558 ||| DT
PCR  ||| S:23558 E:23562 ||| NNP
product  ||| S:23562 E:23580 ||| NN
containing  ||| S:23580 E:23591 ||| VBG
the  ||| S:23591 E:23595 ||| DT
full-length  ||| S:23595 E:23618 ||| JJ
PPT1  ||| S:23618 E:23623 ||| CD
coding  ||| S:23623 E:23630 ||| JJ
region  ||| S:23630 E:23637 ||| NN
was  ||| S:23637 E:23641 ||| VBD
then  ||| S:23641 E:23646 ||| RB
cloned  ||| S:23646 E:23663 ||| VBN
into  ||| S:23663 E:23668 ||| IN
the  ||| S:23668 E:23683 ||| DT
Eco  ||| S:23683 E:23687 ||| JJ
RV  ||| S:23687 E:23690 ||| NN
restriction  ||| S:23690 E:23702 ||| NN
site  ||| S:23702 E:23707 ||| NN
of  ||| S:23707 E:23710 ||| IN
pBII  ||| S:23710 E:23715 ||| NNP
KS  ||| S:23715 E:23728 ||| NNP
-  ||| S:23728 E:23730 ||| :
( ||| S:23730 E:23731 ||| -LRB-
Stratagene ||| S:23731 E:23741 ||| NNP
)  ||| S:23741 E:23743 ||| -RRB-
and  ||| S:23743 E:23747 ||| CC
sequenced ||| S:23747 E:23756 ||| NN
.  ||| S:23756 E:23758 ||| .
A  ||| S:23758 E:23760 ||| DT
fragment  ||| S:23760 E:23769 ||| NN
containing  ||| S:23769 E:23780 ||| VBG
the  ||| S:23780 E:23795 ||| DT
PPT1  ||| S:23795 E:23800 ||| NNP
ORF  ||| S:23800 E:23804 ||| NNP
was  ||| S:23804 E:23808 ||| VBD
excised  ||| S:23808 E:23816 ||| VBN
from  ||| S:23816 E:23821 ||| IN
the  ||| S:23821 E:23835 ||| DT
pBII-PPT1  ||| S:23835 E:23845 ||| NN
using  ||| S:23845 E:23862 ||| VBG
Eco  ||| S:23862 E:23866 ||| NNP
RI  ||| S:23866 E:23869 ||| NNP
and  ||| S:23869 E:23884 ||| CC
Xho  ||| S:23884 E:23888 ||| NNP
I  ||| S:23888 E:23890 ||| NNP
restriction  ||| S:23890 E:23902 ||| NN
enzymes  ||| S:23902 E:23910 ||| NNS
and  ||| S:23910 E:23914 ||| CC
was  ||| S:23914 E:23928 ||| VBD
subcloned  ||| S:23928 E:23938 ||| JJ
downstream  ||| S:23938 E:23949 ||| NN
of  ||| S:23949 E:23952 ||| IN
the  ||| S:23952 E:23956 ||| DT
GST  ||| S:23956 E:23960 ||| NNP
coding  ||| S:23960 E:23967 ||| JJ
region  ||| S:23967 E:23974 ||| NN
into  ||| S:23974 E:23979 ||| IN
the  ||| S:23979 E:23994 ||| DT
Eco  ||| S:23994 E:23998 ||| NNP
RI  ||| S:23998 E:24001 ||| NNP
and  ||| S:24001 E:24016 ||| CC
Sal  ||| S:24016 E:24020 ||| NNP
I  ||| S:24020 E:24022 ||| NNP
sites  ||| S:24022 E:24028 ||| NNS
of  ||| S:24028 E:24031 ||| IN
the  ||| S:24031 E:24035 ||| DT
bacterial  ||| S:24035 E:24055 ||| JJ
expression  ||| S:24055 E:24066 ||| NN
vector  ||| S:24066 E:24073 ||| NN
pET-21a  ||| S:24073 E:24081 ||| NNP
GST  ||| S:24081 E:24085 ||| NNP
[  ||| S:24085 E:24087 ||| -LRB-
37  ||| S:24087 E:24090 ||| CD
]  ||| S:24090 E:24092 ||| -RRB-
.  ||| S:24092 E:24094 ||| .
To  ||| S:24094 E:24097 ||| TO
construct  ||| S:24097 E:24107 ||| VB
the  ||| S:24107 E:24121 ||| DT
pET-GST-PPT1  ||| S:24121 E:24134 ||| NNP
( ||| S:24134 E:24135 ||| -LRB-
1-504 ||| S:24135 E:24140 ||| NNP
)  ||| S:24140 E:24142 ||| -RRB-
plasmid  ||| S:24142 E:24150 ||| VBZ
a  ||| S:24150 E:24152 ||| DT
453  ||| S:24152 E:24156 ||| CD
bp  ||| S:24156 E:24159 ||| JJ
fragment  ||| S:24159 E:24168 ||| NN
was  ||| S:24168 E:24182 ||| VBD
amplified  ||| S:24182 E:24192 ||| VBN
from  ||| S:24192 E:24197 ||| IN
pET-GST-PPT1  ||| S:24197 E:24210 ||| CD
by  ||| S:24210 E:24213 ||| IN
PCR  ||| S:24213 E:24217 ||| NNP
using  ||| S:24217 E:24223 ||| VBG
a  ||| S:24223 E:24225 ||| DT
3 ||| S:24225 E:24226 ||| CD
'  ||| S:24226 E:24228 ||| POS
primer  ||| S:24228 E:24245 ||| NN
containing  ||| S:24245 E:24256 ||| VBG
a  ||| S:24256 E:24269 ||| DT
Xho  ||| S:24269 E:24273 ||| NNP
I  ||| S:24273 E:24275 ||| NNP
restriction  ||| S:24275 E:24287 ||| NN
site  ||| S:24287 E:24292 ||| NN
and  ||| S:24292 E:24296 ||| CC
a  ||| S:24296 E:24298 ||| DT
stop  ||| S:24298 E:24313 ||| NN
codon  ||| S:24313 E:24319 ||| VBZ
designed  ||| S:24319 E:24328 ||| VBN
to  ||| S:24328 E:24331 ||| TO
truncate  ||| S:24331 E:24340 ||| VB
the  ||| S:24340 E:24355 ||| DT
PPT1  ||| S:24355 E:24360 ||| JJ
gene  ||| S:24360 E:24365 ||| NN
product  ||| S:24365 E:24373 ||| NN
at  ||| S:24373 E:24376 ||| IN
Met504  ||| S:24376 E:24393 ||| NNP
( ||| S:24393 E:24394 ||| -LRB-
5 ||| S:24394 E:24395 ||| CD
' ||| S:24395 E:24396 ||| POS
-gatcctcgagTTAcattggttttatatctggg ||| S:24396 E:24429 ||| JJ
)  ||| S:24429 E:24431 ||| -RRB-
and  ||| S:24431 E:24435 ||| CC
a  ||| S:24435 E:24437 ||| DT
5 ||| S:24437 E:24438 ||| CD
'  ||| S:24438 E:24440 ||| POS
primer  ||| S:24440 E:24457 ||| NN
( ||| S:24457 E:24458 ||| -LRB-
5 ||| S:24458 E:24459 ||| CD
' ||| S:24459 E:24460 ||| POS
-gtaatgcatggtggttta ||| S:24460 E:24479 ||| JJ
)  ||| S:24479 E:24481 ||| -RRB-
encompassing  ||| S:24481 E:24494 ||| VBZ
the  ||| S:24494 E:24509 ||| DT
Nsi  ||| S:24509 E:24513 ||| NNP
I  ||| S:24513 E:24515 ||| NNP
restriction  ||| S:24515 E:24527 ||| NN
site  ||| S:24527 E:24532 ||| NN
of  ||| S:24532 E:24546 ||| IN
PPT1  ||| S:24546 E:24551 ||| CD
.  ||| S:24551 E:24553 ||| .
The  ||| S:24553 E:24557 ||| DT
PCR  ||| S:24557 E:24561 ||| NNP
product  ||| S:24561 E:24569 ||| NN
was  ||| S:24569 E:24573 ||| VBD
cloned  ||| S:24573 E:24590 ||| VBN
into  ||| S:24590 E:24595 ||| IN
the  ||| S:24595 E:24610 ||| DT
Nsi  ||| S:24610 E:24614 ||| NNP
I  ||| S:24614 E:24616 ||| NNP
and  ||| S:24616 E:24631 ||| CC
Xho  ||| S:24631 E:24635 ||| NNP
I  ||| S:24635 E:24637 ||| NNP
restriction  ||| S:24637 E:24649 ||| NN
sites  ||| S:24649 E:24655 ||| NNS
of  ||| S:24655 E:24668 ||| IN
pET-GST-PPT1  ||| S:24668 E:24681 ||| NNP
and  ||| S:24681 E:24685 ||| CC
sequenced ||| S:24685 E:24694 ||| NN
.  ||| S:24694 E:24696 ||| .
Each  ||| S:24696 E:24701 ||| DT
construct  ||| S:24701 E:24711 ||| NN
was  ||| S:24711 E:24725 ||| VBD
transformed  ||| S:24725 E:24737 ||| VBN
into  ||| S:24737 E:24753 ||| IN
E.  ||| S:24753 E:24756 ||| NNP
coli  ||| S:24756 E:24761 ||| FW
strain  ||| S:24761 E:24768 ||| FW
BL21  ||| S:24768 E:24773 ||| FW
( ||| S:24773 E:24774 ||| -LRB-
DE3 ||| S:24774 E:24777 ||| NNP
)  ||| S:24777 E:24789 ||| -RRB-
( ||| S:24789 E:24790 ||| -LRB-
Novagen ||| S:24790 E:24797 ||| NNP
) ||| S:24797 E:24798 ||| -RRB-
,  ||| S:24798 E:24800 ||| ,
and  ||| S:24800 E:24804 ||| CC
protein  ||| S:24804 E:24812 ||| NN
was  ||| S:24812 E:24816 ||| VBD
expressed ||| S:24816 E:24825 ||| VBN
,  ||| S:24825 E:24827 ||| ,
purified  ||| S:24827 E:24836 ||| VBG
by  ||| S:24836 E:24849 ||| IN
glutathione-agarose  ||| S:24849 E:24869 ||| JJ
affinity  ||| S:24869 E:24878 ||| JJ
chromatography ||| S:24878 E:24892 ||| NN
,  ||| S:24892 E:24894 ||| ,
cleaved  ||| S:24894 E:24902 ||| VBG
from  ||| S:24902 E:24917 ||| IN
GST  ||| S:24917 E:24921 ||| NNP
and  ||| S:24921 E:24925 ||| CC
stored  ||| S:24925 E:24932 ||| VBD
in  ||| S:24932 E:24935 ||| IN
20  ||| S:24935 E:24938 ||| CD
mM  ||| S:24938 E:24941 ||| JJ
Tris  ||| S:24941 E:24946 ||| NNP
( ||| S:24946 E:24947 ||| -LRB-
pH  ||| S:24947 E:24950 ||| NNP
7.6  ||| S:24950 E:24954 ||| CD
at  ||| S:24954 E:24957 ||| IN
4°C ||| S:24957 E:24960 ||| CD
) ||| S:24960 E:24961 ||| -RRB-
,  ||| S:24961 E:24963 ||| ,
50 ||| S:24963 E:24965 ||| CD
%  ||| S:24965 E:24977 ||| NN
glycerol ||| S:24977 E:24985 ||| NN
,  ||| S:24985 E:24987 ||| ,
1  ||| S:24987 E:24989 ||| CD
mM  ||| S:24989 E:24992 ||| JJ
EGTA ||| S:24992 E:24996 ||| NNP
,  ||| S:24996 E:24998 ||| ,
0.1 ||| S:24998 E:25001 ||| CD
%  ||| S:25001 E:25003 ||| NN
2-mercaptoethanol ||| S:25003 E:25020 ||| NN
,  ||| S:25020 E:25022 ||| ,
4  ||| S:25022 E:25024 ||| CD
mM  ||| S:25024 E:25027 ||| JJ
MnCl  ||| S:25027 E:25043 ||| JJ
2  ||| S:25043 E:25045 ||| CD
at  ||| S:25045 E:25048 ||| IN
-20°C  ||| S:25048 E:25054 ||| CD
as  ||| S:25054 E:25057 ||| IN
previously  ||| S:25057 E:25068 ||| RB
described  ||| S:25068 E:25078 ||| VBN
for  ||| S:25078 E:25092 ||| IN
PP5  ||| S:25092 E:25096 ||| NNP
[  ||| S:25096 E:25098 ||| -LRB-
18  ||| S:25098 E:25101 ||| CD
]  ||| S:25101 E:25103 ||| -RRB-
.  ||| S:25103 E:25105 ||| .
Recombinant  ||| S:25105 E:25117 ||| NNP
Ppt1p  ||| S:25117 E:25123 ||| NNP
and  ||| S:25123 E:25127 ||| CC
Ppt1p  ||| S:25127 E:25133 ||| NNP
( ||| S:25133 E:25134 ||| -LRB-
1-504 ||| S:25134 E:25139 ||| NNP
)  ||| S:25139 E:25141 ||| -RRB-
each  ||| S:25141 E:25156 ||| DT
contain  ||| S:25156 E:25164 ||| VBP
an  ||| S:25164 E:25167 ||| DT
additional  ||| S:25167 E:25178 ||| JJ
seven  ||| S:25178 E:25184 ||| CD
residues ||| S:25184 E:25192 ||| NNS
,  ||| S:25192 E:25204 ||| ,
Gly-Ser-Gly-Ser-Glu-Phe-Asp ||| S:25204 E:25231 ||| NNP
,  ||| S:25231 E:25233 ||| ,
which  ||| S:25233 E:25239 ||| WDT
are  ||| S:25239 E:25243 ||| VBP
remnants  ||| S:25243 E:25252 ||| VBN
of  ||| S:25252 E:25255 ||| IN
the  ||| S:25255 E:25269 ||| DT
thrombin-cleavage  ||| S:25269 E:25287 ||| JJ
site ||| S:25287 E:25291 ||| NN
.  ||| S:25291 E:25293 ||| .
SDS-PAGE  ||| S:25293 E:25302 ||| NNP
and  ||| S:25302 E:25306 ||| CC
Coomassie  ||| S:25306 E:25316 ||| NNP
stained  ||| S:25316 E:25334 ||| NN
gels  ||| S:25334 E:25339 ||| NNS
showed  ||| S:25339 E:25346 ||| VBD
that  ||| S:25346 E:25351 ||| DT
full-length  ||| S:25351 E:25363 ||| JJ
Ppt1p  ||| S:25363 E:25369 ||| NN
and  ||| S:25369 E:25373 ||| CC
Ppt1p  ||| S:25373 E:25379 ||| NNP
( ||| S:25379 E:25380 ||| -LRB-
1-504 ||| S:25380 E:25385 ||| NNP
)  ||| S:25385 E:25387 ||| -RRB-
each  ||| S:25387 E:25402 ||| DT
constituted  ||| S:25402 E:25414 ||| NN
more  ||| S:25414 E:25419 ||| RBR
than  ||| S:25419 E:25424 ||| IN
95 ||| S:25424 E:25426 ||| CD
%  ||| S:25426 E:25428 ||| NN
of  ||| S:25428 E:25431 ||| IN
the  ||| S:25431 E:25435 ||| DT
purified  ||| S:25435 E:25444 ||| JJ
protein  ||| S:25444 E:25452 ||| NN
( ||| S:25452 E:25453 ||| -LRB-
Fig.  ||| S:25453 E:25468 ||| NNP
1A ||| S:25468 E:25470 ||| NNP
) ||| S:25470 E:25471 ||| -RRB-
.  ||| S:25471 E:25501 ||| .
Phosphatase  ||| S:25501 E:25513 ||| NNP
assays  ||| S:25513 E:25530 ||| VBD
32P-labeled  ||| S:25530 E:25542 ||| CD
substrates  ||| S:25542 E:25553 ||| NNS
were  ||| S:25553 E:25558 ||| VBD
prepared  ||| S:25558 E:25567 ||| VBN
and  ||| S:25567 E:25571 ||| CC
assays  ||| S:25571 E:25588 ||| NNS
performed  ||| S:25588 E:25598 ||| VBD
as  ||| S:25598 E:25601 ||| RB
described  ||| S:25601 E:25611 ||| VBN
previously  ||| S:25611 E:25622 ||| RB
[  ||| S:25622 E:25624 ||| -LRB-
18  ||| S:25624 E:25627 ||| CD
]  ||| S:25627 E:25629 ||| -RRB-
.  ||| S:25629 E:25631 ||| .
Briefly ||| S:25631 E:25638 ||| RB
,  ||| S:25638 E:25650 ||| ,
protein  ||| S:25650 E:25658 ||| NN
phosphatase  ||| S:25658 E:25670 ||| NN
reactions  ||| S:25670 E:25680 ||| NNS
contained  ||| S:25680 E:25690 ||| VBD
2  ||| S:25690 E:25692 ||| CD
or  ||| S:25692 E:25695 ||| CC
4  ||| S:25695 E:25697 ||| CD
nM  ||| S:25697 E:25700 ||| JJ
enzyme  ||| S:25700 E:25717 ||| NN
in  ||| S:25717 E:25720 ||| IN
a  ||| S:25720 E:25722 ||| DT
final  ||| S:25722 E:25728 ||| JJ
volume  ||| S:25728 E:25735 ||| NN
of  ||| S:25735 E:25738 ||| IN
30  ||| S:25738 E:25741 ||| CD
μl  ||| S:25741 E:25744 ||| NNS
containing  ||| S:25744 E:25755 ||| VBG
buffer  ||| S:25755 E:25762 ||| NN
A  ||| S:25762 E:25764 ||| DT
( ||| S:25764 E:25765 ||| -LRB-
50  ||| S:25765 E:25768 ||| CD
mM  ||| S:25768 E:25781 ||| JJ
Tris ||| S:25781 E:25785 ||| NNP
,  ||| S:25785 E:25787 ||| ,
pH  ||| S:25787 E:25790 ||| JJ
7.6 ||| S:25790 E:25793 ||| CD
,  ||| S:25793 E:25795 ||| ,
1  ||| S:25795 E:25797 ||| CD
mM  ||| S:25797 E:25800 ||| JJ
EDTA ||| S:25800 E:25804 ||| NNP
,  ||| S:25804 E:25806 ||| ,
1  ||| S:25806 E:25808 ||| CD
mM  ||| S:25808 E:25811 ||| JJ
EGTA ||| S:25811 E:25815 ||| NNP
,  ||| S:25815 E:25817 ||| ,
0.1 ||| S:25817 E:25820 ||| CD
%  ||| S:25820 E:25832 ||| NN
2-mercaptoethanol ||| S:25832 E:25849 ||| CD
) ||| S:25849 E:25850 ||| -RRB-
,  ||| S:25850 E:25852 ||| ,
0.4 ||| S:25852 E:25855 ||| CD
%  ||| S:25855 E:25857 ||| NN
ethanol  ||| S:25857 E:25865 ||| NN
and  ||| S:25865 E:25869 ||| CC
10  ||| S:25869 E:25872 ||| CD
μM  ||| S:25872 E:25875 ||| JJ
radiolabeled  ||| S:25875 E:25898 ||| JJ
phosphosubstrate  ||| S:25898 E:25915 ||| NN
in  ||| S:25915 E:25918 ||| IN
the  ||| S:25918 E:25922 ||| DT
absence  ||| S:25922 E:25930 ||| NN
or  ||| S:25930 E:25933 ||| CC
presence  ||| S:25933 E:25942 ||| NN
of  ||| S:25942 E:25945 ||| IN
AA  ||| S:25945 E:25948 ||| NN
[  ||| S:25948 E:25950 ||| -LRB-
19  ||| S:25950 E:25953 ||| CD
]  ||| S:25953 E:25965 ||| -RRB-
.  ||| S:25965 E:25967 ||| .
Reactions  ||| S:25967 E:25977 ||| NNS
were  ||| S:25977 E:25982 ||| VBD
initiated  ||| S:25982 E:25992 ||| VBN
by  ||| S:25992 E:25995 ||| IN
adding  ||| S:25995 E:26002 ||| VBG
substrate  ||| S:26002 E:26012 ||| NNS
and  ||| S:26012 E:26016 ||| CC
lipid ||| S:26016 E:26021 ||| NN
,  ||| S:26021 E:26033 ||| ,
and  ||| S:26033 E:26037 ||| CC
incubated  ||| S:26037 E:26047 ||| NN
at  ||| S:26047 E:26050 ||| IN
30°C  ||| S:26050 E:26055 ||| CD
for  ||| S:26055 E:26059 ||| IN
10  ||| S:26059 E:26062 ||| CD
to  ||| S:26062 E:26065 ||| TO
15  ||| S:26065 E:26068 ||| CD
min ||| S:26068 E:26071 ||| NNS
.  ||| S:26071 E:26073 ||| .
The  ||| S:26073 E:26077 ||| DT
phosphate  ||| S:26077 E:26097 ||| NN
released  ||| S:26097 E:26106 ||| VBN
from  ||| S:26106 E:26111 ||| IN
each  ||| S:26111 E:26116 ||| DT
substrate  ||| S:26116 E:26126 ||| NN
was  ||| S:26126 E:26130 ||| VBD
less  ||| S:26130 E:26135 ||| JJR
than  ||| S:26135 E:26140 ||| IN
20 ||| S:26140 E:26142 ||| CD
%  ||| S:26142 E:26144 ||| NN
of  ||| S:26144 E:26147 ||| IN
the  ||| S:26147 E:26161 ||| DT
total  ||| S:26161 E:26167 ||| JJ
present ||| S:26167 E:26174 ||| NN
.  ||| S:26174 E:26176 ||| .
The  ||| S:26176 E:26180 ||| DT
amount  ||| S:26180 E:26187 ||| NN
of  ||| S:26187 E:26190 ||| IN
ethanol  ||| S:26190 E:26198 ||| NN
added  ||| S:26198 E:26204 ||| VBD
to  ||| S:26204 E:26217 ||| TO
lipid-stimulated  ||| S:26217 E:26234 ||| JJ
or  ||| S:26234 E:26237 ||| CC
control  ||| S:26237 E:26245 ||| NN
samples  ||| S:26245 E:26253 ||| NNS
had  ||| S:26253 E:26257 ||| VBD
no  ||| S:26257 E:26260 ||| DT
effect  ||| S:26260 E:26267 ||| NN
on  ||| S:26267 E:26280 ||| IN
activity ||| S:26280 E:26288 ||| NN
.  ||| S:26288 E:26318 ||| .
Limited  ||| S:26318 E:26326 ||| JJ
proteolysis  ||| S:26326 E:26338 ||| NN
of  ||| S:26338 E:26341 ||| IN
Ppt1p  ||| S:26341 E:26357 ||| NNP
Recombinant  ||| S:26357 E:26369 ||| NNP
protein  ||| S:26369 E:26377 ||| NN
was  ||| S:26377 E:26381 ||| VBD
incubated  ||| S:26381 E:26391 ||| VBN
with  ||| S:26391 E:26396 ||| IN
either  ||| S:26396 E:26403 ||| DT
trypsin  ||| S:26403 E:26421 ||| NN
( ||| S:26421 E:26422 ||| -LRB-
Roche  ||| S:26422 E:26428 ||| NNP
Molecular  ||| S:26428 E:26438 ||| NNP
Biochemicals ||| S:26438 E:26450 ||| NNP
)  ||| S:26450 E:26452 ||| -RRB-
or  ||| S:26452 E:26455 ||| CC
subtilisin  ||| S:26455 E:26466 ||| NNS
( ||| S:26466 E:26467 ||| -LRB-
Roche  ||| S:26467 E:26483 ||| NNP
Molecular  ||| S:26483 E:26493 ||| NNP
Biochemicals ||| S:26493 E:26505 ||| NNP
)  ||| S:26505 E:26507 ||| -RRB-
in  ||| S:26507 E:26510 ||| IN
the  ||| S:26510 E:26514 ||| DT
absence  ||| S:26514 E:26522 ||| NN
or  ||| S:26522 E:26525 ||| CC
presence  ||| S:26525 E:26534 ||| NN
of  ||| S:26534 E:26537 ||| IN
250  ||| S:26537 E:26551 ||| CD
μM  ||| S:26551 E:26554 ||| JJ
lipid  ||| S:26554 E:26560 ||| NN
for  ||| S:26560 E:26564 ||| IN
0  ||| S:26564 E:26566 ||| CD
to  ||| S:26566 E:26569 ||| TO
30  ||| S:26569 E:26572 ||| CD
min  ||| S:26572 E:26576 ||| NN
at  ||| S:26576 E:26579 ||| IN
30°C ||| S:26579 E:26583 ||| NNP
,  ||| S:26583 E:26585 ||| ,
as  ||| S:26585 E:26588 ||| RB
previously  ||| S:26588 E:26599 ||| RB
described  ||| S:26599 E:26619 ||| VBN
[  ||| S:26619 E:26621 ||| -LRB-
19  ||| S:26621 E:26624 ||| CD
]  ||| S:26624 E:26626 ||| -RRB-
.  ||| S:26626 E:26628 ||| .
To  ||| S:26628 E:26631 ||| TO
assess  ||| S:26631 E:26638 ||| VB
phosphatase  ||| S:26638 E:26650 ||| JJ
activity ||| S:26650 E:26658 ||| NN
,  ||| S:26658 E:26660 ||| ,
an  ||| S:26660 E:26663 ||| DT
aliquot  ||| S:26663 E:26671 ||| NN
of  ||| S:26671 E:26684 ||| IN
the  ||| S:26684 E:26688 ||| DT
digestion  ||| S:26688 E:26698 ||| JJ
reaction  ||| S:26698 E:26707 ||| NN
was  ||| S:26707 E:26711 ||| VBD
diluted  ||| S:26711 E:26719 ||| VBN
in  ||| S:26719 E:26722 ||| IN
buffer  ||| S:26722 E:26729 ||| VBG
A  ||| S:26729 E:26731 ||| DT
containing  ||| S:26731 E:26752 ||| VBG
either  ||| S:26752 E:26759 ||| DT
0.1  ||| S:26759 E:26763 ||| CD
mg ||| S:26763 E:26765 ||| FW
/ ||| S:26765 E:26766 ||| FW
ml  ||| S:26766 E:26769 ||| FW
soybean  ||| S:26769 E:26777 ||| FW
trypsin  ||| S:26777 E:26785 ||| FW
inhibitor  ||| S:26785 E:26795 ||| FW
for  ||| S:26795 E:26799 ||| IN
trypsin ||| S:26799 E:26806 ||| NN
,  ||| S:26806 E:26818 ||| ,
or  ||| S:26818 E:26821 ||| CC
2  ||| S:26821 E:26823 ||| CD
mM  ||| S:26823 E:26826 ||| JJ
PMSF  ||| S:26826 E:26831 ||| NN
for  ||| S:26831 E:26835 ||| IN
subtilisin  ||| S:26835 E:26846 ||| NN
and  ||| S:26846 E:26850 ||| CC
assayed ||| S:26850 E:26857 ||| NN
.  ||| S:26857 E:26859 ||| .
Matched  ||| S:26859 E:26867 ||| VBN
samples  ||| S:26867 E:26885 ||| NNS
from  ||| S:26885 E:26890 ||| IN
the  ||| S:26890 E:26894 ||| DT
proteolysis  ||| S:26894 E:26906 ||| JJ
reaction  ||| S:26906 E:26915 ||| NN
were  ||| S:26915 E:26920 ||| VBD
quenched  ||| S:26920 E:26929 ||| VBN
with  ||| S:26929 E:26944 ||| IN
trichloroacetic  ||| S:26944 E:26960 ||| JJ
acid  ||| S:26960 E:26965 ||| NN
( ||| S:26965 E:26966 ||| -LRB-
10 ||| S:26966 E:26968 ||| CD
% ||| S:26968 E:26969 ||| NN
,  ||| S:26969 E:26971 ||| ,
w ||| S:26971 E:26972 ||| FW
/ ||| S:26972 E:26973 ||| FW
v ||| S:26973 E:26974 ||| FW
) ||| S:26974 E:26975 ||| -RRB-
,  ||| S:26975 E:26977 ||| ,
protein  ||| S:26977 E:26985 ||| NN
was  ||| S:26985 E:26989 ||| VBD
sedimented ||| S:26989 E:26999 ||| CD
,  ||| S:26999 E:27011 ||| ,
then  ||| S:27011 E:27016 ||| RB
boiled  ||| S:27016 E:27023 ||| VBN
in  ||| S:27023 E:27026 ||| IN
( ||| S:27026 E:27027 ||| -LRB-
75  ||| S:27027 E:27030 ||| CD
mM  ||| S:27030 E:27033 ||| JJ
Tris-HCl ||| S:27033 E:27041 ||| NN
,  ||| S:27041 E:27043 ||| ,
pH  ||| S:27043 E:27046 ||| JJ
6.8 ||| S:27046 E:27049 ||| CD
,  ||| S:27049 E:27051 ||| ,
2 ||| S:27051 E:27052 ||| CD
%  ||| S:27052 E:27054 ||| NN
SDS ||| S:27054 E:27057 ||| NNP
,  ||| S:27057 E:27059 ||| ,
10 ||| S:27059 E:27061 ||| CD
%  ||| S:27061 E:27073 ||| NN
glycerol ||| S:27073 E:27081 ||| NN
,  ||| S:27081 E:27083 ||| ,
0.1 ||| S:27083 E:27086 ||| CD
%  ||| S:27086 E:27088 ||| NN
2-mercaptoethanol  ||| S:27088 E:27106 ||| NN
and  ||| S:27106 E:27110 ||| CC
0.01 ||| S:27110 E:27114 ||| CD
%  ||| S:27114 E:27116 ||| NN
bromophenol  ||| S:27116 E:27138 ||| VBZ
blue ||| S:27138 E:27142 ||| JJ
) ||| S:27142 E:27143 ||| -RRB-
,  ||| S:27143 E:27145 ||| ,
subjected  ||| S:27145 E:27155 ||| VBN
to  ||| S:27155 E:27158 ||| TO
SDS-PAGE  ||| S:27158 E:27167 ||| JJ
using  ||| S:27167 E:27173 ||| VBG
10  ||| S:27173 E:27176 ||| CD
or  ||| S:27176 E:27179 ||| CC
15 ||| S:27179 E:27181 ||| CD
%  ||| S:27181 E:27183 ||| NN
resolving  ||| S:27183 E:27203 ||| VBG
gels ||| S:27203 E:27207 ||| NN
,  ||| S:27207 E:27209 ||| ,
and  ||| S:27209 E:27213 ||| CC
protein  ||| S:27213 E:27221 ||| NN
bands  ||| S:27221 E:27227 ||| NNS
visualized  ||| S:27227 E:27238 ||| VBN
by  ||| S:27238 E:27241 ||| IN
Coomassie  ||| S:27241 E:27251 ||| NNP
staining ||| S:27251 E:27259 ||| NN
.  ||| S:27259 E:27271 ||| .
For  ||| S:27271 E:27275 ||| IN
zero  ||| S:27275 E:27280 ||| CD
time  ||| S:27280 E:27285 ||| NN
points ||| S:27285 E:27291 ||| NNS
,  ||| S:27291 E:27293 ||| ,
samples  ||| S:27293 E:27301 ||| NNS
were  ||| S:27301 E:27306 ||| VBD
withdrawn  ||| S:27306 E:27316 ||| VBN
before  ||| S:27316 E:27323 ||| IN
the  ||| S:27323 E:27337 ||| DT
addition  ||| S:27337 E:27346 ||| NN
of  ||| S:27346 E:27349 ||| IN
protease  ||| S:27349 E:27358 ||| NN
but  ||| S:27358 E:27362 ||| CC
were  ||| S:27362 E:27367 ||| VBD
otherwise  ||| S:27367 E:27377 ||| RB
identical ||| S:27377 E:27386 ||| JJ
.  ||| S:27386 E:27416 ||| .
N-terminal  ||| S:27416 E:27427 ||| JJ
sequence  ||| S:27427 E:27436 ||| NN
analysis  ||| S:27436 E:27445 ||| NN
of  ||| S:27445 E:27448 ||| IN
proteolytic  ||| S:27448 E:27470 ||| NN
fragments  ||| S:27470 E:27490 ||| VBZ
Proteolytic  ||| S:27490 E:27502 ||| NNP
fragments  ||| S:27502 E:27512 ||| VBZ
separated  ||| S:27512 E:27522 ||| VBN
by  ||| S:27522 E:27525 ||| IN
SDS-PAGE  ||| S:27525 E:27534 ||| NNP
were  ||| S:27534 E:27549 ||| VBD
transferred  ||| S:27549 E:27561 ||| VBN
to  ||| S:27561 E:27564 ||| TO
ProBlott  ||| S:27564 E:27573 ||| NNP
PVDF  ||| S:27573 E:27578 ||| NNP
membranes  ||| S:27578 E:27588 ||| NNS
( ||| S:27588 E:27589 ||| -LRB-
Applied  ||| S:27589 E:27607 ||| NNP
Biosystems ||| S:27607 E:27617 ||| NNP
,  ||| S:27617 E:27619 ||| ,
Inc. ||| S:27619 E:27623 ||| NNP
)  ||| S:27623 E:27625 ||| -RRB-
as  ||| S:27625 E:27628 ||| RB
described  ||| S:27628 E:27638 ||| VBN
by  ||| S:27638 E:27641 ||| IN
LeGendre  ||| S:27641 E:27661 ||| FW
et  ||| S:27661 E:27664 ||| FW
al  ||| S:27664 E:27667 ||| FW
[  ||| S:27667 E:27669 ||| -LRB-
38  ||| S:27669 E:27672 ||| CD
]  ||| S:27672 E:27674 ||| -RRB-
.  ||| S:27674 E:27676 ||| .
Coomassie-stained  ||| S:27676 E:27704 ||| JJ
protein  ||| S:27704 E:27712 ||| NN
bands  ||| S:27712 E:27718 ||| NNS
were  ||| S:27718 E:27723 ||| VBD
then  ||| S:27723 E:27728 ||| RB
subjected  ||| S:27728 E:27738 ||| VBN
to  ||| S:27738 E:27741 ||| TO
sequence  ||| S:27741 E:27750 ||| VB
analysis  ||| S:27750 E:27769 ||| NN
using  ||| S:27769 E:27775 ||| VBG
either  ||| S:27775 E:27782 ||| RB
a  ||| S:27782 E:27784 ||| DT
Model  ||| S:27784 E:27790 ||| NNP
491  ||| S:27790 E:27794 ||| CD
or  ||| S:27794 E:27797 ||| CC
Model  ||| S:27797 E:27803 ||| NNP
470A  ||| S:27803 E:27808 ||| NNP
gas  ||| S:27808 E:27812 ||| NN
phase  ||| S:27812 E:27828 ||| NN
sequencer  ||| S:27828 E:27838 ||| VBZ
equipped  ||| S:27838 E:27847 ||| VBN
with  ||| S:27847 E:27852 ||| IN
a  ||| S:27852 E:27854 ||| DT
Model  ||| S:27854 E:27860 ||| NNP
120A  ||| S:27860 E:27865 ||| NNP
on-line  ||| S:27865 E:27883 ||| JJ
phenylthiohydantoin  ||| S:27883 E:27903 ||| JJ
analyzer  ||| S:27903 E:27912 ||| NNS
( ||| S:27912 E:27913 ||| -LRB-
Applied  ||| S:27913 E:27921 ||| NNP
Biosystems ||| S:27921 E:27931 ||| NNP
,  ||| S:27931 E:27933 ||| ,
Inc ||| S:27933 E:27936 ||| NNP
) ||| S:27936 E:27937 ||| -RRB-
.  ||| S:27937 E:27949 ||| .
Sequence  ||| S:27949 E:27958 ||| JJ
analysis  ||| S:27958 E:27967 ||| NN
was  ||| S:27967 E:27971 ||| VBD
performed  ||| S:27971 E:27981 ||| VBN
in  ||| S:27981 E:27984 ||| IN
the  ||| S:27984 E:27988 ||| DT
Purdue  ||| S:27988 E:28005 ||| NNP
Macromolecular  ||| S:28005 E:28020 ||| NNP
Structure  ||| S:28020 E:28030 ||| NNP
Facility ||| S:28030 E:28038 ||| NNP
.  ||| S:28038 E:28068 ||| .
Cloning ||| S:28068 E:28075 ||| NNP
,  ||| S:28075 E:28077 ||| ,
subcloning ||| S:28077 E:28087 ||| NN
,  ||| S:28087 E:28089 ||| ,
and  ||| S:28089 E:28093 ||| CC
gene  ||| S:28093 E:28098 ||| NN
replacement  ||| S:28098 E:28110 ||| NN
for  ||| S:28110 E:28114 ||| IN
the  ||| S:28114 E:28128 ||| DT
expression  ||| S:28128 E:28139 ||| NN
of  ||| S:28139 E:28142 ||| IN
HA-Ppt1p  ||| S:28142 E:28151 ||| CD
in  ||| S:28151 E:28154 ||| IN
yeast  ||| S:28154 E:28160 ||| NN
cells  ||| S:28160 E:28176 ||| NNS
For  ||| S:28176 E:28180 ||| IN
expression  ||| S:28180 E:28191 ||| NN
of  ||| S:28191 E:28194 ||| IN
HA-tagged  ||| S:28194 E:28204 ||| JJ
Ppt1p  ||| S:28204 E:28210 ||| NN
under  ||| S:28210 E:28216 ||| IN
control  ||| S:28216 E:28224 ||| NN
of  ||| S:28224 E:28227 ||| IN
the  ||| S:28227 E:28252 ||| DT
GAL1  ||| S:28252 E:28257 ||| JJ
promoter ||| S:28257 E:28265 ||| NN
,  ||| S:28265 E:28267 ||| ,
a  ||| S:28267 E:28280 ||| DT
PPT1  ||| S:28280 E:28285 ||| NNP
DNA  ||| S:28285 E:28289 ||| NNP
fragment  ||| S:28289 E:28298 ||| NN
was  ||| S:28298 E:28302 ||| VBD
cut  ||| S:28302 E:28306 ||| VBN
from  ||| S:28306 E:28321 ||| IN
pET-GST-PPT1  ||| S:28321 E:28334 ||| CD
by  ||| S:28334 E:28348 ||| IN
EcoR  ||| S:28348 E:28353 ||| JJ
I  ||| S:28353 E:28355 ||| NN
and  ||| S:28355 E:28370 ||| CC
Not  ||| S:28370 E:28374 ||| RB
I  ||| S:28374 E:28376 ||| PRP
digestion  ||| S:28376 E:28386 ||| VBP
and  ||| S:28386 E:28390 ||| CC
subcloned  ||| S:28390 E:28400 ||| NN
into  ||| S:28400 E:28415 ||| IN
the  ||| S:28415 E:28430 ||| DT
EcoR  ||| S:28430 E:28435 ||| JJ
I ||| S:28435 E:28436 ||| PRP
/  ||| S:28436 E:28449 ||| VBP
Not  ||| S:28449 E:28453 ||| RB
I-digested  ||| S:28453 E:28464 ||| JJ
YCpIF16  ||| S:28464 E:28472 ||| NNP
( ||| S:28472 E:28473 ||| -LRB-
ATCC  ||| S:28473 E:28478 ||| NNP
No.  ||| S:28478 E:28492 ||| NNP
87091 ||| S:28492 E:28497 ||| CD
) ||| S:28497 E:28498 ||| -RRB-
,  ||| S:28498 E:28500 ||| ,
a  ||| S:28500 E:28502 ||| DT
centromeric  ||| S:28502 E:28514 ||| JJ
plasmid ||| S:28514 E:28521 ||| NN
.  ||| S:28521 E:28523 ||| .
The  ||| S:28523 E:28527 ||| DT
resulting  ||| S:28527 E:28537 ||| JJ
plasmid ||| S:28537 E:28544 ||| NN
,  ||| S:28544 E:28556 ||| ,
YCpIF16-PPT1 ||| S:28556 E:28568 ||| NNP
,  ||| S:28568 E:28570 ||| ,
was  ||| S:28570 E:28574 ||| VBD
transformed  ||| S:28574 E:28586 ||| VBN
into  ||| S:28586 E:28591 ||| IN
yeast  ||| S:28591 E:28597 ||| CD
W303  ||| S:28597 E:28602 ||| CD
cells  ||| S:28602 E:28608 ||| NNS
(  ||| S:28608 E:28621 ||| -LRB-
MAT  ||| S:28621 E:28636 ||| FW
a  ||| S:28636 E:28638 ||| FW
,  ||| S:28638 E:28651 ||| ,
can1-100 ||| S:28651 E:28659 ||| NNP
,  ||| S:28659 E:28661 ||| ,
leu2-3,112 ||| S:28661 E:28671 ||| NNP
,  ||| S:28671 E:28673 ||| ,
his3-11,15 ||| S:28673 E:28683 ||| NNP
,  ||| S:28683 E:28695 ||| ,
trp1-1 ||| S:28695 E:28701 ||| NNP
,  ||| S:28701 E:28703 ||| ,
ura3-1 ||| S:28703 E:28709 ||| NNP
,  ||| S:28709 E:28711 ||| ,
ade2-1  ||| S:28711 E:28718 ||| CD
) ||| S:28718 E:28719 ||| -RRB-
.  ||| S:28719 E:28721 ||| .
Transformed  ||| S:28721 E:28733 ||| JJ
cells  ||| S:28733 E:28739 ||| NNS
were  ||| S:28739 E:28754 ||| VBD
grown  ||| S:28754 E:28760 ||| VBN
in  ||| S:28760 E:28763 ||| IN
SC-Trp  ||| S:28763 E:28770 ||| JJ
medium  ||| S:28770 E:28777 ||| NN
at  ||| S:28777 E:28780 ||| IN
30°C  ||| S:28780 E:28785 ||| CD
to  ||| S:28785 E:28788 ||| TO
OD  ||| S:28788 E:28802 ||| NNP
600  ||| S:28802 E:28806 ||| CD
nm  ||| S:28806 E:28809 ||| CD
0.5 ||| S:28809 E:28812 ||| CD
,  ||| S:28812 E:28814 ||| ,
washed  ||| S:28814 E:28821 ||| VBD
twice  ||| S:28821 E:28827 ||| RB
to  ||| S:28827 E:28830 ||| TO
remove  ||| S:28830 E:28847 ||| VB
glucose ||| S:28847 E:28854 ||| NN
,  ||| S:28854 E:28856 ||| ,
then  ||| S:28856 E:28861 ||| RB
grown  ||| S:28861 E:28867 ||| VBN
in  ||| S:28867 E:28870 ||| IN
SG-Trp  ||| S:28870 E:28877 ||| JJ
medium  ||| S:28877 E:28884 ||| NN
containing  ||| S:28884 E:28895 ||| VBG
2 ||| S:28895 E:28896 ||| CD
%  ||| S:28896 E:28908 ||| NN
galactose  ||| S:28908 E:28918 ||| VBZ
instead  ||| S:28918 E:28926 ||| RB
of  ||| S:28926 E:28929 ||| IN
glucose  ||| S:28929 E:28937 ||| NN
for  ||| S:28937 E:28941 ||| IN
12-16  ||| S:28941 E:28947 ||| CD
hr  ||| S:28947 E:28950 ||| NN
at  ||| S:28950 E:28953 ||| IN
room  ||| S:28953 E:28968 ||| NN
temperature  ||| S:28968 E:28980 ||| NN
to  ||| S:28980 E:28983 ||| TO
induce  ||| S:28983 E:28990 ||| VB
protein  ||| S:28990 E:28998 ||| NN
expression ||| S:28998 E:29008 ||| NN
.  ||| S:29008 E:29020 ||| .
A  ||| S:29020 E:29022 ||| DT
strain  ||| S:29022 E:29029 ||| NN
expressing  ||| S:29029 E:29040 ||| VBG
HA-Ppt1p  ||| S:29040 E:29049 ||| NNP
was  ||| S:29049 E:29053 ||| VBD
made  ||| S:29053 E:29058 ||| VBN
using  ||| S:29058 E:29064 ||| VBG
the  ||| S:29064 E:29078 ||| DT
two-step  ||| S:29078 E:29087 ||| JJ
gene  ||| S:29087 E:29092 ||| NN
replacement  ||| S:29092 E:29104 ||| NN
strategy  ||| S:29104 E:29113 ||| NN
[  ||| S:29113 E:29115 ||| -LRB-
39  ||| S:29115 E:29118 ||| CD
]  ||| S:29118 E:29120 ||| -RRB-
.  ||| S:29120 E:29122 ||| .
First ||| S:29122 E:29127 ||| NNP
,  ||| S:29127 E:29129 ||| ,
the  ||| S:29129 E:29143 ||| DT
upstream  ||| S:29143 E:29152 ||| JJ
sequence  ||| S:29152 E:29161 ||| NN
of  ||| S:29161 E:29175 ||| IN
PPT1  ||| S:29175 E:29180 ||| NNP
( ||| S:29180 E:29181 ||| -LRB-
-955  ||| S:29181 E:29186 ||| CD
to  ||| S:29186 E:29189 ||| TO
-1 ||| S:29189 E:29191 ||| CD
)  ||| S:29191 E:29193 ||| -RRB-
was  ||| S:29193 E:29197 ||| VBD
amplified  ||| S:29197 E:29217 ||| VBN
from  ||| S:29217 E:29222 ||| IN
yeast  ||| S:29222 E:29228 ||| NN
genomic  ||| S:29228 E:29236 ||| NN
DNA  ||| S:29236 E:29240 ||| NN
by  ||| S:29240 E:29243 ||| IN
PCR  ||| S:29243 E:29247 ||| NNP
using  ||| S:29247 E:29253 ||| VBG
a  ||| S:29253 E:29255 ||| DT
5 ||| S:29255 E:29256 ||| CD
'  ||| S:29256 E:29258 ||| POS
primer  ||| S:29258 E:29275 ||| NN
containing  ||| S:29275 E:29286 ||| VBG
a  ||| S:29286 E:29299 ||| DT
Kpn  ||| S:29299 E:29303 ||| NNP
I  ||| S:29303 E:29305 ||| NNP
restriction  ||| S:29305 E:29317 ||| NN
site  ||| S:29317 E:29332 ||| NN
( ||| S:29332 E:29333 ||| -LRB-
5 ||| S:29333 E:29334 ||| CD
' ||| S:29334 E:29335 ||| POS
-gatcGGTACCattagcacggtgccttaacca-3 ||| S:29335 E:29369 ||| NNP
' ||| S:29369 E:29370 ||| POS
)  ||| S:29370 E:29372 ||| -RRB-
and  ||| S:29372 E:29376 ||| CC
a  ||| S:29376 E:29378 ||| DT
3 ||| S:29378 E:29379 ||| CD
'  ||| S:29379 E:29381 ||| POS
primer  ||| S:29381 E:29398 ||| NN
containing  ||| S:29398 E:29409 ||| VBG
a  ||| S:29409 E:29422 ||| DT
Xho  ||| S:29422 E:29426 ||| NNP
I  ||| S:29426 E:29428 ||| NNP
site  ||| S:29428 E:29433 ||| NN
and  ||| S:29433 E:29437 ||| CC
HA  ||| S:29437 E:29440 ||| NNP
coding  ||| S:29440 E:29447 ||| FW
sequence  ||| S:29447 E:29466 ||| FW
( ||| S:29466 E:29467 ||| -LRB-
5 ||| S:29467 E:29468 ||| CD
' ||| S:29468 E:29469 ||| POS
-gatcCTCGAGatcgataccgtcgagctagcgtagtctgggacgtcgtatgggtatcgactcatATTCGAGATATTTGATTATACCAAGGC-3 ||| S:29469 E:29562 ||| NNP
' ||| S:29562 E:29563 ||| POS
) ||| S:29563 E:29564 ||| -RRB-
.  ||| S:29564 E:29576 ||| .
In  ||| S:29576 E:29579 ||| IN
the  ||| S:29579 E:29583 ||| DT
3 ||| S:29583 E:29584 ||| CD
'  ||| S:29584 E:29586 ||| POS
primer ||| S:29586 E:29592 ||| NN
,  ||| S:29592 E:29594 ||| ,
the  ||| S:29594 E:29598 ||| DT
sequence  ||| S:29598 E:29607 ||| NN
from  ||| S:29607 E:29612 ||| IN
the  ||| S:29612 E:29627 ||| DT
Xho  ||| S:29627 E:29631 ||| NNP
I  ||| S:29631 E:29633 ||| NNP
restriction  ||| S:29633 E:29645 ||| NN
site  ||| S:29645 E:29650 ||| NN
to  ||| S:29650 E:29653 ||| TO
the  ||| S:29653 E:29657 ||| DT
HA  ||| S:29657 E:29670 ||| NNP
coding  ||| S:29670 E:29677 ||| JJ
sequence  ||| S:29677 E:29686 ||| NN
was  ||| S:29686 E:29690 ||| VBD
identical  ||| S:29690 E:29700 ||| JJ
to  ||| S:29700 E:29703 ||| TO
that  ||| S:29703 E:29708 ||| DT
present  ||| S:29708 E:29716 ||| JJ
in  ||| S:29716 E:29719 ||| IN
YCpIF16 ||| S:29719 E:29726 ||| CD
.  ||| S:29726 E:29738 ||| .
The  ||| S:29738 E:29742 ||| DT
amplified  ||| S:29742 E:29752 ||| JJ
DNA  ||| S:29752 E:29756 ||| NN
fragment  ||| S:29756 E:29765 ||| NN
was  ||| S:29765 E:29769 ||| VBD
cloned  ||| S:29769 E:29776 ||| VBN
into  ||| S:29776 E:29781 ||| IN
pRS306  ||| S:29781 E:29788 ||| NNP
( ||| S:29788 E:29789 ||| -LRB-
New  ||| S:29789 E:29803 ||| NNP
England  ||| S:29803 E:29811 ||| NNP
Biolabs ||| S:29811 E:29818 ||| NNP
,  ||| S:29818 E:29820 ||| ,
Inc. ||| S:29820 E:29824 ||| NNP
)  ||| S:29824 E:29826 ||| -RRB-
using  ||| S:29826 E:29843 ||| VBG
Kpn  ||| S:29843 E:29847 ||| NNP
I  ||| S:29847 E:29849 ||| NNP
and  ||| S:29849 E:29864 ||| CC
Xho  ||| S:29864 E:29868 ||| NNP
I  ||| S:29868 E:29870 ||| NNP
restriction  ||| S:29870 E:29882 ||| NN
sites  ||| S:29882 E:29888 ||| NNS
to  ||| S:29888 E:29891 ||| TO
generate  ||| S:29891 E:29910 ||| VB
pRS306-955HA ||| S:29910 E:29922 ||| CD
.  ||| S:29922 E:29924 ||| .
Then ||| S:29924 E:29928 ||| RB
,  ||| S:29928 E:29930 ||| ,
a  ||| S:29930 E:29932 ||| DT
fragment  ||| S:29932 E:29941 ||| NN
containing  ||| S:29941 E:29952 ||| VBG
the  ||| S:29952 E:29967 ||| DT
PPT1  ||| S:29967 E:29972 ||| NNP
ORF  ||| S:29972 E:29976 ||| NNP
was  ||| S:29976 E:29980 ||| VBD
excised  ||| S:29980 E:29988 ||| VBN
from  ||| S:29988 E:30003 ||| IN
YCpIF16-PPT1  ||| S:30003 E:30016 ||| CD
by  ||| S:30016 E:30030 ||| IN
Xho  ||| S:30030 E:30034 ||| NNP
I  ||| S:30034 E:30036 ||| NNP
and  ||| S:30036 E:30051 ||| CC
Not  ||| S:30051 E:30055 ||| RB
I  ||| S:30055 E:30057 ||| PRP
digestion  ||| S:30057 E:30067 ||| VBP
and  ||| S:30067 E:30071 ||| CC
subcloned  ||| S:30071 E:30081 ||| NN
into  ||| S:30081 E:30096 ||| IN
this  ||| S:30096 E:30101 ||| DT
plasmid  ||| S:30101 E:30109 ||| NN
to  ||| S:30109 E:30112 ||| TO
form  ||| S:30112 E:30117 ||| VB
pRS306-955HAPPT1 ||| S:30117 E:30133 ||| CD
.  ||| S:30133 E:30135 ||| .
The  ||| S:30135 E:30139 ||| DT
plasmid  ||| S:30139 E:30147 ||| NN
was  ||| S:30147 E:30161 ||| VBD
linearized  ||| S:30161 E:30172 ||| VBN
by  ||| S:30172 E:30186 ||| IN
Bam  ||| S:30186 E:30190 ||| NNP
HI  ||| S:30190 E:30193 ||| NNP
digestion ||| S:30193 E:30202 ||| NN
,  ||| S:30202 E:30204 ||| ,
transformed  ||| S:30204 E:30216 ||| VBN
into  ||| S:30216 E:30231 ||| IN
the  ||| S:30231 E:30235 ||| DT
yeast  ||| S:30235 E:30241 ||| NN
strain ||| S:30241 E:30247 ||| NN
,  ||| S:30247 E:30249 ||| ,
W303 ||| S:30249 E:30253 ||| NNP
,  ||| S:30253 E:30255 ||| ,
and  ||| S:30255 E:30259 ||| CC
the  ||| S:30259 E:30263 ||| DT
transformed  ||| S:30263 E:30275 ||| JJ
cells  ||| S:30275 E:30281 ||| NNS
were  ||| S:30281 E:30296 ||| VBD
plated  ||| S:30296 E:30303 ||| VBN
on  ||| S:30303 E:30306 ||| IN
a  ||| S:30306 E:30308 ||| DT
SC-Ura  ||| S:30308 E:30315 ||| JJ
plate ||| S:30315 E:30320 ||| NN
.  ||| S:30320 E:30322 ||| .
The  ||| S:30322 E:30326 ||| DT
resulting  ||| S:30326 E:30336 ||| VBG
colonies  ||| S:30336 E:30345 ||| NNS
were  ||| S:30345 E:30360 ||| VBD
then  ||| S:30360 E:30365 ||| RB
grown  ||| S:30365 E:30371 ||| VBN
in  ||| S:30371 E:30374 ||| IN
YPAD  ||| S:30374 E:30379 ||| NNP
media  ||| S:30379 E:30385 ||| NNS
( ||| S:30385 E:30386 ||| -LRB-
1 ||| S:30386 E:30387 ||| CD
%  ||| S:30387 E:30389 ||| NN
yeast  ||| S:30389 E:30395 ||| NN
extract ||| S:30395 E:30402 ||| NN
,  ||| S:30402 E:30404 ||| ,
2 ||| S:30404 E:30405 ||| CD
%  ||| S:30405 E:30407 ||| NN
peptone ||| S:30407 E:30414 ||| NN
,  ||| S:30414 E:30426 ||| ,
0.04 ||| S:30426 E:30430 ||| CD
%  ||| S:30430 E:30432 ||| NN
adenine ||| S:30432 E:30439 ||| NN
,  ||| S:30439 E:30441 ||| ,
and  ||| S:30441 E:30445 ||| CC
2 ||| S:30445 E:30446 ||| CD
%  ||| S:30446 E:30448 ||| NN
glucose ||| S:30448 E:30455 ||| NN
)  ||| S:30455 E:30457 ||| -RRB-
and  ||| S:30457 E:30461 ||| CC
plated  ||| S:30461 E:30468 ||| NN
on  ||| S:30468 E:30471 ||| IN
5-FOA  ||| S:30471 E:30477 ||| CD
plates  ||| S:30477 E:30494 ||| NN
to  ||| S:30494 E:30497 ||| TO
select  ||| S:30497 E:30504 ||| VB
clones  ||| S:30504 E:30511 ||| NNS
emerging  ||| S:30511 E:30520 ||| VBG
by  ||| S:30520 E:30523 ||| IN
a  ||| S:30523 E:30525 ||| DT
second  ||| S:30525 E:30532 ||| JJ
recombination  ||| S:30532 E:30546 ||| JJ
event  ||| S:30546 E:30562 ||| NN
that  ||| S:30562 E:30567 ||| WDT
eliminated  ||| S:30567 E:30578 ||| VBD
the  ||| S:30578 E:30593 ||| DT
URA3  ||| S:30593 E:30598 ||| JJ
gene  ||| S:30598 E:30603 ||| NN
together  ||| S:30603 E:30612 ||| RB
with  ||| S:30612 E:30617 ||| IN
the  ||| S:30617 E:30631 ||| DT
additional  ||| S:30631 E:30642 ||| JJ
copy  ||| S:30642 E:30647 ||| NN
of  ||| S:30647 E:30661 ||| IN
PPT1  ||| S:30661 E:30666 ||| CD
.  ||| S:30666 E:30668 ||| .
To  ||| S:30668 E:30671 ||| TO
confirm  ||| S:30671 E:30679 ||| VB
gene  ||| S:30679 E:30684 ||| NN
replacement ||| S:30684 E:30695 ||| NN
,  ||| S:30695 E:30707 ||| ,
chromosomal  ||| S:30707 E:30719 ||| JJ
DNA  ||| S:30719 E:30723 ||| NN
from  ||| S:30723 E:30728 ||| IN
these  ||| S:30728 E:30734 ||| DT
clones  ||| S:30734 E:30741 ||| NNS
was  ||| S:30741 E:30745 ||| VBD
used  ||| S:30745 E:30750 ||| VBN
for  ||| S:30750 E:30754 ||| IN
PCR  ||| S:30754 E:30768 ||| NNP
amplification  ||| S:30768 E:30782 ||| NN
of  ||| S:30782 E:30785 ||| IN
the  ||| S:30785 E:30789 ||| DT
region  ||| S:30789 E:30796 ||| NN
encoding  ||| S:30796 E:30805 ||| VBD
HA-Ppt1p ||| S:30805 E:30813 ||| CD
.  ||| S:30813 E:30815 ||| .
Amplified  ||| S:30815 E:30835 ||| JJ
product  ||| S:30835 E:30843 ||| NN
was  ||| S:30843 E:30847 ||| VBD
then  ||| S:30847 E:30852 ||| RB
analyzed  ||| S:30852 E:30861 ||| VBN
by  ||| S:30861 E:30875 ||| IN
Xho  ||| S:30875 E:30879 ||| NNP
I  ||| S:30879 E:30881 ||| PRP
digest ||| S:30881 E:30887 ||| VBP
,  ||| S:30887 E:30889 ||| ,
which  ||| S:30889 E:30895 ||| WDT
can  ||| S:30895 E:30899 ||| MD
only  ||| S:30899 E:30904 ||| RB
cut  ||| S:30904 E:30918 ||| VB
amplified  ||| S:30918 E:30928 ||| VBN
product  ||| S:30928 E:30936 ||| NN
from  ||| S:30936 E:30941 ||| IN
the  ||| S:30941 E:30945 ||| DT
replaced  ||| S:30945 E:30954 ||| JJ
gene ||| S:30954 E:30958 ||| NN
.  ||| S:30958 E:30988 ||| .
Immunoblotting  ||| S:30988 E:31003 ||| NNP
and  ||| S:31003 E:31007 ||| CC
immunocytochemical  ||| S:31007 E:31026 ||| JJ
analysis  ||| S:31026 E:31035 ||| NN
of  ||| S:31035 E:31048 ||| IN
HA-Ppt1p  ||| S:31048 E:31057 ||| CD
expression  ||| S:31057 E:31078 ||| NN
Wild  ||| S:31078 E:31083 ||| NNP
type  ||| S:31083 E:31088 ||| NN
( ||| S:31088 E:31089 ||| -LRB-
W303 ||| S:31089 E:31093 ||| NNP
)  ||| S:31093 E:31095 ||| -RRB-
cell  ||| S:31095 E:31100 ||| NN
and  ||| S:31100 E:31104 ||| CC
WHT4-1  ||| S:31104 E:31111 ||| CD
cells  ||| S:31111 E:31117 ||| NNS
were  ||| S:31117 E:31122 ||| VBD
grown  ||| S:31122 E:31128 ||| VBN
in  ||| S:31128 E:31141 ||| IN
YPAD  ||| S:31141 E:31146 ||| NNP
medium ||| S:31146 E:31152 ||| NN
.  ||| S:31152 E:31154 ||| .
The  ||| S:31154 E:31158 ||| DT
expression  ||| S:31158 E:31169 ||| NN
of  ||| S:31169 E:31172 ||| IN
HA-Ppt1p  ||| S:31172 E:31181 ||| NNP
was  ||| S:31181 E:31185 ||| VBD
detected  ||| S:31185 E:31194 ||| VBN
by  ||| S:31194 E:31207 ||| IN
immunoblot  ||| S:31207 E:31218 ||| NNS
using  ||| S:31218 E:31224 ||| VBG
the  ||| S:31224 E:31228 ||| DT
12CA5  ||| S:31228 E:31234 ||| FW
monoclonal  ||| S:31234 E:31245 ||| FW
anti-HA  ||| S:31245 E:31253 ||| FW
antibody  ||| S:31253 E:31272 ||| FW
( ||| S:31272 E:31273 ||| -LRB-
Roche  ||| S:31273 E:31279 ||| NNP
Molecular  ||| S:31279 E:31289 ||| NNP
Biochemicals ||| S:31289 E:31301 ||| NNP
) ||| S:31301 E:31302 ||| -RRB-
.  ||| S:31302 E:31304 ||| .
The  ||| S:31304 E:31308 ||| DT
total  ||| S:31308 E:31314 ||| JJ
protein  ||| S:31314 E:31322 ||| NN
was  ||| S:31322 E:31336 ||| VBD
extracted  ||| S:31336 E:31346 ||| VBN
from  ||| S:31346 E:31351 ||| IN
approximately  ||| S:31351 E:31365 ||| RB
10  ||| S:31365 E:31368 ||| CD
7cells  ||| S:31368 E:31375 ||| CD
by  ||| S:31375 E:31378 ||| IN
vortexing  ||| S:31378 E:31388 ||| NN
with  ||| S:31388 E:31403 ||| IN
glass  ||| S:31403 E:31409 ||| NN
beads ||| S:31409 E:31414 ||| NN
,  ||| S:31414 E:31416 ||| ,
then  ||| S:31416 E:31421 ||| RB
resolved  ||| S:31421 E:31430 ||| VBN
by  ||| S:31430 E:31433 ||| IN
SDS-PAGE  ||| S:31433 E:31442 ||| JJ
on  ||| S:31442 E:31445 ||| IN
12 ||| S:31445 E:31447 ||| CD
%  ||| S:31447 E:31449 ||| NN
gel ||| S:31449 E:31452 ||| NN
,  ||| S:31452 E:31454 ||| ,
and  ||| S:31454 E:31468 ||| CC
transferred  ||| S:31468 E:31480 ||| VBN
to  ||| S:31480 E:31483 ||| TO
nitrocellulose  ||| S:31483 E:31498 ||| VB
at  ||| S:31498 E:31501 ||| IN
55V  ||| S:31501 E:31505 ||| CD
in  ||| S:31505 E:31508 ||| IN
( ||| S:31508 E:31509 ||| -LRB-
25  ||| S:31509 E:31512 ||| CD
mM  ||| S:31512 E:31515 ||| JJ
Tris ||| S:31515 E:31519 ||| NNP
,  ||| S:31519 E:31521 ||| ,
250  ||| S:31521 E:31535 ||| CD
mM  ||| S:31535 E:31538 ||| JJ
glycine ||| S:31538 E:31545 ||| NN
,  ||| S:31545 E:31547 ||| ,
0.1 ||| S:31547 E:31550 ||| CD
%  ||| S:31550 E:31552 ||| NN
SDS ||| S:31552 E:31555 ||| NNP
,  ||| S:31555 E:31557 ||| ,
and  ||| S:31557 E:31561 ||| CC
20 ||| S:31561 E:31563 ||| CD
%  ||| S:31563 E:31565 ||| NN
methanol ||| S:31565 E:31573 ||| NN
)  ||| S:31573 E:31575 ||| -RRB-
for  ||| S:31575 E:31579 ||| IN
1  ||| S:31579 E:31581 ||| CD
hr  ||| S:31581 E:31584 ||| NN
at  ||| S:31584 E:31587 ||| IN
room  ||| S:31587 E:31602 ||| NN
temperature ||| S:31602 E:31613 ||| NN
.  ||| S:31613 E:31615 ||| .
The  ||| S:31615 E:31619 ||| DT
membrane  ||| S:31619 E:31628 ||| NN
was  ||| S:31628 E:31632 ||| VBD
blocked  ||| S:31632 E:31640 ||| VBN
with  ||| S:31640 E:31645 ||| IN
3 ||| S:31645 E:31646 ||| CD
%  ||| S:31646 E:31648 ||| NN
non-fat  ||| S:31648 E:31656 ||| JJ
dry  ||| S:31656 E:31670 ||| JJ
milk  ||| S:31670 E:31675 ||| NN
( ||| S:31675 E:31676 ||| -LRB-
Bio-Rad ||| S:31676 E:31683 ||| NNP
) ||| S:31683 E:31684 ||| -RRB-
,  ||| S:31684 E:31686 ||| ,
0.1 ||| S:31686 E:31689 ||| CD
%  ||| S:31689 E:31691 ||| NN
tween-20  ||| S:31691 E:31700 ||| NN
in  ||| S:31700 E:31703 ||| IN
TBS  ||| S:31703 E:31707 ||| NNP
( ||| S:31707 E:31708 ||| -LRB-
pH  ||| S:31708 E:31711 ||| NNP
7.4 ||| S:31711 E:31714 ||| CD
) ||| S:31714 E:31715 ||| -RRB-
,  ||| S:31715 E:31717 ||| ,
then  ||| S:31717 E:31722 ||| RB
cut  ||| S:31722 E:31736 ||| VBN
at  ||| S:31736 E:31739 ||| IN
molecular  ||| S:31739 E:31749 ||| JJ
weight  ||| S:31749 E:31756 ||| NN
marker  ||| S:31756 E:31763 ||| VBD
45  ||| S:31763 E:31766 ||| CD
kDa ||| S:31766 E:31769 ||| NN
.  ||| S:31769 E:31771 ||| .
The  ||| S:31771 E:31775 ||| DT
upper  ||| S:31775 E:31781 ||| JJ
half  ||| S:31781 E:31786 ||| NN
was  ||| S:31786 E:31800 ||| VBD
probed  ||| S:31800 E:31807 ||| VBN
with  ||| S:31807 E:31812 ||| IN
anti-HA  ||| S:31812 E:31820 ||| JJ
antibody  ||| S:31820 E:31829 ||| NN
( ||| S:31829 E:31830 ||| -LRB-
4  ||| S:31830 E:31832 ||| CD
μg ||| S:31832 E:31834 ||| CD
/ ||| S:31834 E:31835 ||| CD
ml ||| S:31835 E:31837 ||| CD
) ||| S:31837 E:31838 ||| -RRB-
,  ||| S:31838 E:31840 ||| ,
followed  ||| S:31840 E:31849 ||| VBN
by  ||| S:31849 E:31862 ||| IN
HRP-conjugated  ||| S:31862 E:31877 ||| JJ
anti-mouse  ||| S:31877 E:31888 ||| JJ
IgG  ||| S:31888 E:31892 ||| NN
( ||| S:31892 E:31893 ||| -LRB-
1 ||| S:31893 E:31894 ||| LS
: ||| S:31894 E:31895 ||| :
5,000 ||| S:31895 E:31900 ||| CD
,  ||| S:31900 E:31902 ||| ,
CalBiochem ||| S:31902 E:31912 ||| NNP
) ||| S:31912 E:31913 ||| -RRB-
,  ||| S:31913 E:31915 ||| ,
and  ||| S:31915 E:31929 ||| CC
the  ||| S:31929 E:31933 ||| DT
signal  ||| S:31933 E:31940 ||| NN
was  ||| S:31940 E:31944 ||| VBD
detected  ||| S:31944 E:31953 ||| VBN
using  ||| S:31953 E:31959 ||| VBG
ECL  ||| S:31959 E:31963 ||| NNP
reagents  ||| S:31963 E:31972 ||| NNS
( ||| S:31972 E:31973 ||| -LRB-
Amersham  ||| S:31973 E:31992 ||| NNP
Pharmacia  ||| S:31992 E:32002 ||| NNP
Biotech  ||| S:32002 E:32010 ||| NNP
UK  ||| S:32010 E:32013 ||| NNP
Ltd. ||| S:32013 E:32017 ||| NNP
) ||| S:32017 E:32018 ||| -RRB-
.  ||| S:32018 E:32020 ||| .
The  ||| S:32020 E:32024 ||| DT
lower  ||| S:32024 E:32030 ||| JJR
half  ||| S:32030 E:32035 ||| NN
was  ||| S:32035 E:32039 ||| VBD
probed  ||| S:32039 E:32056 ||| VBN
with  ||| S:32056 E:32061 ||| IN
anti-Cdc28p  ||| S:32061 E:32073 ||| CD
antibody  ||| S:32073 E:32082 ||| NN
( ||| S:32082 E:32083 ||| -LRB-
Santa  ||| S:32083 E:32089 ||| NNP
Cruz  ||| S:32089 E:32094 ||| NNP
Biotechnology ||| S:32094 E:32107 ||| NNP
)  ||| S:32107 E:32109 ||| -RRB-
to  ||| S:32109 E:32122 ||| TO
ensure  ||| S:32122 E:32129 ||| VB
that  ||| S:32129 E:32134 ||| IN
an  ||| S:32134 E:32137 ||| DT
equal  ||| S:32137 E:32143 ||| JJ
amount  ||| S:32143 E:32150 ||| NN
of  ||| S:32150 E:32153 ||| IN
protein  ||| S:32153 E:32161 ||| NN
was  ||| S:32161 E:32165 ||| VBD
loaded  ||| S:32165 E:32172 ||| VBN
in  ||| S:32172 E:32175 ||| IN
each  ||| S:32175 E:32190 ||| DT
lane ||| S:32190 E:32194 ||| NN
.  ||| S:32194 E:32196 ||| .
The  ||| S:32196 E:32200 ||| DT
relative  ||| S:32200 E:32209 ||| JJ
level  ||| S:32209 E:32215 ||| NN
of  ||| S:32215 E:32218 ||| IN
HA-Ppt1p  ||| S:32218 E:32227 ||| CD
expression  ||| S:32227 E:32238 ||| NN
was  ||| S:32238 E:32252 ||| VBD
determined  ||| S:32252 E:32263 ||| VBN
by  ||| S:32263 E:32266 ||| IN
comparing  ||| S:32266 E:32276 ||| VBG
the  ||| S:32276 E:32280 ||| DT
band  ||| S:32280 E:32285 ||| NN
intensity  ||| S:32285 E:32295 ||| NN
of  ||| S:32295 E:32298 ||| IN
HA-Ppt1p  ||| S:32298 E:32307 ||| CD
to  ||| S:32307 E:32320 ||| TO
that  ||| S:32320 E:32325 ||| DT
of  ||| S:32325 E:32328 ||| IN
Cdc28p  ||| S:32328 E:32335 ||| CD
using  ||| S:32335 E:32341 ||| VBG
ImageQuant  ||| S:32341 E:32352 ||| JJ
software  ||| S:32352 E:32361 ||| NN
version  ||| S:32361 E:32369 ||| NN
5.1  ||| S:32369 E:32383 ||| CD
( ||| S:32383 E:32384 ||| -LRB-
Molecular  ||| S:32384 E:32394 ||| NNP
Dynamics ||| S:32394 E:32402 ||| NNPS
) ||| S:32402 E:32403 ||| -RRB-
.  ||| S:32403 E:32415 ||| .
Cells  ||| S:32415 E:32421 ||| NNS
were  ||| S:32421 E:32426 ||| VBD
prepared  ||| S:32426 E:32435 ||| VBN
for  ||| S:32435 E:32439 ||| IN
immunocytochemistry  ||| S:32439 E:32459 ||| VBG
as  ||| S:32459 E:32472 ||| RB
described  ||| S:32472 E:32482 ||| VBN
by  ||| S:32482 E:32485 ||| IN
Harlow  ||| S:32485 E:32492 ||| NNP
and  ||| S:32492 E:32496 ||| CC
Lane  ||| S:32496 E:32501 ||| NNP
[  ||| S:32501 E:32503 ||| -LRB-
40  ||| S:32503 E:32506 ||| CD
]  ||| S:32506 E:32508 ||| -RRB-
.  ||| S:32508 E:32510 ||| .
Briefly ||| S:32510 E:32517 ||| RB
,  ||| S:32517 E:32519 ||| ,
WHT4-1  ||| S:32519 E:32536 ||| CD
cells  ||| S:32536 E:32542 ||| NNS
were  ||| S:32542 E:32547 ||| VBD
grown  ||| S:32547 E:32553 ||| VBN
to  ||| S:32553 E:32556 ||| TO
early  ||| S:32556 E:32562 ||| JJ
log-phase  ||| S:32562 E:32572 ||| NN
( ||| S:32572 E:32573 ||| -LRB-
OD  ||| S:32573 E:32587 ||| NNP
600  ||| S:32587 E:32591 ||| CD
nm  ||| S:32591 E:32594 ||| CD
1.0-1.5 ||| S:32594 E:32601 ||| CD
) ||| S:32601 E:32602 ||| -RRB-
,  ||| S:32602 E:32604 ||| ,
fixed  ||| S:32604 E:32610 ||| VBN
by  ||| S:32610 E:32613 ||| IN
4 ||| S:32613 E:32614 ||| CD
%  ||| S:32614 E:32626 ||| NN
para-formaldehyde ||| S:32626 E:32643 ||| NN
,  ||| S:32643 E:32645 ||| ,
and  ||| S:32645 E:32649 ||| CC
the  ||| S:32649 E:32653 ||| DT
cell  ||| S:32653 E:32658 ||| NN
wall  ||| S:32658 E:32663 ||| NN
was  ||| S:32663 E:32667 ||| VBD
removed  ||| S:32667 E:32675 ||| VBN
by  ||| S:32675 E:32688 ||| IN
treatment  ||| S:32688 E:32698 ||| NN
with  ||| S:32698 E:32703 ||| IN
β-glucuronidase  ||| S:32703 E:32719 ||| JJ
and  ||| S:32719 E:32723 ||| CC
zymolase ||| S:32723 E:32731 ||| NN
.  ||| S:32731 E:32733 ||| .
The  ||| S:32733 E:32747 ||| DT
resulting  ||| S:32747 E:32757 ||| VBG
spheroplasts  ||| S:32757 E:32770 ||| NNS
were  ||| S:32770 E:32775 ||| VBD
attached  ||| S:32775 E:32784 ||| VBN
to  ||| S:32784 E:32787 ||| TO
poly-L-lysine  ||| S:32787 E:32811 ||| JJ
coated  ||| S:32811 E:32818 ||| JJ
coverslips  ||| S:32818 E:32829 ||| NN
and  ||| S:32829 E:32833 ||| CC
treated  ||| S:32833 E:32841 ||| VBN
with  ||| S:32841 E:32846 ||| IN
cold  ||| S:32846 E:32851 ||| JJ
methanol ||| S:32851 E:32859 ||| NN
,  ||| S:32859 E:32861 ||| ,
then  ||| S:32861 E:32876 ||| RB
acetone ||| S:32876 E:32883 ||| VBN
.  ||| S:32883 E:32885 ||| .
After  ||| S:32885 E:32891 ||| IN
blocking  ||| S:32891 E:32900 ||| VBG
non-specific  ||| S:32900 E:32913 ||| JJ
binding  ||| S:32913 E:32921 ||| JJ
sites  ||| S:32921 E:32927 ||| NNS
with  ||| S:32927 E:32942 ||| IN
3 ||| S:32942 E:32943 ||| CD
%  ||| S:32943 E:32945 ||| NN
BSA ||| S:32945 E:32948 ||| NNP
,  ||| S:32948 E:32950 ||| ,
0.1 ||| S:32950 E:32953 ||| CD
%  ||| S:32953 E:32955 ||| NN
tween-20  ||| S:32955 E:32964 ||| NN
in  ||| S:32964 E:32967 ||| IN
PBS ||| S:32967 E:32970 ||| NNP
,  ||| S:32970 E:32972 ||| ,
the  ||| S:32972 E:32976 ||| DT
coverslips  ||| S:32976 E:32987 ||| NN
were  ||| S:32987 E:33002 ||| VBD
incubated  ||| S:33002 E:33012 ||| VBN
with  ||| S:33012 E:33017 ||| IN
anti-HA  ||| S:33017 E:33025 ||| NNP
( ||| S:33025 E:33026 ||| -LRB-
40  ||| S:33026 E:33029 ||| CD
μg ||| S:33029 E:33031 ||| CD
/ ||| S:33031 E:33032 ||| CD
ml ||| S:33032 E:33034 ||| CD
)  ||| S:33034 E:33036 ||| -RRB-
or  ||| S:33036 E:33039 ||| CC
anti-GFP  ||| S:33039 E:33048 ||| JJ
antibody  ||| S:33048 E:33067 ||| NN
( ||| S:33067 E:33068 ||| -LRB-
40  ||| S:33068 E:33071 ||| CD
μg ||| S:33071 E:33073 ||| CD
/ ||| S:33073 E:33074 ||| CD
ml ||| S:33074 E:33076 ||| CD
) ||| S:33076 E:33077 ||| -RRB-
,  ||| S:33077 E:33079 ||| ,
rabbit  ||| S:33079 E:33086 ||| JJ
anti-mouse  ||| S:33086 E:33097 ||| JJ
IgG  ||| S:33097 E:33101 ||| NN
( ||| S:33101 E:33102 ||| -LRB-
Pierce ||| S:33102 E:33108 ||| NNP
,  ||| S:33108 E:33110 ||| ,
1 ||| S:33110 E:33111 ||| CD
: ||| S:33111 E:33112 ||| :
200 ||| S:33112 E:33115 ||| CD
) ||| S:33115 E:33116 ||| -RRB-
,  ||| S:33116 E:33128 ||| ,
biotin-conjugated  ||| S:33128 E:33146 ||| JJ
anti-rabbit  ||| S:33146 E:33158 ||| JJ
IgG  ||| S:33158 E:33162 ||| NN
( ||| S:33162 E:33163 ||| -LRB-
Vector  ||| S:33163 E:33170 ||| NNP
Laboratories ||| S:33170 E:33182 ||| NNPS
,  ||| S:33182 E:33194 ||| ,
1 ||| S:33194 E:33195 ||| CD
: ||| S:33195 E:33196 ||| :
200 ||| S:33196 E:33199 ||| CD
) ||| S:33199 E:33200 ||| -RRB-
,  ||| S:33200 E:33202 ||| ,
and  ||| S:33202 E:33206 ||| CC
streptavidin  ||| S:33206 E:33219 ||| JJ
conjugated  ||| S:33219 E:33230 ||| NN
with  ||| S:33230 E:33235 ||| IN
either  ||| S:33235 E:33242 ||| DT
Alexa  ||| S:33242 E:33248 ||| NNP
488  ||| S:33248 E:33262 ||| CD
or  ||| S:33262 E:33265 ||| CC
Alexa  ||| S:33265 E:33271 ||| NNP
594  ||| S:33271 E:33275 ||| CD
( ||| S:33275 E:33276 ||| -LRB-
Molecular  ||| S:33276 E:33286 ||| NNP
Probes ||| S:33286 E:33292 ||| NNP
,  ||| S:33292 E:33294 ||| ,
1 ||| S:33294 E:33295 ||| CD
: ||| S:33295 E:33296 ||| :
200 ||| S:33296 E:33299 ||| CD
) ||| S:33299 E:33300 ||| -RRB-
.  ||| S:33300 E:33302 ||| .
After  ||| S:33302 E:33308 ||| IN
staining  ||| S:33308 E:33327 ||| JJ
nuclei  ||| S:33327 E:33334 ||| NN
with  ||| S:33334 E:33339 ||| IN
4 ||| S:33339 E:33340 ||| CD
' ||| S:33340 E:33341 ||| POS
6-diamidino-2-phenylindole  ||| S:33341 E:33368 ||| NNP
( ||| S:33368 E:33369 ||| -LRB-
DAPI ||| S:33369 E:33373 ||| NNP
) ||| S:33373 E:33374 ||| -RRB-
,  ||| S:33374 E:33376 ||| ,
the  ||| S:33376 E:33390 ||| DT
coverslips  ||| S:33390 E:33401 ||| NN
were  ||| S:33401 E:33406 ||| VBD
mounted  ||| S:33406 E:33414 ||| VBN
on  ||| S:33414 E:33417 ||| IN
slides  ||| S:33417 E:33424 ||| NNS
using  ||| S:33424 E:33430 ||| VBG
ProLong  ||| S:33430 E:33438 ||| JJ
anti-fade  ||| S:33438 E:33458 ||| JJ
reagent  ||| S:33458 E:33466 ||| NNS
( ||| S:33466 E:33467 ||| -LRB-
Molecular  ||| S:33467 E:33477 ||| NNP
Probes ||| S:33477 E:33483 ||| NNP
) ||| S:33483 E:33484 ||| -RRB-
.  ||| S:33484 E:33486 ||| .
The  ||| S:33486 E:33490 ||| DT
specimens  ||| S:33490 E:33500 ||| NN
were  ||| S:33500 E:33505 ||| VBD
examined  ||| S:33505 E:33524 ||| VBN
with  ||| S:33524 E:33529 ||| IN
a  ||| S:33529 E:33531 ||| DT
BX60  ||| S:33531 E:33536 ||| FW
fluorescence  ||| S:33536 E:33549 ||| FW
microscope  ||| S:33549 E:33560 ||| FW
( ||| S:33560 E:33561 ||| -LRB-
Olympus ||| S:33561 E:33568 ||| NNP
)  ||| S:33568 E:33570 ||| -RRB-
and  ||| S:33570 E:33574 ||| CC
images  ||| S:33574 E:33591 ||| NNS
captured  ||| S:33591 E:33600 ||| VBN
using  ||| S:33600 E:33606 ||| VBG
a  ||| S:33606 E:33608 ||| DT
RT220  ||| S:33608 E:33614 ||| JJ
color  ||| S:33614 E:33620 ||| NN
digital  ||| S:33620 E:33628 ||| JJ
camera  ||| S:33628 E:33635 ||| NN
( ||| S:33635 E:33636 ||| -LRB-
Diagnostic  ||| S:33636 E:33657 ||| NNP
Instruments ||| S:33657 E:33668 ||| NNP
,  ||| S:33668 E:33670 ||| ,
Inc. ||| S:33670 E:33674 ||| NNP
) ||| S:33674 E:33675 ||| -RRB-
.  ||| S:33675 E:33677 ||| .
W303  ||| S:33677 E:33682 ||| NNP
cells  ||| S:33682 E:33688 ||| NNS
treated  ||| S:33688 E:33696 ||| VBN
in  ||| S:33696 E:33699 ||| IN
the  ||| S:33699 E:33703 ||| DT
same  ||| S:33703 E:33708 ||| JJ
manner  ||| S:33708 E:33725 ||| NN
were  ||| S:33725 E:33730 ||| VBD
used  ||| S:33730 E:33735 ||| VBN
as  ||| S:33735 E:33738 ||| IN
a  ||| S:33738 E:33740 ||| DT
negative  ||| S:33740 E:33749 ||| JJ
control ||| S:33749 E:33756 ||| NN
.  ||| S:33756 E:33786 ||| .
Northern  ||| S:33786 E:33795 ||| JJ
blot  ||| S:33795 E:33800 ||| JJ
analysis  ||| S:33800 E:33809 ||| NN
of  ||| S:33809 E:33812 ||| IN
PPT1mRNA  ||| S:33812 E:33831 ||| NNP
Total  ||| S:33831 E:33837 ||| NNP
RNA  ||| S:33837 E:33841 ||| NNP
was  ||| S:33841 E:33845 ||| VBD
prepared  ||| S:33845 E:33854 ||| VBN
from  ||| S:33854 E:33859 ||| IN
W303  ||| S:33859 E:33864 ||| NNP
and  ||| S:33864 E:33868 ||| CC
WHT4-1  ||| S:33868 E:33875 ||| CD
yeast  ||| S:33875 E:33891 ||| NN
cells  ||| S:33891 E:33897 ||| NNS
using  ||| S:33897 E:33903 ||| VBG
hot  ||| S:33903 E:33907 ||| JJ
acid  ||| S:33907 E:33912 ||| NN
phenol  ||| S:33912 E:33919 ||| NN
extraction  ||| S:33919 E:33930 ||| NNS
[  ||| S:33930 E:33932 ||| -LRB-
41  ||| S:33932 E:33935 ||| CD
]  ||| S:33935 E:33937 ||| -RRB-
.  ||| S:33937 E:33939 ||| .
For  ||| S:33939 E:33953 ||| IN
electrophoresis ||| S:33953 E:33968 ||| NN
,  ||| S:33968 E:33970 ||| ,
20  ||| S:33970 E:33973 ||| CD
μg  ||| S:33973 E:33976 ||| NN
of  ||| S:33976 E:33979 ||| IN
RNA  ||| S:33979 E:33983 ||| NNP
per  ||| S:33983 E:33987 ||| IN
sample  ||| S:33987 E:33994 ||| NN
was  ||| S:33994 E:33998 ||| VBD
resolved  ||| S:33998 E:34007 ||| VBN
on  ||| S:34007 E:34020 ||| IN
a  ||| S:34020 E:34022 ||| DT
1 ||| S:34022 E:34023 ||| CD
%  ||| S:34023 E:34025 ||| NN
agarose  ||| S:34025 E:34033 ||| NNS
gel  ||| S:34033 E:34037 ||| VBP
containing  ||| S:34037 E:34048 ||| VBG
2.2  ||| S:34048 E:34052 ||| CD
M  ||| S:34052 E:34054 ||| NNP
formaldehyde  ||| S:34054 E:34067 ||| NN
at  ||| S:34067 E:34070 ||| IN
5V ||| S:34070 E:34072 ||| CD
/ ||| S:34072 E:34073 ||| CD
cm  ||| S:34073 E:34086 ||| NN
until  ||| S:34086 E:34092 ||| IN
the  ||| S:34092 E:34096 ||| DT
bromophenol  ||| S:34096 E:34108 ||| JJ
blue  ||| S:34108 E:34113 ||| JJ
migrated  ||| S:34113 E:34122 ||| NN
8  ||| S:34122 E:34124 ||| CD
cm ||| S:34124 E:34126 ||| NNS
.  ||| S:34126 E:34128 ||| .
The  ||| S:34128 E:34132 ||| DT
gel  ||| S:34132 E:34136 ||| NN
was  ||| S:34136 E:34150 ||| VBD
rinsed  ||| S:34150 E:34157 ||| VBN
with  ||| S:34157 E:34162 ||| IN
diethylpyrocarbonate-treated  ||| S:34162 E:34191 ||| NNP
H  ||| S:34191 E:34204 ||| NNP
2  ||| S:34204 E:34206 ||| CD
O  ||| S:34206 E:34208 ||| NNP
and  ||| S:34208 E:34212 ||| CC
the  ||| S:34212 E:34216 ||| DT
RNA  ||| S:34216 E:34220 ||| NNP
was  ||| S:34220 E:34224 ||| VBD
transferred  ||| S:34224 E:34236 ||| VBN
to  ||| S:34236 E:34239 ||| TO
a  ||| S:34239 E:34251 ||| DT
Hybond  ||| S:34251 E:34258 ||| NNP
N+  ||| S:34258 E:34261 ||| FW
membrane  ||| S:34261 E:34270 ||| FW
( ||| S:34270 E:34271 ||| -LRB-
Amersham  ||| S:34271 E:34280 ||| NNP
Biosciences ||| S:34280 E:34291 ||| NNP
)  ||| S:34291 E:34293 ||| -RRB-
by  ||| S:34293 E:34296 ||| IN
capillary  ||| S:34296 E:34316 ||| JJ
transfer  ||| S:34316 E:34325 ||| NN
in  ||| S:34325 E:34328 ||| IN
alkaline  ||| S:34328 E:34337 ||| JJ
solution  ||| S:34337 E:34346 ||| NN
( ||| S:34346 E:34347 ||| -LRB-
0.01  ||| S:34347 E:34352 ||| NNP
N  ||| S:34352 E:34354 ||| NNP
NaOH ||| S:34354 E:34358 ||| NNP
,  ||| S:34358 E:34360 ||| ,
3  ||| S:34360 E:34362 ||| CD
M  ||| S:34362 E:34364 ||| NNP
NaCl ||| S:34364 E:34368 ||| NNP
)  ||| S:34368 E:34370 ||| -RRB-
for  ||| S:34370 E:34384 ||| IN
overnight ||| S:34384 E:34393 ||| JJ
.  ||| S:34393 E:34395 ||| .
The  ||| S:34395 E:34399 ||| DT
membrane  ||| S:34399 E:34408 ||| NN
was  ||| S:34408 E:34412 ||| VBD
pre-hybridized  ||| S:34412 E:34427 ||| JJ
with  ||| S:34427 E:34442 ||| IN
PERFECTHYB  ||| S:34442 E:34453 ||| NNP
PLUS  ||| S:34453 E:34458 ||| NNP
solution  ||| S:34458 E:34467 ||| NN
( ||| S:34467 E:34468 ||| -LRB-
Sigma ||| S:34468 E:34473 ||| NNP
)  ||| S:34473 E:34475 ||| -RRB-
at  ||| S:34475 E:34478 ||| IN
68°C  ||| S:34478 E:34483 ||| CD
for  ||| S:34483 E:34487 ||| IN
1  ||| S:34487 E:34489 ||| CD
hr ||| S:34489 E:34491 ||| NN
,  ||| S:34491 E:34493 ||| ,
and  ||| S:34493 E:34497 ||| CC
a  ||| S:34497 E:34509 ||| DT
cDNA  ||| S:34509 E:34514 ||| JJ
probe  ||| S:34514 E:34520 ||| NN
for  ||| S:34520 E:34535 ||| IN
PPT1  ||| S:34535 E:34540 ||| NNP
was  ||| S:34540 E:34544 ||| VBD
added  ||| S:34544 E:34550 ||| VBN
and  ||| S:34550 E:34554 ||| CC
incubated  ||| S:34554 E:34564 ||| NN
at  ||| S:34564 E:34577 ||| IN
42°C  ||| S:34577 E:34582 ||| CD
for  ||| S:34582 E:34586 ||| IN
overnight ||| S:34586 E:34595 ||| JJ
.  ||| S:34595 E:34597 ||| .
The  ||| S:34597 E:34601 ||| DT
cDNA  ||| S:34601 E:34606 ||| JJ
probe  ||| S:34606 E:34612 ||| NN
was  ||| S:34612 E:34616 ||| VBD
prepared  ||| S:34616 E:34625 ||| VBN
by  ||| S:34625 E:34638 ||| IN
restriction  ||| S:34638 E:34650 ||| NN
digestion  ||| S:34650 E:34660 ||| NN
of  ||| S:34660 E:34663 ||| IN
pET-GST-PPT1  ||| S:34663 E:34676 ||| CD
with  ||| S:34676 E:34692 ||| IN
Bsm  ||| S:34692 E:34696 ||| NNP
I  ||| S:34696 E:34698 ||| NNP
and  ||| S:34698 E:34713 ||| CC
Nco  ||| S:34713 E:34717 ||| NNP
I.  ||| S:34717 E:34720 ||| NNP
The  ||| S:34720 E:34724 ||| DT
879  ||| S:34724 E:34728 ||| CD
bp  ||| S:34728 E:34731 ||| JJ
DNA  ||| S:34731 E:34735 ||| NN
fragment  ||| S:34735 E:34754 ||| NN
generated ||| S:34754 E:34763 ||| VBD
,  ||| S:34763 E:34765 ||| ,
corresponding  ||| S:34765 E:34779 ||| JJ
to  ||| S:34779 E:34782 ||| TO
544-1422  ||| S:34782 E:34791 ||| CD
of  ||| S:34791 E:34805 ||| IN
PPT1  ||| S:34805 E:34810 ||| CD
coding  ||| S:34810 E:34817 ||| JJ
sequence ||| S:34817 E:34825 ||| NN
,  ||| S:34825 E:34827 ||| ,
was  ||| S:34827 E:34841 ||| VBD
gel-purified  ||| S:34841 E:34854 ||| JJ
and  ||| S:34854 E:34858 ||| CC
labeled  ||| S:34858 E:34866 ||| VBN
with  ||| S:34866 E:34871 ||| IN
0.67  ||| S:34871 E:34876 ||| NNP
μM  ||| S:34876 E:34879 ||| NNP
[ ||| S:34879 E:34880 ||| -LRB-
α-  ||| S:34880 E:34883 ||| NNP
32P ||| S:34883 E:34886 ||| NNP
]  ||| S:34886 E:34888 ||| -RRB-
CTP  ||| S:34888 E:34892 ||| NNP
( ||| S:34892 E:34893 ||| -LRB-
3000  ||| S:34893 E:34908 ||| CD
Ci ||| S:34908 E:34910 ||| CD
/ ||| S:34910 E:34911 ||| CD
mmol ||| S:34911 E:34915 ||| CD
)  ||| S:34915 E:34917 ||| -RRB-
using  ||| S:34917 E:34923 ||| VBG
the  ||| S:34923 E:34927 ||| DT
DECAprimeII  ||| S:34927 E:34939 ||| JJ
random  ||| S:34939 E:34946 ||| JJ
priming  ||| S:34946 E:34954 ||| JJ
kit  ||| S:34954 E:34968 ||| NN
( ||| S:34968 E:34969 ||| -LRB-
Ambion ||| S:34969 E:34975 ||| NNP
)  ||| S:34975 E:34977 ||| -RRB-
according  ||| S:34977 E:34987 ||| VBG
to  ||| S:34987 E:34990 ||| TO
the  ||| S:34990 E:34994 ||| DT
user  ||| S:34994 E:34999 ||| NN
manual ||| S:34999 E:35005 ||| NN
.  ||| S:35005 E:35007 ||| .
After  ||| S:35007 E:35013 ||| IN
washing  ||| S:35013 E:35021 ||| VBG
with  ||| S:35021 E:35036 ||| IN
1  ||| S:35036 E:35038 ||| CD
×  ||| S:35038 E:35040 ||| CD
SSC ||| S:35040 E:35043 ||| NNP
,  ||| S:35043 E:35045 ||| ,
0.1 ||| S:35045 E:35048 ||| CD
%  ||| S:35048 E:35050 ||| NN
SDS  ||| S:35050 E:35054 ||| NN
for  ||| S:35054 E:35058 ||| IN
20  ||| S:35058 E:35061 ||| CD
min  ||| S:35061 E:35065 ||| NN
at  ||| S:35065 E:35068 ||| IN
room  ||| S:35068 E:35073 ||| NN
temperature  ||| S:35073 E:35085 ||| NN
and  ||| S:35085 E:35089 ||| CC
0.2  ||| S:35089 E:35103 ||| CD
×  ||| S:35103 E:35105 ||| CD
SSC ||| S:35105 E:35108 ||| NNP
,  ||| S:35108 E:35110 ||| ,
0.1 ||| S:35110 E:35113 ||| CD
%  ||| S:35113 E:35115 ||| NN
SDS  ||| S:35115 E:35119 ||| NN
for  ||| S:35119 E:35123 ||| IN
20  ||| S:35123 E:35126 ||| CD
min  ||| S:35126 E:35130 ||| CD
three  ||| S:35130 E:35136 ||| CD
times  ||| S:35136 E:35142 ||| NNS
at  ||| S:35142 E:35145 ||| IN
68°C ||| S:35145 E:35149 ||| NNP
,  ||| S:35149 E:35151 ||| ,
the  ||| S:35151 E:35165 ||| DT
membrane  ||| S:35165 E:35174 ||| NN
was  ||| S:35174 E:35178 ||| VBD
exposed  ||| S:35178 E:35186 ||| VBN
to  ||| S:35186 E:35189 ||| TO
a  ||| S:35189 E:35191 ||| DT
storage  ||| S:35191 E:35199 ||| NN
phosphor  ||| S:35199 E:35208 ||| NN
screen  ||| S:35208 E:35215 ||| NN
GP  ||| S:35215 E:35228 ||| NNP
( ||| S:35228 E:35229 ||| -LRB-
Kodak ||| S:35229 E:35234 ||| NNP
)  ||| S:35234 E:35236 ||| -RRB-
or  ||| S:35236 E:35239 ||| CC
x-ray  ||| S:35239 E:35245 ||| JJ
film  ||| S:35245 E:35250 ||| NN
( ||| S:35250 E:35251 ||| -LRB-
BMS  ||| S:35251 E:35255 ||| NNP
1 ||| S:35255 E:35256 ||| CD
,  ||| S:35256 E:35258 ||| ,
Kodak ||| S:35258 E:35263 ||| NNP
) ||| S:35263 E:35264 ||| -RRB-
.  ||| S:35264 E:35266 ||| .
The  ||| S:35266 E:35270 ||| DT
membrane  ||| S:35270 E:35279 ||| NN
was  ||| S:35279 E:35293 ||| VBD
stripped  ||| S:35293 E:35302 ||| VBN
in  ||| S:35302 E:35305 ||| IN
50 ||| S:35305 E:35307 ||| CD
%  ||| S:35307 E:35309 ||| NN
formamide ||| S:35309 E:35318 ||| NN
,  ||| S:35318 E:35320 ||| ,
0.1  ||| S:35320 E:35324 ||| CD
×  ||| S:35324 E:35326 ||| CD
SSC ||| S:35326 E:35329 ||| NNP
,  ||| S:35329 E:35331 ||| ,
0.1 ||| S:35331 E:35334 ||| CD
%  ||| S:35334 E:35336 ||| NN
SDS  ||| S:35336 E:35340 ||| NN
for  ||| S:35340 E:35344 ||| IN
2  ||| S:35344 E:35346 ||| CD
hr  ||| S:35346 E:35359 ||| NN
at  ||| S:35359 E:35362 ||| IN
68°C ||| S:35362 E:35366 ||| NNP
,  ||| S:35366 E:35368 ||| ,
and  ||| S:35368 E:35372 ||| CC
reprobed  ||| S:35372 E:35381 ||| NN
with  ||| S:35381 E:35386 ||| IN
a  ||| S:35386 E:35388 ||| DT
cDNA  ||| S:35388 E:35393 ||| JJ
for  ||| S:35393 E:35408 ||| IN
ACT1  ||| S:35408 E:35413 ||| NNP
( ||| S:35413 E:35414 ||| -LRB-
yeast  ||| S:35414 E:35420 ||| NN
actin  ||| S:35420 E:35426 ||| NN
gene ||| S:35426 E:35430 ||| NN
) ||| S:35430 E:35431 ||| -RRB-
.  ||| S:35431 E:35433 ||| .
The  ||| S:35433 E:35437 ||| DT
DNA  ||| S:35437 E:35451 ||| NN
fragment  ||| S:35451 E:35460 ||| NN
corresponding  ||| S:35460 E:35474 ||| JJ
214-694  ||| S:35474 E:35482 ||| NN
of  ||| S:35482 E:35485 ||| IN
actin  ||| S:35485 E:35491 ||| JJ
coding  ||| S:35491 E:35498 ||| JJ
sequence  ||| S:35498 E:35517 ||| NN
was  ||| S:35517 E:35521 ||| VBD
amplified  ||| S:35521 E:35531 ||| VBN
by  ||| S:35531 E:35534 ||| IN
PCR  ||| S:35534 E:35538 ||| NNP
using  ||| S:35538 E:35544 ||| VBG
yeast  ||| S:35544 E:35550 ||| NN
genomic  ||| S:35550 E:35558 ||| NN
DNA  ||| S:35558 E:35562 ||| NN
as  ||| S:35562 E:35565 ||| IN
template  ||| S:35565 E:35584 ||| NN
and  ||| S:35584 E:35599 ||| CC
ACT1  ||| S:35599 E:35604 ||| FW
-specific  ||| S:35604 E:35614 ||| FW
oligonucleotide  ||| S:35614 E:35640 ||| FW
primers  ||| S:35640 E:35648 ||| FW
( ||| S:35648 E:35649 ||| -LRB-
5 ||| S:35649 E:35650 ||| CD
'  ||| S:35650 E:35652 ||| POS
primer ||| S:35652 E:35658 ||| NN
,  ||| S:35658 E:35670 ||| ,
5 ||| S:35670 E:35671 ||| CD
' ||| S:35671 E:35672 ||| POS
-gaacacggtattgtcaccaactgggacgatatgg ||| S:35672 E:35707 ||| JJ
;  ||| S:35707 E:35709 ||| :
3 ||| S:35709 E:35710 ||| CD
'  ||| S:35710 E:35712 ||| POS
primer ||| S:35712 E:35718 ||| NN
,  ||| S:35718 E:35730 ||| ,
5 ||| S:35730 E:35731 ||| CD
' ||| S:35731 E:35732 ||| POS
-gagcagcggtttgcatttcttgttcgaagtcc ||| S:35732 E:35765 ||| JJ
) ||| S:35765 E:35766 ||| -RRB-
.  ||| S:35766 E:35768 ||| .
The  ||| S:35768 E:35772 ||| DT
481  ||| S:35772 E:35776 ||| CD
bp  ||| S:35776 E:35779 ||| JJ
DNA  ||| S:35779 E:35793 ||| NN
fragment  ||| S:35793 E:35802 ||| NN
was  ||| S:35802 E:35806 ||| VBD
labeled  ||| S:35806 E:35814 ||| VBN
and  ||| S:35814 E:35818 ||| CC
used  ||| S:35818 E:35823 ||| VBN
essentially  ||| S:35823 E:35835 ||| RB
as  ||| S:35835 E:35838 ||| RB
described  ||| S:35838 E:35858 ||| VBN
for  ||| S:35858 E:35862 ||| IN
the  ||| S:35862 E:35877 ||| DT
PPT1  ||| S:35877 E:35882 ||| JJ
probe ||| S:35882 E:35887 ||| NN
.  ||| S:35887 E:35889 ||| .
The  ||| S:35889 E:35893 ||| DT
storage  ||| S:35893 E:35901 ||| NN
phosphor  ||| S:35901 E:35920 ||| NN
screen  ||| S:35920 E:35927 ||| NN
was  ||| S:35927 E:35931 ||| VBD
scanned  ||| S:35931 E:35939 ||| VBN
using  ||| S:35939 E:35945 ||| VBG
Typhoon  ||| S:35945 E:35953 ||| JJ
scanner  ||| S:35953 E:35961 ||| NNS
( ||| S:35961 E:35962 ||| -LRB-
Molecular  ||| S:35962 E:35982 ||| NNP
Dynamics ||| S:35982 E:35990 ||| NNPS
) ||| S:35990 E:35991 ||| -RRB-
,  ||| S:35991 E:35993 ||| ,
and  ||| S:35993 E:35997 ||| CC
the  ||| S:35997 E:36001 ||| DT
relative  ||| S:36001 E:36010 ||| JJ
level  ||| S:36010 E:36016 ||| NN
of  ||| S:36016 E:36030 ||| IN
PPT1  ||| S:36030 E:36035 ||| CD
message  ||| S:36035 E:36043 ||| NN
was  ||| S:36043 E:36047 ||| VBD
determined  ||| S:36047 E:36058 ||| VBN
by  ||| S:36058 E:36071 ||| IN
comparing  ||| S:36071 E:36081 ||| VBG
the  ||| S:36081 E:36085 ||| DT
band  ||| S:36085 E:36090 ||| NN
intensity  ||| S:36090 E:36100 ||| NN
of  ||| S:36100 E:36114 ||| IN
PPT1  ||| S:36114 E:36119 ||| CD
mRNA  ||| S:36119 E:36124 ||| JJ
to  ||| S:36124 E:36127 ||| TO
that  ||| S:36127 E:36132 ||| DT
of  ||| S:36132 E:36135 ||| IN
actin  ||| S:36135 E:36141 ||| JJ
mRNA  ||| S:36141 E:36156 ||| JJ
using  ||| S:36156 E:36162 ||| VBG
ImageQuant  ||| S:36162 E:36173 ||| JJ
software  ||| S:36173 E:36182 ||| NN
version  ||| S:36182 E:36190 ||| NN
5.1  ||| S:36190 E:36194 ||| CD
( ||| S:36194 E:36195 ||| -LRB-
Molecular  ||| S:36195 E:36215 ||| NNP
Dynamics ||| S:36215 E:36223 ||| NNPS
) ||| S:36223 E:36224 ||| -RRB-
.  ||| S:36224 E:36257 ||| .
List  ||| S:36257 E:36262 ||| NN
of  ||| S:36262 E:36265 ||| IN
abbreviations  ||| S:36265 E:36287 ||| JJ
PP ||| S:36287 E:36289 ||| NNP
,  ||| S:36289 E:36291 ||| ,
protein  ||| S:36291 E:36299 ||| NN
phosphatase ||| S:36299 E:36310 ||| NNS
;  ||| S:36310 E:36312 ||| :
MBP ||| S:36312 E:36315 ||| NNP
,  ||| S:36315 E:36317 ||| ,
myelin  ||| S:36317 E:36324 ||| JJ
basic  ||| S:36324 E:36330 ||| JJ
protein ||| S:36330 E:36337 ||| NN
;  ||| S:36337 E:36339 ||| :
TPR ||| S:36339 E:36342 ||| NNP
,  ||| S:36342 E:36352 ||| ,
tetratricopeptide  ||| S:36352 E:36370 ||| JJ
repeat ||| S:36370 E:36376 ||| NN
;  ||| S:36376 E:36378 ||| :
AA ||| S:36378 E:36380 ||| NN
,  ||| S:36380 E:36382 ||| ,
arachidonic  ||| S:36382 E:36394 ||| JJ
acid ||| S:36394 E:36398 ||| NN
;  ||| S:36398 E:36400 ||| :
HA ||| S:36400 E:36402 ||| NNP
,  ||| S:36402 E:36412 ||| ,
hemagglutinin ||| S:36412 E:36425 ||| NN
.  ||| S:36425 E:36449 ||| .
Competing  ||| S:36449 E:36459 ||| VBG
interests  ||| S:36459 E:36477 ||| NNS
None  ||| S:36477 E:36482 ||| NN
declared ||| S:36482 E:36490 ||| VBD
.  ||| S:36490 E:36514 ||| .
Authors ||| S:36514 E:36521 ||| NNP
'  ||| S:36521 E:36523 ||| POS
contributions  ||| S:36523 E:36545 ||| NNS
JYJ  ||| S:36545 E:36549 ||| VBP
cloned ||| S:36549 E:36555 ||| VBN
,  ||| S:36555 E:36557 ||| ,
expressed ||| S:36557 E:36566 ||| VBD
,  ||| S:36566 E:36568 ||| ,
and  ||| S:36568 E:36572 ||| CC
performed  ||| S:36572 E:36582 ||| VBD
initial  ||| S:36582 E:36598 ||| JJ
characterization  ||| S:36598 E:36615 ||| NN
studies  ||| S:36615 E:36623 ||| NNS
of  ||| S:36623 E:36626 ||| IN
recombinant  ||| S:36626 E:36638 ||| JJ
Ppt1p ||| S:36638 E:36643 ||| NN
,  ||| S:36643 E:36645 ||| ,
performed  ||| S:36645 E:36663 ||| VBN
gene  ||| S:36663 E:36668 ||| NN
replacement ||| S:36668 E:36679 ||| NN
,  ||| S:36679 E:36681 ||| ,
immunoblot  ||| S:36681 E:36692 ||| NN
and  ||| S:36692 E:36696 ||| CC
immunolocalization  ||| S:36696 E:36723 ||| JJ
studies ||| S:36723 E:36730 ||| NNS
,  ||| S:36730 E:36732 ||| ,
and  ||| S:36732 E:36736 ||| CC
prepared  ||| S:36736 E:36745 ||| VBN
the  ||| S:36745 E:36749 ||| DT
manuscript ||| S:36749 E:36759 ||| NN
.  ||| S:36759 E:36761 ||| .
JJ  ||| S:36761 E:36764 ||| NNP
and  ||| S:36764 E:36768 ||| CC
CS  ||| S:36768 E:36779 ||| NNP
characterized  ||| S:36779 E:36793 ||| VBD
PPT1  ||| S:36793 E:36798 ||| CD
activity  ||| S:36798 E:36807 ||| NN
following  ||| S:36807 E:36817 ||| VBG
truncation  ||| S:36817 E:36828 ||| NNS
or  ||| S:36828 E:36831 ||| CC
limited  ||| S:36831 E:36847 ||| JJ
proteolysis  ||| S:36847 E:36859 ||| NN
and  ||| S:36859 E:36863 ||| CC
identified  ||| S:36863 E:36874 ||| VBN
proteolysis  ||| S:36874 E:36886 ||| JJ
sites ||| S:36886 E:36891 ||| NNS
.  ||| S:36891 E:36893 ||| .
JYJ  ||| S:36893 E:36897 ||| NNP
and  ||| S:36897 E:36901 ||| CC
JMP  ||| S:36901 E:36913 ||| NNP
carried  ||| S:36913 E:36921 ||| VBD
out  ||| S:36921 E:36925 ||| RP
Northern  ||| S:36925 E:36934 ||| JJ
blot  ||| S:36934 E:36939 ||| JJ
analyses ||| S:36939 E:36947 ||| NNS
.  ||| S:36947 E:36949 ||| .
SR  ||| S:36949 E:36952 ||| NNP
helped  ||| S:36952 E:36959 ||| VBD
design ||| S:36959 E:36965 ||| NN
,  ||| S:36965 E:36975 ||| ,
supervise  ||| S:36975 E:36985 ||| NN
and  ||| S:36985 E:36989 ||| CC
interpret  ||| S:36989 E:36999 ||| VB
studies  ||| S:36999 E:37007 ||| NNS
and  ||| S:37007 E:37011 ||| CC
with  ||| S:37011 E:37016 ||| IN
manuscript  ||| S:37016 E:37035 ||| JJ
preparation ||| S:37035 E:37046 ||| NN
.  ||| S:37046 E:37048 ||| .
All  ||| S:37048 E:37052 ||| DT
authors  ||| S:37052 E:37060 ||| NNS
read  ||| S:37060 E:37065 ||| VBP
and  ||| S:37065 E:37069 ||| CC
approved  ||| S:37069 E:37078 ||| VBD
the  ||| S:37078 E:37082 ||| DT
final  ||| S:37082 E:37096 ||| JJ
manuscript ||| S:37096 E:37106 ||| NN
.  ||| S:37106 E:37123 ||| .
